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Diabetes is a global health problem. The consumption of dietary polyphenols may help 
to decrease the risk of type 2 diabetes and slow the progression of diabetic complications. 
Aronia (Aronia melanocarpa) and elderberry (Sambucus nigra L. ssp. canadensis) fruits are rich 
in polyphenols and exhibit health-promoting properties, but they are underutilized. Aronia and 
elderberries are rarely consumed raw due to the astringent mouth feel. New food products are 
needed to increase their consumption. Kefir, a fermented dairy beverage, was chosen to be the 
matrix for incorporating berries due to: 1) the protein matrix can help mask the astringency; 2) 
an acidic environment is beneficial for the stability of phenolic compounds; 3) fermentative 
microorganisms may be able to increase the bioavailability of polyphenols. 
The first objective of this research was to develop new palatable products using 
underutilized berries and different sweeteners (sucrose, stevia and monk fruit extracts). 
Sensory evaluations were conducted to assess consumer acceptability of berry-containing 
 
 
kefirs. The results showed that aronia and elderberry kefirs sweetened with stevia or sucrose 
were all accepted by consumers where sucrose was the best-accepted sweetener. The second 
objective was to assess the health-promoting characteristics of the berry-containing kefirs. 
Aronia kefirs contained high levels of total phenolics and anthocyanins. Elderberry kefirs were 
moderate in total phenolics. All kefirs exhibited antioxidant capacity. The third objective was to 
evaluate the diabetes-beneficial properties of aronia kefir using an in-vitro digestion model. The 
impacts of fermentation on aronia polyphenols were also assessed. The results showed that the 
levels of bioaccessible polyphenols were elevated during digestion and the antioxidant capacity 
increased. Fermentation enhanced the inhibitory activity of aronia kefir on α-glucosidase but 
did not alter its weak inhibition on pancreatic α-amylase. Specific inhibition of α-glucosidase 
may decrease the absorption of carbohydrates and contribute to blood glucose control without 
side effects compared to pharmaceutical agents, such as acarbose. 
In conclusion, new berry-containing kefirs were well-accepted by the consumers and the 
consumption of berry-containing kefirs may help to reduce oxidative stress and aid in blood 
glucose control. In addition, fermentation may be a good strategy to increase the bioavailability 
of dietary polyphenols.  
 
iii 
 
DEDICATION 
 I would like to dedicate this dissertation to my grandmother, Xiuying Gao, who had 
always been there for me when I lose faith, and told me “don’t give up, the best is yet to 
come”.  
 I also want to dedicate this dissertation to my parents, Jige Du and Li Xue, for their 
support and for believing in me. To Yusen Zhai, my fiancé, who was tolerant of my bad temper 
and encouraged me when I doubted myself.  
iv 
 
ACKNOWLEDGEMENTS 
 First, I would like to express my sincere gratitude to my major advisor, Dr. Angela D. 
Myracle for her patient guidance, instructive suggestions and constant support of my Ph.D. 
study. Her massive knowledge and kindness helps me to be a better researcher and a better 
person. In addition, I would like to acknowledge all my committee members, Dr. Beth Calder for 
her valuable suggestions about kefir production, Dr. Harold B. Dowse for his treasurable advice 
on the organization of my manuscript, Dr. L. Brian Perkins, whose help is essential for my work 
with UPLC; Dr.Jennifer J. Perry, her expertise is irreplaceable for me when I need to do any 
microorganisms-related work.  
 I would also like to thank Katherine Davis-Dentici, Bouhee Kang, Zakkary Castonguay, 
Amber Elwell, for their help during sensory tests; to Dr. Rebecca Van Beneden, Dr. Jason Bolton 
and Dr. Mary Ellen Camire for their help during my PhD study. I am grateful for all the guidance 
and support I received from my advisors, for all the tears and laughs I shared with friends, for 
everything that happened at the University of Maine.  
 
 
 
 
 
 
v 
 
TABLE OF CONTENTS 
DEDICATION ................................................................................................................................... iii 
ACKNOWLEDGEMENTS ................................................................................................................. iv 
LIST OF TABLES .............................................................................................................................. xi 
LIST OF FIGURES ........................................................................................................................... xii 
LIST OF ABBREVIATIONS .............................................................................................................. xiv 
CHAPTER 1 LITERATURE REVIEW ................................................................................................... 1 
1.1 Oxidative Stress and Type 2 Diabetes ................................................................................... 1 
1.1.1 Oxidative Stress .............................................................................................................. 2 
1.1.2 Oxidative Stress and Chronic Inflammation ................................................................... 3 
1.1.3 Diabetes Mellitus ............................................................................................................ 4 
1.1.3.1 Introduction to Diabetes Mellitus ............................................................................ 4 
1.1.3.2 Diabetic Complications ............................................................................................ 5 
1.1.4 Vicious Cycle between Type 2 Diabetes and Oxidative Stress ....................................... 7 
1.1.5 Oxidative Stress and Diabetic Complications ................................................................. 9 
1.1.5.1 Oxidative Stress and Diabetic Microvascular Complications ................................... 9 
1.1.5.2 Oxidative Stress and Diabetic Macrovascular Complications .................................. 9 
1.1.6 Dietary Strategies to Decrease Oxidative Stress .......................................................... 10 
1.2 Polyphenols ......................................................................................................................... 11 
1.2.1 Introduction .................................................................................................................. 11 
1.2.1.1 Anthocyanins ......................................................................................................... 13 
1.2.1.2 Proanthocyanins .................................................................................................... 15 
1.2.1.3 Phenolic Acids ........................................................................................................ 16 
vi 
 
1.2.2 Potential Health-Promoting Characteristics of Polyphenols ........................................ 16 
1.2.2.1 Polyphenols and Oxidative Stress .......................................................................... 16 
1.2.2.2 Polyphenols and Chronic Inflammation ................................................................ 17 
1.2.2.3 Polyphenols and Type 2 Diabetes .......................................................................... 18 
1.2.2.3.1 Polyphenols and insulin sensitivity .............................................................................. 19 
1.2.2.3.2 Polyphenols and insulin-independent blood glucose control. .................................... 19 
1.2.2.1.3 Polyphenols and AGE production ................................................................................ 20 
1.3 Bioavailability of Phenolic Compounds ............................................................................... 21 
1.3.1 Bioavailability of Proanthocyanins ............................................................................... 21 
1.3.2 Bioavailability of Anthocyanins .................................................................................... 23 
1.3.3 Bioavailability of Phenolic Acids ................................................................................... 24 
1.3.4 Factors Affecting the Bioavailability of Phenolic Compounds ..................................... 25 
1.3.5 Potential Methods to Improve Bioavailability of Phenolic Compounds ...................... 26 
1.3.5.1 Thermal Processing ................................................................................................ 26 
1.3.5.2 Fermentation ......................................................................................................... 27 
1.4 Aronia Berries ...................................................................................................................... 28 
1.4.1 Botany and Current Commercial Utilization of Aronia Berries .................................... 28 
1.4.2 Nutritional Value and Bioactive Compounds of Aronia Berries ................................... 29 
1.4.3 Health-promoting Characteristics of Aronia Berries .................................................... 31 
1.4.3.1 Antioxidant Capacity of Aronia Berries .................................................................. 31 
1.4.3.2 Anti-inflammatory Activity of Aronia Berries ........................................................ 32 
 
vii 
 
1.4.3.3 Aronia and Diabetes............................................................................................... 34 
1.4.3.4 Aronia and Other Health Problems ....................................................................... 36 
1.4.4 Challenge of Incorporating Aronia Berries in Diet ....................................................... 37 
1.5 Elderberries ......................................................................................................................... 38 
1.5.1 Botany and Current Commercial Utilization of Elderberries ........................................ 38 
1.5.2. Nutritional Value and Bioactive Compounds of Elderberries ..................................... 39 
1.5.3 Health Promoting Characteristics of Elderberries ........................................................ 41 
1.5.3.1 Antioxidant Capacity of Elderberries ..................................................................... 41 
1.5.3.2 Anti-inflammatory Activity of Elderberries ............................................................ 42 
1.6 Kefir ..................................................................................................................................... 44 
1.6.1 History and Production of Kefir .................................................................................... 44 
1.6.2 Nutritional Value of Kefir .............................................................................................. 46 
1.6.3 Health Promoting Characteristics of Kefir .................................................................... 47 
1.6.3.1 Anti-inflammatory Activity of Kefir ........................................................................ 47 
1.6.3.2 Kefir Benefits for Diabetes ..................................................................................... 48 
1.7 Conclusions .......................................................................................................................... 49 
CHAPTER 2 DEVELOPMENT AND EVALUATION OF KEFIR PRODUCTS MADE WITH               
ARONIA OR ELDERBERRY JUICE: SENSORY AND PHYTOCHEMICAL                   
CHARACTERISTICS ................................................................................................................ 52 
2.1 Chapter Abstract ................................................................................................................. 52 
2.2 Introduction ......................................................................................................................... 53 
 
viii 
 
2.3 Material and Methods......................................................................................................... 55 
2.3.1 Chemicals ...................................................................................................................... 55 
2.3.2 Dietary Material ............................................................................................................ 55 
2.3.3 Kefir Manufacture and Formulas.................................................................................. 56 
2.3.4 Sensory Analyses .......................................................................................................... 58 
2.3.5 pH, Titratable Acidity, Total Soluble Solids and Color Measurements ........................ 58 
2.3.6 Extraction ...................................................................................................................... 59 
2.3.7 Total Phenolic Content ................................................................................................. 60 
2.3.8 Total Monomeric Anthocyanin Content ....................................................................... 60 
2.3.9 Antioxidant Capacity ..................................................................................................... 61 
2.3.10 Statistical Analysis ...................................................................................................... 61 
2.4 Results and Discussion ........................................................................................................ 62 
2.4.1 Aronia Kefir Evaluations ............................................................................................... 62 
2.4.1.1 Aronia Kefir Sensory Test ....................................................................................... 62 
2.4.1.2 Aronia Kefir Quality Parameters ............................................................................ 64 
2.4.1.3 Aronia Kefir Phytochemical Analyses .................................................................... 66 
2.4.2 Elderberry Kefir Evaluations (Commercial Juice) ......................................................... 68 
2.4.2.1 Elderberry Kefir Sensory Test ................................................................................ 68 
2.4.2.2 Elderberry Kefir Quality Parameters (Commercial Juice) ...................................... 71 
2.4.2.3 Elderberry Kefir Phytochemical Analyses (Commercial Juice) .............................. 71 
2.4.3 Elderberry Kefir Evaluation (Fresh Juice)...................................................................... 72 
2.5 Conclusion ........................................................................................................................... 74 
ix 
 
CHAPTER 3 FERMENTATION ALTERS THE BIOACCESSIBLE PHENOLIC COMPOUNDS                  
AND INCREASES THE ALPHA-GLUCOSIDASE INHIBITORY EFFECTS OF ARONIA                   
JUICE IN A DAIRY MATRIX FOLLOWING IN-VITRO DIGESTION ............................................ 75 
3.1 Chapter Abstract ................................................................................................................. 75 
3.2 Introduction ......................................................................................................................... 76 
3.3 Materials and Methods ....................................................................................................... 79 
3.3.1 Chemicals ...................................................................................................................... 79 
3.3.2 Food Material ............................................................................................................... 79 
3.3.3 Sample Preparation ...................................................................................................... 80 
3.3.4 in-vitro Digestion Procedure ......................................................................................... 81 
3.3.5 UPLC Analysis of Phenolic Compounds ........................................................................ 84 
3.3.6 DPPH Free Radical Scavenging Assay ........................................................................... 85 
3.3.7 Rat Intestinal α-glucosidase Inhibitory Activities ......................................................... 85 
3.3.8 Porcine Pancreatic α-amylase Inhibitory Activities ...................................................... 86 
3.3.9 Statistical Analysis ........................................................................................................ 87 
3.4 Results ................................................................................................................................. 88 
3.4.1 Quantification of Bioaccessible Phenolic Compounds ................................................. 88 
3.4.2 Antioxidant Capacity ..................................................................................................... 91 
3.4.3 Inhibitory Activity of Carbohydrate-hydrolyzing Enzymes ........................................... 92 
3.5 Discussion ............................................................................................................................ 93 
3.6 Conclusion ........................................................................................................................... 99 
 
x 
 
CHAPTER 4 OVERALL CONCLUSIONS AND FUTURE DIRECTIONS .............................................. 100 
4.1 Study Conclusions ............................................................................................................. 100 
4.2 Study Limitations ............................................................................................................... 104 
4.3 Future Directions ............................................................................................................... 104 
4.3.1 Impacts of Kefir Culture on Proanthocyanins ............................................................ 104 
4.3.2 Identification of the Metabolites in Aronia Kefir after Digestion .............................. 105 
4.3.3 Evaluation of Berry-incorporated Kefir with in-vivo Studies ...................................... 105 
BIBLIOGRAPHY ........................................................................................................................... 107 
APPENDIX A: EFFECTS OF SWEETENERS ON THE LEVELS OF PHENOLIC COMPOUNDS               
AND ANTIOXIDANT CAPACITY OF ARONIA AND ELDERBERRY KEFIRS DURING           
STORAGE ............................................................................................................................ 140 
APPENDIX B: APPLICATION FOR APPROVAL OF RESEARCH WITH HUMAN SUBJECTS .............. 167 
APPENDIX C: ELDERBERRY KEFIR TASTING RECRUITMENT NOTICE .......................................... 173 
APPENDIX D: ARONIA KEFIR TASTING RECRUITMENT NOTICE ................................................. 174 
APPENDIX E: ELDERBERRY KEFIR INFORMED CONSENT FORM ................................................. 175 
APPENDIX F: ARONIA KEFIR INFORMED CONSENT FORM ........................................................ 177 
APPENDIX G: SENSORY EVALUATION QUESTIONNAIRE OF ELDERBERRY KEFIR ....................... 179 
APPENDIX H: SENSORY EVALUATION QUESTIONNAIRE OF ARONIA KEFIR ............................... 183 
BIOGRAPHY OF THE AUTHOR .................................................................................................... 187 
 
  
xi 
 
LIST OF TABLES  
Table 1.1 Health-promoting characteristics of phenolic compounds, aronia berry,         
elderberry and kefir ............................................................................................................. 51 
Table 2.1 Formulas of kefir products for sensory evaluation ..................................................... 57 
Table 2.2 Quality evaluation of juices, aronia kefir, elderberry kefir made with            
commercial juice, and elderberry kefir made with fresh juice ............................................ 65 
Table 2.3 Phytochemical evaluation results of juices, aronia kefir, elderberry kefir                 
made with commercial juice and elderberry kefir made with fresh juice .......................... 67 
Table 3.1 The composition of digestive juices ............................................................................ 83 
Table 3.2 Quantification of individual phenolic compounds (mg/part) ...................................... 89 
Table 4.1 Key findings of this study ........................................................................................... 103 
Table A.1 Aronia kefir formulas sweetened with sucrose ........................................................ 144 
Table A.2 Aronia kefir formulas sweetened with different sweeteners ................................... 145 
Table A.3 Elderberry kefir formulas sweetened with different sweeteners ............................. 145 
 
 
 
 
 
xii 
 
LIST OF FIGURES 
Figure 1.1 Structure of polyphenols ............................................................................................ 12 
Figure 1.2 Structures of most common anthocyanidins ............................................................. 14 
Figure 1.3 Molecular structure of anthocyanins in different environmental pH levels.............. 15 
Figure 1.4 Brief flowchart of traditional kefir production ........................................................... 45 
Figure 2.1. Consumer acceptability of aronia kefir made with different sweeteners ................ 64 
Figure 2.2 Consumer acceptability of elderberry kefir made with different Sweeteners .......... 70 
Figure 3.1 Quantification of total anthocyanins during in-vitro digestion .................................. 90 
Figure 3.2 Antioxidant capacity of kefir during in-vitro digestion ............................................... 91 
Figure 3.3 α-glucosidase inhibitory activity ................................................................................. 92 
Figure 3.4 Pancreatic α-amylase inhibitory activity .................................................................... 93 
Figure A.1 Total phenolic compound levels of aronia kefir sweetened with different 
concentrations of sucrose .................................................................................................. 149 
Figure A.2 Total monomeric anthocyanin levels in aronia kefir sweetened with                 
different concentrations of sucrose .................................................................................. 150 
Figure A.3 DPPH IC50 values of aronia kefir sweetened with different concentrations                   
of sucrose ........................................................................................................................... 151 
Figure A.4 Total phenolic compound levels of aronia kefir sweetened with sucrose,              
stevia extract and monk fruit extracts ............................................................................... 152 
Figure A.5 Total monomeric anthocyanin levels of aronia kefir sweetened with                
sucrose, stevia extract and monk fruit extracts ................................................................ 154 
xiii 
 
Figure A.6 DPPH IC50 means of aronia kefir sweetened with sucrose, stevia extract                   
and monk fruit extracts...................................................................................................... 155 
Figure A.7 Total phenolic compound levels of elderberry kefir sweetened with                   
sucrose, stevia extract and monk fruit extracts ................................................................ 157 
Figure A.8 Total monomeric anthocyanin content of elderberry kefir sweetened                      
with sucrose, stevia extract and monk fruit extracts ........................................................ 159 
Figure A.9 DPPH IC50 means of elderberry kefir sweetened with sucrose, stevia                    
extract and monk fruit extracts ......................................................................................... 160 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
LIST OF ABBREVIATIONS 
AGE: Advanced glycation end product 
Abs: Absorbance 
CAT: Catalase 
C3G: Cyanidin-3-glucoside 
CBG: Cytosolic β-glucosidase 
CDC: Centers for Disease Control and Prevention 
COX: Cyclooxygenase 
CVD: Cardiovascular disease 
DM: Diabetes Mellitus 
DPP IV: Dipeptidyl peptidase 
DPPH: 2,2-diphenyl-1-picrylhydrazyl 
DR: Diabetic Retinopathy 
ETC: Electron-Transport Chain 
FRAP: Ferric reducing antioxidant power 
GAE: Gallic acid equivalent 
GAPDH: Glyceraldehyde-3 phosphate dehydrogenase 
xv 
 
GFAT: Glutamine fructose-6 phosphate amidotransferase 
GIT: Gastrointestinal tract 
GPx: Glutathione Peroxidase 
GSH: Glutathione 
HbA1C: Hemoglobin A1C 
IL: Interleukin 
LDL: Low-density lipoprotein 
LPH: Lactate phlorizin hydrolase 
LPS: Lipopolysaccharide 
MCT: Monocarboxylic acids transporter 
NADPH: Nicotinamide adenine dinucleotide phosphate 
NO: Nitric Oxide 
PG: Prostaglandin  
PKC: Protein kinase C 
RNS: Reactive Nitrogen Species 
ROS: Reactive Oxygen Species 
SGLT: Sodium-dependent glucose transporter 
xvi 
 
SOD: Superoxide Dismutase 
STD: Streptozotocin 
T1DM: Type 1 Diabetes Mellitus 
T2DM: Type 2 Diabetes Mellitus 
TA: Titratable acidity 
TBARS: Thiobarbituric acid-reactive substances 
TMA: Total monomeric anthocyanins 
TNF-α: Tumor Necrosis Factor-α 
TP: Total phenolics 
TPA: 12-o-tetradecanoylphorbol-13-acetate 
 
 
 
 
 
1 
 
CHAPTER 1 
LITERATURE REVIEW 
The prevalence of diabetes has grown rapidly. In 2015, 9.4% of the United States 
population had diabetes [1]. Epidemiological studies demonstrate that the consumption of 
bioactive compounds from various fruits and vegetables may help to decrease the risk of 
chronic diseases, including diabetes [2, 3]. In addition, bioactive compounds obtained from the 
diet have been shown to be beneficial to prevent and delay secondary diabetic complications 
[4]. Aronia berries and elderberries are rich in bioactive compounds, but they lack palatability 
and are rarely consumed raw. New food products using aronia and elderberries were 
developed in this research. The hypotheses of this research were: 1) sucrose-sweetened berry 
kefirs will be better accepted by consumers compared to products sweetened with non-
nutritive sweeteners; and 2) fermentation will improve the bioavailability of dietary 
polyphenols. In this literature review, the mechanism of diabetes, the health-promoting 
properties and the bioavailability of polyphenols will be introduced. In addition, current studies 
focusing on the health-beneficial properties of aronia berries, elderberry and kefir will be 
discussed in detail.  
1.1 Oxidative Stress and Type 2 Diabetes 
Oxidative stress is an underlying mechanism for the development and progression of 
type 2 Diabetes Mellitus (T2DM). In individuals with T2DM, hyperglycemia can increase the 
production of reactive oxygen/nitrogen species, which elevates cellular oxidative stress [4]. 
Strategies that decrease oxidative stress may help to decrease the risk of T2DM and its 
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secondary complications. The occurrence of oxidative stress and its relationship with T2DM will 
be explained in this section. 
1.1.1 Oxidative Stress 
Under aerobic conditions, oxygen participates in the energy production process in living 
organisms [5]. In eukaryotes, more than 90% of consumed oxygen is converted to water by 
cytochrome oxidase located in electron-transport chain (ETC) in mitochondria. Less than 10% of 
consumed oxygen is reduced to reactive oxygen species (ROS) [6]. ROS include hydrogen 
peroxide (H2O2), hydroxyl radicals (·OH), and superoxide radical (O2·-). ROS are important 
molecules involved in the normal metabolism of cells. They can directly interact with signaling 
molecules and participate in pathways that are critical to cell survival and proliferation [7, 8]. In 
addition to mitochondria, plasma membranes, endoplasmic reticulum and lysosomes also 
generate ROS [9]. Cells have an antioxidant defense system to scavenge ROS and maintain 
redox homeostasis. Antioxidant enzymes, such as superoxide dismutase (SOD), glutathione 
peroxidase (GPx) and catalase (CAT), are vital players in the free radical detoxifying process 
[10]. SOD can neutralize superoxide to less toxic hydrogen peroxide. Hydrogen peroxide can be 
converted to water and hydrogen by CAT and/or GPx [11]. Under normal conditions, the 
capacity of the antioxidant defense system is adequate to neutralize the ROS and no oxidative 
damage occurs to cells and tissues. 
Oxidative stress is defined as an imbalance between the production of ROS and the 
elimination capacity of the antioxidant defense system where oxidative damages may occur to 
cellular proteins, lipids and DNA [12, 13]. Oxidative stress is associated with the overproduction 
of ROS and/or a decline in the antioxidant defense system. Oxidative stress can be triggered by 
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an unhealthy diet, such as high-fat and high-sugar diets. In addition, sedentary lifestyle and 
abnormal metabolic conditions including hyperglycemia and hyperlipidemia can aggravate 
oxidative stress [14]. Under oxidative stress conditions, excessive ROS can react with nitric 
oxide (NO) and form reactive nitrogen species (RNS), including peroxynitrite (ONOO-) and 
nitrogen dioxide (NO2) [15]. RNS is another group of free radicals that can result in oxidative 
damages to cells. Excessive ROS/RNS can modify the structure of proteins and lipids, and impair 
their function [15]. Elevated ROS/RNS may lead to damages to the mitochondrial membrane 
and DNA, which can result in apoptosis [16]. Oxidative stress can intensify metabolic disorders 
and increase the risk of several diseases, such as cardiovascular disease, neurodegenerative 
diseases and diabetes mellitus. Additionally, oxidative stress can accelerate the development 
and progression of secondary complications of chronic diseases. 
1.1.2 Oxidative Stress and Chronic Inflammation  
Inflammation is part of the body’s defense system against threats, such as infection and 
injury  [17]. There are two stages of inflammation: acute and chronic [18]. Acute inflammation 
only persists for a short duration and benefits the host. If acute inflammation cannot eliminate 
these threats, the inflammatory response will continue and chronic inflammation will be 
developed [19]. Chronic inflammation is closely interrelated with oxidative stress [20]. ROS can 
activate pro-inflammatory pathways, such as NF-ƙB and elevate the production of pro-
inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) [19]. 
Under chronic inflammatory conditions, the phagocytic cells can generate ROS/RNS and induce 
oxidative damage to tissues. In addition, the pro-inflammatory cytokines can also trigger the 
generation of ROS/RNS in non-phagocytic cells [21]. Thus, a vicious cycle between chronic 
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inflammation and oxidative stress is formed. In addition to oxidative stress, chronic 
inflammation is one of the underlying mechanism of the initiation and progression of chronic 
diseases [22]. 
1.1.3 Diabetes Mellitus 
1.1.3.1 Introduction to Diabetes Mellitus 
Diabetes Mellitus (DM) is a chronic metabolic disease that is characterized by high blood 
glucose levels (fasting blood glucose level ≥7 mmol/L) [23], which is associated with insulin 
deficiency and/or insulin resistance [24]. There are two major types of diabetes: type 1 diabetes 
mellitus (T1DM) and type 2 diabetes mellitus (T2DM). T1DM is also known as insulin-dependent 
diabetes and accounts for about 10% of diabetic cases [24]. T1DM is caused by the autoimmune 
destruction of β cells in the pancreatic islets. T1DM can be genetically linked and/or influenced 
by environmental factors [25]. T1DM typically develops in children and teenagers younger than 
19 years old [26]. The destruction of β cells leads to diminished insulin production and 
eventually no production at all.  For type 1 diabetic patients, lifelong exogenous insulin 
administration is necessary to control blood glucose [27]. T2DM is the more predominant type 
which accounts for approximately 90% of all diabetic cases [24]. T2DM is characterized by an 
impairment of insulin secretion and/or a decline in insulin sensitivity [28]. The onset of T2DM is 
strongly influenced by environmental factors, such as unhealthy eating habits, a sedentary 
lifestyle and obesity [29]. Healthy eating habits, regular exercise and pharmaceutical 
medication such as acarbose are used to assist blood glucose control in T2DM patients. 
Exogenous insulin administration may not be involved at the early stage but may be necessary 
when T2DM progresses over time [30]. 
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From a global perspective in 2016, 422 million people were reported to have diabetes 
[31]. The United States Centers for Disease Control and Prevention (CDC) reported that 30.3 
million (9.4%) of the United States population had diabetes in 2015 including 1.5 million newly 
diagnosed patients [1]. Diabetic patients need strict control of their blood glucose levels, 
otherwise complications may occur and deteriorate the individual's quality of life [32]. In the 
United States, the expense of diabetic health care is the highest among 155 disease conditions 
and health-related problems, including ischemic heart disease and cancer [33]. The annual 
expense of diabetic health care in 2013 was $101.4 billion where 57.6% was spent on 
medication and 23.5% was spent on ambulatory care. From 1996 to 2013, the prevalence of 
diabetes in the United States increased from 3.0% to 6.5% and the diabetic health care cost 
increased $64.4 billion in this time period [31, 33].  
1.1.3.2 Diabetic Complications 
Individuals with diabetes may suffer chronic or acute complications. Acute diabetic 
complications include ketoacidosis in individuals with T1DM and coma due to hypoglycemia 
[11]. Chronic diabetic complications are associated with damage to vascular endothelial cells 
caused by hyperglycemia. Vascular endothelial cells are susceptible to hyperglycemia due to 
lack of ability to down-regulate glucose uptake while extracellular glucose levels are elevated. 
[34]. Chronic diabetic complications are grouped into either microvascular (retinopathy, 
neuropathy and nephropathy) or macrovascular complications (diabetic cardiovascular 
diseases).  
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Diabetic retinopathy (DR) is diagnosed by the lesions in the retinal vascular system. The 
development of DR is associated with increased vascular permeability. This is caused by 
hyperglycemia via damage to the blood-retinal barrier, inducing edema and loss of pericytes 
[35, 36]. DR is the leading cause of vision loss worldwide among middle-aged and elderly people 
[37] and the vision loss is irreversible. The prevalence of diabetic retinopathy is estimated to 
reach 247.3 million by 2030 [38]. Almost all T1DM patients will develop retinopathy after 
twenty years of being diagnosed with diabetes [37]. More than 80% of insulin-treated and 50% 
of non-insulin-treated T2DM patients will develop some degree of retinopathy after having 
diabetes for two decades. Early detection and tight blood glucose control are beneficial to delay 
the progression of diabetic retinopathy [39].  
Diabetic neuropathy is associated with progressive degeneration of the nerve fibers or 
whole nerve cells.  Glucose toxicity is the primary cause of the nerve damage [40]. Patients with 
neuropathy have impaired sensation in the limbs, suffer extreme pain or may be asymptomatic 
[40]. The risk of peripheral neuropathy of diabetes increases along with the duration of 
diabetes and it is estimated that more than half of diabetic patients develop neuropathy to 
some extent [41]. For most cases, diabetic peripheral neuropathy is not reversible [40, 42].  
Patients with nephropathy are characterized with morphological and ultrastructural 
changes in the kidney, such as the accumulation of extracellular matrix proteins, glomerular 
basement membrane thickening, podocyte injury, mesangial matrix expansion and 
tubulointerstitial damage [43-45]. Genetic predisposition and environmental factors, such as 
smoking and a sedentary lifestyle, contribute to the development of nephropathy [46, 47]. 
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More than one-third of diabetic patients have hyperglycemia-induced renal changes [48]. 
Kidney transplant or dialysis may be necessary when nephropathy progresses to maintain the 
patient’s life [43]. 
Cardiovascular disease (CVD) is a common macrovascular complication of diabetes 
mellitus, including accelerated atherosclerosis, cardiomyopathy, and stroke [49]. CVD is the 
leading cause of mortality in diabetes where 80% of deaths are caused by myocardial infarction 
and stroke [24, 50]. Diabetic patients have an estimated three to ten-fold higher risk of 
developing cardiovascular diseases compared to the non-diabetic population [51]. Even with 
adequate glycemic control, diabetic patients can still develop diabetic cardiovascular diseases 
[52]. This phenomenon indicates that hyperglycemia is not the only factor in the development 
of diabetic cardiovascular diseases. Other factors, such as excessive ROS, may be more relevant 
[49]. A healthy lifestyle, such as healthy eating habits, frequent exercise and smoking cessation, 
is a necessary component to delay the development and progression of diabetic cardiovascular 
diseases [53, 54].  
1.1.4 Vicious Cycle between Type 2 Diabetes and Oxidative Stress 
 Elevated oxidative stress is common in T2DM. High serum glucose levels can enhance 
ROS/RNS production in the mitochondrial ETC [55]. High glucose level can partially block the 
electron transportation in complex III, which is a multisubunit transmembrane protein that 
plays a critical role in ETC, via increasing the hyperpolarization of the inner mitochondrial 
membrane potential. The inhibited electron transportation leads to excessive electrons which 
are accumulated to coenzyme Q and eventually result in the incomplete reduction of O2 and 
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form superoxide [5]. Increased superoxide production contributes to glucose-induced damages 
to cells by inhibiting glyceraldehyde-3 phosphate dehydrogenase (GAPDH). Hyperglycemia 
activates the following pathways: the polyol pathway, the protein kinase C (PKC) pathway, the 
hexosamine pathway and the advanced glycation end product (AGE) pathway [56]. The 
activation of these pathways will contribute to oxidative stress. In the polyol pathway, an 
increased amount of glucose triggers aldose reductase to convert glucose to poly-alcohol. 
Nicotinamide adenine dinucleotide phosphate (NADPH) is consumed in this process. The 
decreased NADPH leads to a reduced regeneration of glutathione (GSH), which is a ROS 
scavenger, and eventually increases the ROS level [5]. Endothelial hyperglycemia activates the 
PKC pathway by increasing diacylglycerol synthesis. The activated PKC pathway results in the 
activation of NADPH oxidase and generates more ROS [5]. In the hexosamine pathway, 
fructose-6-phosphate is converted to uridine di-phosphate by glutamine fructose-6 phosphate 
amidotransferase (GFAT). Hyperglycemia can increase hexosamine pathway flux and lead to 
elevated GFAT activity. Increased GFAT activity causes more modification of proteins, including 
the modified transcription factor SP1, transforming growth factor β1 and plasminogen activator 
inhibitor-1, which are harmful to blood vessels [5, 56]. AGEs are formed by non-enzymatic 
reactions between extracellular proteins and glucose. In a hyperglycemic condition, the 
inhibition of GAPDH leads to an increased production of the AGE precursor – methylglyoxal that 
is formed from glyceraldehyde-3 phosphate [56]. The increased AGE levels can bind their 
receptors and activate NADPH oxidase. The activation of NADPH oxidase favors the production 
of ROS [5]. In summary, hyperglycemia can contribute to oxidative stress in diabetic patients. 
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Oxidative stress can aggravate the dysfunction of β-cells and insulin resistance which can then 
accelerate the progression of type 2 diabetes. 
1.1.5 Oxidative Stress and Diabetic Complications 
1.1.5.1 Oxidative Stress and Diabetic Microvascular Complications 
Under oxidative stress conditions, the excessive activation of PKC pathways can cause 
and accelerate diabetic complications by inducing blood-flow abnormalities & capillary 
occlusions and increasing vascular permeability [57]. In addition, oxidative stress can increase 
the production of AGE [58]. The intracellular accumulated AGE levels may alter cytoplasmic and 
nuclear factors, such as the alteration of gene transcription [58, 59]. In addition, the AGE can 
cross-link with structural proteins, such as collagen, and result in microvascular structural and 
functional changes. These changes include membrane thickening with reduced elasticity and 
sensitivity to protein clearance [36, 58]. Another mechanism behind increased AGE levels the 
diabetic microvascular complications is the interaction between AGE and their receptors which 
are located on the plasma membrane. This interaction can alter intracellular signaling, gene 
expression, release pro-inflammatory cytokines and free radicals, which can, in turn, increase 
the production of AGEs and result in a vicious cycle [58].  
1.1.5.2 Oxidative Stress and Diabetic Macrovascular Complications 
The development and progression of diabetic cardiovascular disease is associated with 
chronic inflammation which is linked to oxidative stress. Excessive free radicals in the system 
can increase the oxidation of low-density lipoprotein (LDL). The oxidized LDL will increase 
vascular inflammation via augmentation of the intimal macrophage infiltration and the 
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formation of foam-cells [60]. The reaction between AGE and AGE receptors also contributes to 
vascular inflammation by activating nuclear factor (NF)-κB signaling [58]. Chronic vascular 
inflammation contributes to the atherogenesis and the formation of arterial thrombus [61]. In 
addition, ROS can damage contractile function[60]  and induce cardiomyocyte apoptosis [62, 
63]. Thus, the development and progression of diabetic macrovascular complications can be 
accelerated by low-grade inflammation and the action of ROS. 
1.1.6 Dietary Strategies to Decrease Oxidative Stress  
Nutrition plays an important role in the status of redox homeostasis. It is reported that 
diets containing high-sugar and high-fat content can cause oxidative stress [64]. Thus, these 
unhealthy diets can increase the risk of metabolic syndrome and chronic diseases. A decreased 
consumption of fat and sugar may reduce the production of ROS. The consumption of dietary 
antioxidants has been suggested as an effective strategy to decrease oxidative stress due to 
their capacity to eliminate ROS and/or boost the antioxidant defense system. Dietary 
antioxidants, include but are not limited to polyphenols, antioxidant vitamins (such as vitamin C 
and E), carotenoids and oil lecithin [65]. Some minerals, such as selenium and zinc, are also 
considered dietary antioxidants due to their essential roles as cofactors of endogenous 
antioxidant enzymes. The next section will focus on polyphenols and their impacts on T2DM.  
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1.2 Polyphenols 
1.2.1 Introduction  
Polyphenols are secondary, plant-based metabolites that are directly involved in the 
defense system of the plant to overcome abiotic stress [66, 67]. They are the largest group of 
phytochemicals [68]. Polyphenols are categorized by the number of aromatic rings and the 
basic structural elements that bind to the rings. Polyphenols are generally classified into two 
groups: non-flavonoids and flavonoids. Non-flavonoids are sub-classified as phenolic acids, 
lignans and stilbenes [68, 69]. Phenolic acids include hydroxyderivatives of benzoic acid and 
cinnamic acid and their esters. Stilbenes, such as resveratrol, have a double bond between the 
phenolic rings. Lignans are characterized by 2-phenylpropane units  [70]. Flavonoids consist of 
more than 6000 phenolic compounds and account for 60% of total dietary polyphenols [70, 71]. 
Flavonoids are further sub-categorized as flavones, flavonols, isoflavones, anthocyanins, 
flavanols, tannins and flavanones [72]. The chemical structures of some polyphenols are shown 
in Figure 1.1.  
Polyphenols are found in fruits, vegetables and cereal grains [72]. Berries, citrus fruits 
and broccoli are naturally rich in polyphenols. The amount of polyphenols in plants is affected 
by environmental factors, such as sun exposure and rainfall [68]. Polyphenol levels in plants 
may increase due to a response to stressful environmental conditions [66]. In addition, the 
degree of ripeness influences the amount of polyphenols in a fruit. During ripening, the 
phenolic acid content in the fruit decreases while the anthocyanin content usually increases 
[66]. The phenolic compound levels of fruits and vegetables may decrease during processing or 
storage [73]. The stability of individual phenolic compounds is related to structure. For instance, 
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catechin and ellagic acid are susceptible to heat due to its highly hydroxylated structure [73]. 
Cyanidins and delphinidins are less stable than pelargonidins during storage due to catechol 
groups [74]. 
 
                  
 
 
                              
Figure 1.1 Structure of polyphenols 
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 Polyphenols, especially flavanol polymers, are associated with bitter flavors and an 
astringent sensation [75, 76]. Astringency is defined as a puckering, rough and/or dry-mouth 
feel [75]. Bitter and astringency are generally considered as unappealing sensory properties to 
consumers. The plant-based foods that are rich in polyphenols, especially those that are rich in 
flavanols, may lack palatability due to astringency [76]. Sweeteners, like sucrose, are used to 
minimize bitterness and astringency in polyphenol-rich beverages, but beverages with added 
sugar may be less attractive to health-conscious consumers [77].  In order to better capitalize 
on the potential health benefits offered by polyphenols, effective strategies are needed to 
mask the less pleasant flavor and sensation. 
1.2.1.1 Anthocyanins 
Anthocyanins are a subclass of flavonoids that belong to the polyphenol group. They act 
as pollinator attractants and phytoprotective agents. Anthocyanins occur in all parts of plant: 
the leaves, stems, roots, flowers and fruits  [78]. Anthocyanins are odorless and almost 
flavorless, but as other phenolic compounds, they contribute to the astringent.  Structurally, 
anthocyanins have two benzene rings (A and B rings) and a heterocyclic ring (C ring). Most 
anthocyanins are derived from six common aglycones (anthocyanidins): malvidin, petunidin, 
delphinidin, peonidin, pelargonidin and cyanidin [79]. The structure of these aglycones is shown 
in Figure 1.2. In plants, anthocyanins are commonly found in the form of glycosides. A sugar 
moiety normally bonds to form the aglycone at position 3 of the C ring [79]. Sugar moieties that 
are frequently linked to anthocyanidins are glucose, galactose, arabinose and rutinose [79]. 
Anthocyanins are strong antioxidants. The antioxidant capacity of anthocyanins depends on 
their structure [80]. The ability of anthocyanins to neutralize free radicals depends on the 
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delocalization of the π-electron system of aromatic rings. The free radical scavenging capacity 
of anthocyanins is also related to the position of the hydroxyl groups [70].  
 
Figure 1.2 Structures of most common anthocyanidins [79] 
Anthocyanins are also natural pigments that are responsible for the blue, red and purple 
color in plants [78]. In the food industry, they are used as natural dyes [78]. The color of 
anthocyanins is depended on the pH of the environment. When the environmental pH level 
shifts from a strong acid to a mild alkaline, the structure of anthocyanins shifts from a flavylium 
cation to a quinonoid (Figure 1.3) and the color changes from red to blue [81]. Anthocyanins are 
colorless at a pH level of 4.5 [82]. Anthocyanins are labile to pH of the environment and an 
acidic environment (pH 1-4) is beneficial to their stability, as they can easily degrade in alkaline 
environments [83]. Many factors can accelerate the degradation of anthocyanins, such as 
strong light and heat exposure [81]. The instability of anthocyanins restricts their utilization in 
the food industry and negatively affects their bioavailability. 
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Figure 1.3 Molecular structure of anthocyanins in different environmental pH levels [84] 
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temperature [88]. Proanthocyanins have a strong ability to bind to proteins and metal ions due 
to their multiple phenolic hydroxyl groups [89]. The interaction between proanthocyanins and 
salivary proteins causes an astringent sensation in the mouth. The intensity of this 
astringency/bitterness is associated with the structure of proanthocyanins, especially the 
degree of polymerization [90]. The levels of proanthocyanins decrease during the ripening 
process of berries due to oxidation/degradation [90]. Food products using berries at their full 
ripeness can help to reduce the unpalatable astringent sensation to some extent. 
1.2.1.3 Phenolic Acids 
 Phenolic acids exist naturally in plants and are subcategorized as benzoic and cinnamic 
acids depending on the number of carbon atoms (Figure 1.1). Benzoic acids contain seven 
carbon atoms, such as gallic acid, salicylic acid, protocatechuic acid and ellagic acid. Cinnamic 
acids contain nine carbon atoms, which include caffeic acid, ferulic acid, chlorogenic acid, p-
coumaric acid, etc. [91]. Compared to hydroxybenzoic acids, hydroxycinnamic acids are more 
commonly found in plant-based foods [92]. Phenolic acids are antioxidants and their 
antioxidant capacity is related to its structure. Based on their antioxidant activity, phenolic 
acids are utilized in the food industry as food preservatives and/or are used to prevent 
enzymatic browning [93]. 
1.2.2 Potential Health-Promoting Characteristics of Polyphenols  
1.2.2.1 Polyphenols and Oxidative Stress 
The consumption of polyphenol-rich foods can increase the antioxidant capacity of the 
human serum. Plaza et al. observed an enhanced serum antioxidant capacity in healthy 
volunteers after consumption of jaboticaba peel (containing 1.25 g total phenolics with 
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anthocyanins as the predominant phenolic compound) [94]. The ability of polyphenols to 
increase serum antioxidant capacity may be achieved by improving the activity of endogenous 
antioxidant enzymes, such as GPx, SOD and CAT. Noratto et al. demonstrated that the GPx 
activity in obese diabetic mice fed with raspberry powder (containing 963 mg of extracted gallic 
acid equivalent phenolics) was higher than the control group (no consumption of raspberry) 
[95]. Wu et al. reported that the consumption of anthocyanin-rich mulberry extract and cherry 
extract (200 mg/kg body weight) increased the activity of SOD and GPx in obese mice [96]. Shen 
et al. conducted an experiment using mice fed with a high-fat diet and demonstrated that 
supplementation with a polyphenol extract (containing flavonols and phenolic acids) from black 
highland barley (600 mg/kg body weight) increased the levels of CAT, SOD and GPx in the liver 
[97]. Increases in the gene expression of these antioxidant enzymes were also observed [97]. 
The improvement in the activity of antioxidant enzymes may enhance the antioxidant defense 
system and be beneficial to reduce oxidative stress. In summary, polyphenol intake shows 
promise to enhance the antioxidant capacity of the blood serum and decrease oxidative stress 
by improving the activity and gene expression of endogenous antioxidant enzymes. 
1.2.2.2 Polyphenols and Chronic Inflammation 
Polyphenols can attenuate chronic inflammation by down-regulating the production of 
pro-inflammatory cytokines and/or up-regulating the generation of anti-inflammatory 
molecules. Lee et al. reported that after an eight-week supplementation with blueberries (10g 
freeze-dried blueberry powder/100g diet), levels of pro-inflammatory cytokines (TNF-α and IL-
1β) in rats were lower compared to rats without blueberry supplementation [98]. Roth et al. 
demonstrated that treatment of ingesting anthocyanin-rich bilberry extract reduced 
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inflammation in patients with ulcerative colitis [99]. Compared to baseline levels (before 
treatment), the levels of pro-inflammatory cytokines (TNF-α and interferon-γ) were decreased 
and the levels of anti-inflammatory cytokines (IL-10) were increased [99]. The cytokine 
regulatory activity of polyphenols may be related to their interaction with cellular proteins, 
such as signaling molecules, receptors and transcription factors, and may influence the signaling 
pathways [100, 101]. In addition, polyphenols may interact with nucleic acids and alter the 
protein expression of inflammation-related molecules [100, 102].  
1.2.2.3 Polyphenols and Type 2 Diabetes 
 Epidemiological studies reveal that higher consumption of polyphenols (mostly 
flavonoids) is correlated with a lower risk of T2DM [2]. Wedick et al. investigated the 
consumption of flavonoids and the risk of T2DM, the results showed that a higher intake of 
anthocyanins was related to a lower risk of developing the disease. No relationship was found 
between the consumption of other flavonoids and T2DM [3]. In addition to epidemiologic 
studies, the beneficial properties of polyphenols are well documented in experimental studies. 
Polyphenol intake can decrease cellular oxidative stress generated by metabolism and 
potentially reduce the risk for the initiation and/or delay the progression of T2DM. In addition, 
the consumption of polyphenols can increase insulin sensitivity and/or secretion, inhibit the 
production of AGE and improve glucose homeostasis by decreasing glucose absorption and/or 
increasing the cellular glucose uptake [103-106]. 
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1.2.2.3.1 Polyphenols and insulin sensitivity. Insulin is the key hormone for maintaining 
glucose homeostasis. Insulin resistance commonly occurs in T2DM patients where the insulin 
signaling and/or action on the target tissues is impaired [107]. Insulin resistance leads to a 
lowered glucose uptake in non-hepatic peripheral tissues, a decreased suppression of hepatic 
glucose production and an elevated level of plasma glucose. Polyphenol consumption can 
attenuate insulin resistance. Oral administration of apple procyanidins ameliorated the hepatic 
insulin resistance in diabetic mice by suppressing hepatic inflammation [108]. The 
administration of anthocyanin-rich mulberry extracts improved insulin sensitivity in diabetic 
mice via activation of AMP-activated protein kinase [109]. Insulin sensitivity was increased in 
insulin-resistant-non-diabetic human subjects by consuming 333 mg/day of strawberry and 
cranberry polyphenol mixtures for six weeks [110]. Increased insulin sensitivity may help to 
decrease the hyperproduction of insulin and then restrain the β-cell failure [107, 111]. In 
summary, polyphenol consumption may help to enhance insulin sensitivity and delay the 
progression of T2DM. 
1.2.2.3.2 Polyphenols and insulin-independent blood glucose control. Polyphenol intake 
can aid in blood glucose control by delaying carbohydrate absorption. The inhibitory activity of 
phenolic compounds on carbohydrate-hydrolyzing enzymes, such as pancreatic α-amylase and 
α-glucosidase, has been well documented [112-114]. Pancreatic α –amylase is responsible for 
hydrolyzing the α-bonds of large polysaccharides, such as starch and glycogen. Alpha-
glucosidase can catalyze the breaking down of 1, 4 - α bonds in oligosaccharides and 
disaccharides. The inhibition of these digestive enzymes delays the digestion of complex 
carbohydrates and reduces the proportion of absorbed glucose [103]. In addition, the 
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consumption of polyphenols can increase the glucose uptake in skeletal muscle cells and help 
to maintain blood glucose homeostasis. This effect may be related to the altered expression 
and activity of GLUT4 through the activation of AMPK and/or PPAR gamma pathways [71, 115-
117].  
1.2.2.1.3 Polyphenols and AGE production. The consumption of dietary polyphenols can 
help to suppress the formation of AGEs under hyperglycemic conditions and delay the 
progression of diabetic complications [118]. The anti-glycation activity has been investigated by 
several in-vivo studies. Umadevi et al. stated that gallic acid had a protective effect on AGE-
induced cardiac fibrosis in rats [119]. Chao et al. observed that the consumption of caffeic acid 
and ellagic acid decreased the formation of glycation products in the kidney of diabetic mice 
[120]. The anti-glycation property of polyphenols is related to their free radical scavenging 
capacity, metal chelating activity and their capacity to trap reactive carbonyl species, such as 
methylglyoxal [121].  
In addition to the beneficial effects of phenolic compounds on diabetes, polyphenols are 
reported to have beneficial activity toward other health-related problems, such as 
cardiovascular disease [2], cancer [122], obesity [123], osteoporosis [124] and Alzheimer’s 
disease [125, 126]. In order to better utilize the health-promoting potential of dietary 
polyphenols, the bioavailability of dietary polyphenols from various sources needs to be 
investigated.   
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1.3 Bioavailability of Phenolic Compounds 
 Bioavailability is defined as the proportion of ingested food compounds that enter 
metabolic circulation and reach specific sites in the body to exhibit biological function [127]. 
The bioavailability of different phenolic compounds varies, not only due to structural variations 
in polyphenols, but also because of individual physiological and biochemical differences of 
consumers. Generally, the bioavailability of phenolic compounds is relatively low due to low 
absorption rates, instability of these compounds in the gastrointestinal tract (GIT) and quick 
elimination [128]. Several steps are crucial for food constituents to be bioavailable: liberation, 
absorption, distribution, metabolism and elimination [129]. Bioaccessibility is an important 
factor to evaluate the potential of food compounds to be bioavailable and it is related to the 
liberation process. Bioaccessibility is defined as the amount of food compounds that are 
released in the GIT and have the potential to pass the intestinal barrier to be absorbed [127]. 
In-vitro digestion models are commonly used to evaluate the bioaccessibility of food 
components. The metabolism and bioavailability of proanthocyanins, anthocyanins and 
phenolic acid will be discussed in further detail in this section. 
1.3.1 Bioavailability of Proanthocyanins  
The bioavailability of proanthocyanins (condensed tannins) is generally low due to the 
large molecular size of these compounds. Proanthocyanins are polymerized flavan-3-ols and/or 
flavan-3,4-diols [85, 130]. Due to the large molecular size of proanthocyanins, it is unlikely for 
them to be absorbed intact. In the stomach, in-vitro studies showed that some proanthocyanins 
could be hydrolyzed into monomers due to the acidic environment [85], and then monomers 
22 
 
can be absorbed in the small intestine. However, in-vivo studies suggested that the 
depolymerization of proanthocyanins in the upper GIT (stomach and small intestine) was 
minimal [85, 131, 132]. The absorption characteristics of proanthocyanins in the small intestine 
are largely affected by the degree of polymerization. Dimeric and trimeric proanthocyanins are 
relatively easily absorbed because the permeability coefficients of proanthocyanins are similar 
to a paracellular transport marker – mannitol [133]. The absorbed dimeric and trimeric 
proanthocyanins reach the liver via the portal vein. The absorbed dimers/trimers conjugate in 
the liver. The conjugated derivatives may be exported into the bile and go back to the intestinal 
lumen or be released into the systemic circulation and then distributed to the organs. The 
metabolites are excreted in the urine. Most large proanthocyanins pass the upper GIT without 
alteration and reach the colon in their original form or as complexes with macronutrients. 
Proanthocyanins that are not absorbed may be metabolized by the colonic microflora in the GIT 
and excreted in the feces [134].  
It has been suggested that proanthocyanins can exhibit bioactivity without being 
absorbed by altering the gut microflora profile [135]. A study conducted with rats showed that 
consuming proanthocyanins for three weeks caused a shift towards increasing gram-negative 
bacteria in the GIT [136]. In addition, proanthocyanin-rich grape seed extract (38.5%, w/w) 
increased the population of probiotics (Bifidobacterium) in healthy adults [137]. Gut microbiota 
plays a vital role in human health, such as synthesizing vitamins and protecting the host from 
potentially harmful invasive bacteria [128]. Thus, ingested proanthocyanins may affect human 
health by modulating the composition and catabolic activity of the gut microbiota [138, 139]. 
23 
 
More studies are needed to better understand the impacts of proanthocyanins on gut 
microflora and to better utilize the potential benefits of proanthocyanins.  
1.3.2 Bioavailability of Anthocyanins 
 Anthocyanins are relatively easily absorbed compared to proanthocyanins. The stomach 
is a major site for the liberation of anthocyanins from food matrices. The stomach pH and body 
temperature helps to hydrolyze and/or release anthocyanins. The major absorption site of 
anthocyanins is the small intestine [140]. Anthocyanin aglycones can pass the cellular 
membrane of enterocytes via passive diffusion. The absorption of anthocyanin glycosides 
involves enzymes or transporters [128, 141], such as lactate phlorizin hydrolase (LPH). LPH is 
located in the enterocyte brush border and LPH can cleave the glycosidic moieties of 
anthocyanin glycosides in the small intestinal lumen. The released aglycones can then enter the 
enterocytes via passive diffusion [128]. In addition, anthocyanin glycosides can be transported 
into the enterocytes in their glycoside form by using sodium-dependent glucose transporters 
(SGLT) [141]. The anthocyanin glycosides are hydrolyzed within the epithelial cells by a cytosolic 
β-glucosidase (CBG) and release the aglycones [140]. The absorption efficiency of anthocyanins 
varies depending on their structure. Yi et al. demonstrated that the transport efficiency of 
cyanidin glucoside was higher than cyanidin galactosides [142]. The authors also concluded that 
fewer free hydroxy groups and more methoxy groups contributed to a higher absorption 
efficiency [142]. The absorbed anthocyanin aglycones are transported via the portal vein to the 
liver, where anthocyanins undergo phase II transformations including conjugations to methyl, 
glucuronic acid and/or sulfate groups [141, 143]. After being metabolized in the liver, 
anthocyanins can either re-enter the enteric system through bile or can be distributed to 
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organs, such as the eyes, bladder, kidney, and brain [144-149] and then be excreted in urine 
[141].  
One restricting factor for the bioavailability of anthocyanins is their instability in an 
alkaline environment. The small intestine is a mild alkaline environment and anthocyanins may 
degrade in the small intestine before being absorbed [143]. The instability of anthocyanins in 
the small intestine was observed by many studies using in-vitro models. Liu et al. reported that 
42% of total anthocyanins from blueberries degraded during intestinal digestion [150]. 
Strategies that can increase the stability of anthocyanins in the small intestine may help to 
enhance their bioavailability. 
1.3.3 Bioavailability of Phenolic Acids 
 The absorption of phenolic acids can occur in the stomach, small intestine and colon 
[151]. Absorption in the stomach provides the lowest phenolic absorption levels and may be 
achieved by passive diffusion [152]. The small intestine, specifically the jejunum is the major 
absorption site for phenolic acids [153].  The intestinal absorption of phenolic acids can occur 
via monocarboxylic acids transporters (MCT) and the absorption rate is affected by the affinity 
between phenolic acids and MCT [154]. Free phenolic acids are absorbed rapidly in the stomach 
and in the small intestine [155, 156], but the majority of phenolic acids (approximately 80%) in 
plant-based foods are bound to cell wall polymers by covalent cross-linkages [157] and are 
inaccessible for absorption. Bound phenolic acids are insoluble and the human endogenous 
enzymes cannot release them [155]. The microflora in the colon may produce enzymes that are 
able to liberate the bound phenolic acids, such as xylanases and esterases [158]. The absorption 
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of the released phenolic acids in the colon is low due to: 1) poor absorption capacity of the 
colon and 2) break down of the aglycones by colon microflora [155]. Thus, the bound phenolic 
acids can be released and absorbed in the colon to some extent. However, the bioavailability of 
bound phenolic acids is lower than free phenolic acids. 
 After absorption, phenolic acids are distributed to organs and undergo several 
biotransformations in the intestine, liver and kidney where the liver is the major site [151]. The 
biotransformation of phenolic acids includes dehydroxylation, demethylation, 
dehydrogenation, hydrogenation, O-methylation, sulphation, glucuronization, glycination 
and/or GSH conjugation [151]. Phenolic acids and the conjugates may re-enter the intestinal 
lumen via bile when the circulating levels are high. Phenolic acids are mainly excreted in the 
urine in both the intact and biotransformed form [159].  
1.3.4 Factors Affecting the Bioavailability of Phenolic Compounds 
Many factors affect the bioaccessibility and bioavailability of phenolic compounds. First, 
processing methods such as thermal treatments and storage may either increase the 
bioavailability by enhancing the release of polyphenols from the food matrices [160] or 
decrease the bioavailability by accelerating degradation [161]. Second, the interaction with 
other ingested dietary ingredients such as proteins may alter the liberation process of phenolic 
compounds and in most cases negatively affect the bioaccessibility of phenolic compounds 
[162]. Third, the molecular structures of polyphenols have a vital impact on their bioavailability. 
Larger phenolic compounds like proanthocyanins are difficult to absorb while the absorption 
rates of smaller phenolics like phenolic acids are much higher. Fourth, digestion related factors, 
such as the intestinal transit time of polyphenols and enzyme activity, may positively or 
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negatively affect the release of phenolic compounds. Longer retention times in the small 
intestine leads to more degradation of anthocyanins but longer retention times in the stomach 
may cause more liberation [161]. Additionally, the microbiota in the lower GIT may break down 
some larger phenolic compounds and increase their bioavailability [163, 164]. Fifth, the 
frequency of polyphenol consumption may alter the expression of transport proteins and/or 
metabolizing enzymes that associated with polyphenol metabolism in human [166, 167]. Thus, 
consuming polyphenol-rich foods may affect their bioavailability by altering the individual’s 
ability to absorb and metabolize phenolic compounds [165].  
1.3.5 Potential Methods to Improve Bioavailability of Phenolic Compounds 
1.3.5.1 Thermal Processing 
 Thermal processing methods are frequently used to heat treat food ingredients. 
Thermal treatments can decrease the bioavailability of polyphenols in food by accelerating the 
degradation process. Some phenolic compounds, such as anthocyanins, are labile to heat [168]. 
However, some thermal processing methods are found to be beneficial to enhance the 
bioavailability of phenolic compounds in certain foods. For example, roasting nuts can increase 
the amount of free phenolic acids which are more bioavailable compared to bound phenolic 
acids [73, 169]. Rossi et al. reported that steam blanching blueberries inactivated the 
polyphenol oxidase and resulted in an increase in extractable polyphenols [170]. Arkoub-
Djermoune et al. demonstrated that some thermal processing methods, such as grilling and 
baking, enhanced the total phenolic compounds content and flavonol content in eggplant but 
decreased the flavonoid and anthocyanin levels [171]. In summary, thermal processing may 
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increase the bioavailability of some phenolic compounds in certain food matrices, but the 
effects vary and need to be investigated on a case by case basis.  
1.3.5.2 Fermentation 
Fermentation has been widely utilized to process polyphenol-rich foods for centuries, as 
in the making of wine. Fermentation not only adds flavor to the food but also modifies the food 
components including phenolic compounds. Lactic acid bacteria are commonly utilized in 
fermentation [172]. Some lactic acid bacteria, such as Lactobacillus plantarum, can metabolize 
phenolic compounds and the metabolites may be more bioavailable [173]. Frediansyah et al. 
demonstrated that black grape juice fermented with Lactobacillus plantarum exhibited higher 
α-glucosidase inhibitory activity than non-fermented black grape juice [174]. Hole et al. 
observed that fermentation with lactic acid bacteria increased the level of free phenolic acids in 
whole barley grains and improved their bioavailability [175]. These increases may be caused by 
the liberation of bound phenolic acids due to the esterase activity of lactic acid bacteria [175]. 
Similarly, Curiel et al. reported that due to the esterase activity, L. plantarum fermentation 
increased the levels of gallic acid, ellagic acid, myricetin and quercetin in Myrtus communis 
berries and increased radical scavenging capacity [176]. In addition to lactic acid bacteria, other 
fermentative microorganisms may have the capacity to alter the bioavailability of phenolic 
compounds. Wang et al. demonstrated that fermentation with yeast (Saccharomyces cerevisiae 
bayanus EC 118) enhanced the anti-inflammatory activity of maqui berry juice by improving the 
capacity to inhibit the expression of iNOS and COX-2 in a macrophage cell line (RAW264.7) 
[177]. The authors concluded that this enhancement might be related to the increase of gallic 
acid due to yeast fermentation [177]. In summary, fermentation may increase the 
28 
 
bioavailability of dietary polyphenols by altering the structure, generating more bioavailable 
metabolites and/or releasing the bound phenolic compounds. Studies in regard to the impacts 
of fermentation on the bioavailability of phenolic compounds are limited. More research 
involving various microorganisms and different food matrices is needed.  
 In addition to the above-listed processing methods (thermal processing and 
fermentation), other methods, such as milling, high-pressure processing and encapsulation may 
have positive impacts on the bioavailability of phenolic compounds [160, 178]. The effects of 
processing on the bioavailability of phenolics depend on not only the processing methods, but 
also the phenolic compounds structure and the food matrix. Currently, research studies are 
investigating impacts of a variety of processing methods on the bioavailability of phenolic 
compounds from different food matrices, but more processing studies are needed to efficiently 
utilize the potential health benefits of certain phenolic compounds.   
1.4 Aronia Berries 
1.4.1 Botany and Current Commercial Utilization of Aronia Berries 
 Aronia shrubs are native to North America [179]. The genus Aronia (belongs to the 
Rosaceae family and Maloideae subfamily) includes two species: Aronia melanocarpa and 
Aronia arbutifolia. A. melanocarpa fruits are black, also known as the “black chokeberry”, “wild 
gooseberry”, “chokepear” or “dogberry”. A. arbutifolia fruits are red and are known as the “red 
chokeberry”. A third controversial species is called A. prunifolia (purple chokeberry), which is 
considered a hybrid of A. melanocarpa and A. arbutifolia [180]. Most research has been 
conducted on the black aronia – A. melanocarpa. In this thesis, the word “aronia” is used to 
indicate the black aronia, specifically. Aronia are relatively easy to grow and they are not 
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susceptible to severe diseases and pests [179]. Birds do not consume the fruit which may be 
due to its astringent taste [179, 181, 182]. Mature aronia shrubs can be 2-3 meters in height 
and yield up to 1.2 kg fruit/m2 in five years [183]. Aronia has been traditionally used as an 
alternative medicine to treat colds among Native Americans [179]. Aronia gained popularity in 
the Soviet Union and Eastern Europe in the 20th century, and it was used as a treatment for 
hypertension, atherosclerosis, hemorrhoids and achlorhydria [179]. Currently, aronia extracts 
are used as natural food colorants to provide dark purple or blue color [184]. Some food 
products made with aronia, such as juice, jam, jelly and tea are commercially available in the 
United States, but these products are limited. More products need to be developed with aronia 
berries to increase their consumption [185].  
1.4.2 Nutritional Value and Bioactive Compounds of Aronia Berries 
 The content of nutrients and bioactive compounds in aronia berries are affected by 
several factors, such as the shrub cultivar, the maturation of the berries, the variety and 
frequency of fertilizers used and the growth location/climate [186, 187]. Fresh aronia berries 
contain 5.6% dietary fiber which includes pectin [188, 189]. The seedless fraction of aronia 
pomace  contains 70% dietary fiber on a dry weight basis [190]. Total sugar content in fresh 
aronia is approximately 620 mmol/kg including 3.5% glucose, 2.8% fructose and 0.41% sucrose 
[191]. Though the reported individual sugar content varies, glucose and fructose are the 
dominant sugars in aronia berries [192, 193].  Aronia berries contain a relatively high amount of 
sorbitol (46.2 g/kg), which is a sugar alcohol [192]. Malic acid is the predominant organic acid in 
aronia berries, which is approximately 1.22 g/100 g in fresh berries, followed by citric acid (0.13 
g/100 g). Tartaric acid, fumaric acid and shikimic acid are detected in aronia berries but these 
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amounts are low [191]. Fresh aronia berries contain small amounts of fat (0.14 g/100g) and up 
to 0.7 g/100g protein [183]. The predominant fatty acid is linoleic acid which is contained in its 
seeds [194]. Aronia berries have a relatively high concentration of potassium (0.22 g/100g fresh 
weight). Vitamins B1 (17-19 µg/100g), B2 (17-27 µg/100g), B6 (24-29 µg/100g), B9 (2-4 µg/100g), 
C (4.0-19.3 mg/100g), niacin (27-34 µg/100g) and pantothenic acid (225-382 µg/100g) have also 
been identified in aronia berries [183, 195]. 
 Phenolic compounds are the most important bioactive compounds in aronia berries. 
They are potentially responsible for the pharmaceutical effects of aronia, such as anti-influenza 
activity [183]. Aronia berries are rich in phenolic compounds ranging from 1013 to 2010 mg 
gallic acid equivalents/100 g fresh berries, which is higher than that in blueberries, bilberries, 
blackberries, strawberries, blackcurrants and cranberries [191, 196 - 198]. The major type of 
phenolic compounds in aronia are proanthocyanidins [199]. Procyanidins are the only form of 
proanthocyanidins found in aronia berries. Procyanidins are a subcategory of 
proanthocyanidins that consist of (epi)catechin subunits and aronia berries have a high 
concentration of procyanidins [198]. The degree of polymerization of aronia procyanidins 
ranges from 2 to over 30 where large polymers are dominant. The major linkages between the 
subunits of aronia procyanidins are C4-C6 and C4-C8 bonds [179]. The content of procyanidins 
in dried aronia berries is above 5 g/100 g which is higher than the proanthocyanidins in other 
berries, such as bluberries [200]. Anthocyanins are the second most dominant phenolic group in 
aronia berries [179]. Aronia is one of the berries that contains the largest concentration of 
anthocyanins [79]. Wu et al. reported that the total anthocyanin content in fresh aronia berries 
was 1480 mg/100 g, which is higher than that in black raspberry (687 mg/100 g),  wild blueberry 
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(486.5 mg/100 g), blackcurrant (476 mg/100 g), blackberry (245 mg/100 g), cranberry (140 
mg/100g) , and strawberry (21.2 mg/100 g) [201]. There are four major anthocyanins in aronia 
berries: cyanidin-3-galactoside, cyanidin-3-glucoside, cyanidin-3-xyloside and cyanidin-3-
arabinoside where cyanidin-3-galactoside is the dominant anthocyanin followed by cyanidin-3-
arabinoside [199, 202]. Other anthocyanins were occasionally detected at low concentrations, 
such as pelargonidin-3-arabinoside [198]. The major phenolic acids in aronia berries are 
chlorogenic acid and neo-chlorogenic acid, the contents of which range from 16.3 to 301.8 and 
from 92.3 to 291 mg/100 g in dried aronia berries, respectively [199, 203]. Other phenolic acids, 
such as caffeic and ferulic acids were only occasionally identified in aronia berries [204]. 
1.4.3 Health-promoting Characteristics of Aronia Berries 
1.4.3.1 Antioxidant Capacity of Aronia Berries 
Antioxidant capacity is an important parameter to evaluate the potential health-
beneficial properties of a food ingredient. Aronia berries exhibit strong antioxidant capacity due 
to the large amounts of phenolic compounds [196]. In addition, other compounds, such as 
vitamin C and β-carotene, contribute to its antioxidant activity [205]. The consumption of 
aronia berries can help to reduce oxidative stress and decrease cellular oxidative damage. 
Aronia intake can increase the antioxidant capacity of the plasma and scavenge the excessive 
free radicals in the human body. Nowak et al. observed an increase in plasma antioxidant 
capacity in healthy people after one-week consumption of aronia juice [206]. In a double-blind 
study with rowing athletes, Skarpanska-Stejnborn et al. stated that the antioxidant capacity of 
plasma in athletes supplemented with aronia juice consumption (150 mL/day) for eight weeks  
was higher than the placebo group [207]. Pilaczynska-Szczesniak et al.  observed that daily 
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intake of 150 mL aronia juice (containing 34.5 mg anthocyanins) reduced the levels of 
thiobarbituric acid-reactive substances (TBARS) in the blood and concluded that an increase in 
anthocyanin consumption could decrease exercise-induced oxidative damage to red blood cells 
in athletes [208]. Lee et al. reported that aronia extracts reduced ROS production in HT22 
mouse hippocampal cells and protected the cells against the glutamate-induced oxidative stress 
[209]. The consumption of aronia berries can also improve the antioxidant defense system by 
boosting the activity of endogenous antioxidative enzymes. Kardum et al. observed that after 
consuming aronia juice for three months, the SOD and GPx activity in healthy women was 
increased significantly [210]. Faff et al. observed that the reduction of GSH caused by exercise 
was alleviated in aronia-fed rats [211]. A study conducted by Francik et al. showed that aronia 
juice administration increased the activity of plasma CAT in rats fed a high-fat diet [212]. 
Kondeva-Burdina et al. stated that aronia juice prevented GSH depletion caused by tert-butyl 
hydroperoxide-induced oxidative stress in rat hepatocytes and increased cell viability [213]. The 
positive impacts of aronia on oxidative stress are potentially beneficial to prevent chronic 
diseases and slow their progression. 
1.4.3.2 Anti-inflammatory Activity of Aronia Berries 
 Chronic low-grade inflammation is one of the underlying factors of chronic diseases. A 
reduction in low-grade inflammation may benefit the diabetic individuals by dealying the 
progression of diabetic complications. Additionally, decreased low-grade inflammation may 
reduce the risk of T2DM in individuals with metabolic syndroms. The anti-inflammatory effects 
of aronia berries have been documented in in-vitro studies using cell models for understanding 
the mechanisms. Appeal et al. stated that aronia juice concentrate activated the NF-ƙB pathway 
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in RAW264.7 macrophages and inhibited the production of pro-inflammatory cytokines (TNF-α, 
IL-6 and IL-8) in human peripheral monocytes which were isolated from a healthy human 
volunteer [214]. Martin et al. reported that aronia berries inhibited IL-6 production in 
lipopolysaccharide (LPS)-simulated mice splenocytes and that cyanidin-3-arabinoside might be 
the major effective anthocyanin [215]. These studies demonstrate that aronia berries exhibit 
anti-inflammatory activity by suppressing the production of pro-inflammatory cytokines. 
In addition to in-vitro studies, the anti-inflammatory activity of aronia berries has been 
tested in animal models. Ohgami et al. reported that aronia extract decreased the levels of NO, 
TNF-α and prostaglandin (PG)-E2 in rats with endotoxin-induced uveitis [216]. Goh et al. 
observed that aronia concentrate suppressed the formation of 12-o-tetradecanoylphorbol-13-
acetate (TPA)-induced ear edema in mice and decreased the production of pro-inflammatory 
cytokines (TNF-α, IL-1β and IL-6) [217]. Kang et al. concluded that the consumption of aronia 
berries ameliorated the symptoms of dextran sulfate sodium-induced ulcerative colitis (a type 
of inflammatory bowel disease) in mice, and decreased the production of NO, IL-6 and TNF-α 
[218]. Loo et al. carried out an intervention with individuals with slightly high blood pressure 
levels and demonstrated that the consumption of dried aronia powder or aronia juice 
(equivalent to about 336 g fresh berries per day) decreased low-grade inflammation, while 
reductions in TNF-α were observed [219]. Low-grade chronic inflammation increases the risk of 
T2DM and CVD. The anti-inflammatory activity of aronia berries can aid in the prevention and 
treatment of chronic diseases. More in-vivo, especially clinical research studies, are needed to 
establish recommended dosages. 
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1.4.3.3 Aronia and Diabetes 
The potential benefits of aronia berries for diabetes were suggested by several in-vitro 
studies. Rugina et al. demonstrated that aronia extract helped to protect mouse pancreatic β-
cells (βTC3 cell line) from high glucose-induced cytotoxicity. The authors also observed that the 
insulin secretion increased in the aronia extract-treated βTC3 cells [220]. Aronia extracts may 
benefit insulin secretion by inhibiting the activity of dipeptidyl peptidase IV (DPP IV). DPP IV is a 
serine peptidase which can reduce insulin secretion by inactivating incretin. The inhibition of 
DPP IV can increase the secretion of insulin and be beneficial to diabetic individuals. Kozuka et 
al. investigated the DPP IV inhibitory activity of aronia juice in-vitro and concluded that the 
cyanidin 3,5-diglucoside was more efficient than cyanidin or cyanidin-3-glucoside to inhibit DPP 
IV [221]. Aronia consumption may aid in modulating blood glucose levels by inhibiting enzymes 
involved in carbohydrate absorption, such as α-glucosidase [222]. Wangensteen et al. 
investigated the inhibitory activity of aronia extracts against α-glucosidase and demonstrated 
that the inhibitory activity of aronia extracts was stronger than acarbose, which is a therapeutic 
agent for diabetes [200]. In-vitro studies suggest that aronia may benefit diabetic individuals by 
increasing the secretion of insulin and inhibiting carbohydrate-hydrolyzing enzymes. 
The hypoglycemic effects of aronia have been documented by in-vivo studies using 
animal models. Valcheva-Kuzmanova et al. reported that the levels of plasma glucose levels in 
streptozotocin (STD)-induced diabetic rats were reduced after a six-week administration of 
aronia juice. The authors observed 44% and 42% decreases in blood glucose in diabetic rats fed 
with 10 and 20 mL/kg aronia juice, respectively [223]. Oprea et al. demonstrated that the 
consumption of aronia juice decreased the blood glucose levels of alloxan-induced diabetic rats 
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by 42.83% [224]. In a study conducted by Yamane et al., the blood glucose levels of diabetic 
mice (KK-Ay mice) supplemented with aronia juice was lower than the control group (without 
the supplementation of aronia juice). The trend was consistent over the entire experiment (28 
days) [225]. In the same study, aronia juice consumption led to an inhibition of α-glucosidase 
activity in the upper small intestine of diabetic mice. Hypoglycemic activity of aronia was also 
observed in animal models with metabolic syndrome but not diabetes. Qin and Anderson 
performed a study with Wistar rats fed a fructose-rich diet. They demonstrated that the 
administration of aronia berry extracts (100 or 200 mg/kg body weight) lowered the risk factors 
related to insulin resistance via a variety of possible mechanisms, such as enhancing mRNA 
levels of insulin receptor substrate 1 and 2, which may help to increase insulin sensitivity [226]. 
Takahashi et al. illustrated that four weeks of aronia extract consumption (17.4 g aronia 
polyphenols per kg diet) decreased the fasting blood glucose levels in high-fat diet-induced 
obese rats [227]. In a human intervention conducted by Simeonov et al., three-month 
consumption of aronia juice (200 mL/day) lowered the fasting blood glucose in 21 patients with 
non-insulin dependent diabetes [228]. These studies demonstrate that aronia berries can help 
to normalize blood glucose levels not only in diabetic individuals, but also in individuals with 
metabolic syndrome. Clinical studies in regards to the impacts of aronia on diabetes are limited. 
More studies are needed to confirm the beneficial properties of aronia for T2DM and to 
establish effective dosages for human. 
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1.4.3.4 Aronia and Other Health Problems 
In addition to the antioxidant, anti-inflammatory properties and potential benefits for 
daibetes, the consumption of aronia berries is also beneficial for other health problems. The 
anti-influenza activity of aronia was reported by Park et al. in both in-vivo and in-vitro 
experiments [229]. In this study, aronia extracts (0.125 mg/mL) exhibited more than 60% 
inhibition against all five tested viruses (H1/K09, H3/PE16, B/BR60, H1/K2785 and HPAI 
rH5/IS06) including oseltamivir-resistant strains (H1/K2785 and HPAI rH5/IS06). Oseltamivir is 
an antiviral drug used to treat and prevent influenza. The inhibitory activity of aronia extracts 
on the influenza virus was dose-dependent. Additionally, the authors observed that the lethal 
rate of rPR8-GFP virus-infected mice was reduced by aronia treatment (1 mg/kg, twice daily) 
[229]. In a long-term crossover intervention performed by Handeland et al., the incidence of 
urinary tract infections (UTI) among nursing home residents was reduced after patients 
consumed aronia juice for three months (containing 715 mg/100 mL gallic acid equivalent total 
phenolics). The authors observed a 55% and a 38% decrease in UTIs among groups given 156 
mL and 89 mL juice consumption, respectively [230]. Aronia consumption may have other 
potential beneficials in addition to the properties mentioned above, such as chemoprotective 
activity. More studies need to be performed to optimize the health-promoting properties of 
aronia and the effective dosages of aronia consumption should be established. Additionally, 
more mechanistic research should be carried out to further understand the mechanisms of how 
aronia can have positively effects on human health.  
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1.4.4 Challenge of Incorporating Aronia Berries in Diet  
 Regular consumption of aronia berries can increase the consumers’ daily intake of 
phenolic compounds and potentially benefit their health. However, aronia berries are not 
commonly consumed because they are less palatable than other popular berries, such as 
blueberries. A major sensory attribute that negatively affects the flavor of aronia is the 
astringency caused by the high phenolic content, especially procyanidins. Duffy et al. conducted 
a sensory evaluation of aronia juice and concluded that the juice was not widely accepted due 
to the low sweetness and high astringency [77]. The consumer acceptance was increased when 
sweeteners were added to the juice [77]. Troszynska et al. observed that the addition of 
polysaccharides (guar, xanthan, arabic gums and carboxymethylcellulose) decreased the 
sensation of astringency in aronia extracts whereas carboxymethylcellulose was observed to 
have  the best effects on lowering astringency compared to other gums [231]. Ares et al. 
investigated the ability of sucrose, sucralose, polydextrose and milk to mask the astringency of 
phenolic-rich extracts from Achyrocline satureioides and Baccharis trimera by conducting a 
sensory study [232]. Results of this study showed that milk was the most efficient in lowering 
the astringent sensation followed by sucrose. Astringency is caused by the interaction between 
polyphenols and salivary proteins. The authors stated that the milk proteins could complex with 
polyphenols and yielded less available polyphenols to form insoluble compounds with salivary 
proteins. Thus, the astringent mouth-feel was reduced [232]. One concern about using other 
food ingredients to reduce astringency is the possibility of lowering the bioavailability of aronia 
polyphenols. The liberation pattern of aronia polyphenols during digestion can be altered if 
they interact with other food matrices, which affects the absorption of polyphenols. Another 
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concern about incorporating aronia into other food matrices is the stability of aronia 
polyphenols may be lowered. For example, the addition of milk is able to decrease the 
astringency of the phenolic-rich extract [232]. The pH of milk is neutral to slightly alkaline, 
which negatively affects the stability of anthocyanins. Food products incorporated with aronia 
in a neutral food matrix may not be able to maintain the full potential of health-promoting 
properties during shelf life. In summary, in order to increase the consumption of aronia, 
products with reduced astringency need to be developed. Additionally, in regard to optimize 
the potential health benefits of aronia berries, the bioavailability of aronia polyphenols in the 
new developed food products should not be decreased. 
1.5 Elderberries 
1.5.1 Botany and Current Commercial Utilization of Elderberries 
 Black elderberries (Sambucus nigra L. Family Adoxaceae) are deciduous shrubs that can 
be located in shady, moist areas in Europe, northern Africa, west and central Asia, and North 
America [233]. There are two subspecies of black elderberries: European elderberries 
(Sambucus nigra L. ssp Nigra) and American elderberries (Sambucus nigra L. ssp. canadensis) 
[234]. European and American elderberries are similar in most botanical characteristics, except 
European elderberries are shrubs with a single or a few trunks while American elderberries 
usually have many canes and can spread by underground rhizomes [235]. This thesis will focus 
on the American elderberry, also known as the “American elder”. 
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American elderberry is native to eastern and central North America [236]. American 
elderberry plants are multi-stemmed shrubs that can reach up to 9 m in height [236]. The plants 
bloom in early summer showing umbrella-shaped clusters of small, white flowers, which 
develop into dark purplish-black berries in the late summer or early fall. A cluster of elderberry 
fruits can contain up to 2,000 berries (5-9 mm in diameter for an individual berry) [236]. 
Elderberries are a very attractive food for birds. After consuming the berries, birds will then 
disperse the seeds. Elderberry colonies are commonly located in areas where birds nest, such 
as along railways, roadways, forest edges and fence lines [235]. Second-year American 
elderberry shrubs can yield up to 3 kg per plant. At the fourth year, 8 kg average yields can be 
achieved [236]. American elderberries can produce high yields (about 6 kg per plant) in cold 
areas, such as Normandin, Quebec, Canada [237]. Traditionally, American elderberries and 
elderberry flowers are used as herbal remedies to treat colds, flus and inflammation [238]. 
Elderberry food products have limited availability in the United States. Elderberry jams, pies, 
wines and juices are the major types of food products on the market. However, the demand for 
elderberries has increased due to their health-promoting properties [239]. More market-
available products using elderberries may encourage farmers to grow elderberries, develop 
value-added elderberry products and increase their income.  
 1.5.2. Nutritional Value and Bioactive Compounds of Elderberries 
 The nutrient level in elderberries is affected by many factors, such as the cultivar of the 
plant, the degree of fruit ripeness and environmental conditions [239]. Citric acid is the 
dominant acid in most cultivars of American elderberries followed by malic and succinic acid. 
Fructose is the dominant sugar in elderberries followed by glucose [240]. American elderberries 
40 
 
are a good source of vitamin C (36 mg/100 g fresh weight basis), potassium (280 mg/100 g fresh 
weight basis), phosphorus (39 mg/100 g fresh weight basis), calcium (38 mg/100 g fresh weight 
basis) and magnesium (5 mg/100 g fresh weight basis) [241].  
 American elderberries are rich in polyphenols. Phenolic compounds are the most 
important group of bioactive compounds in elderberries. The total phenolic content of fresh 
berries ranges from 277 to 532 mg gallic acid equivalents/100 g [235, 242, 243]. Elderberries 
are among the berries that contain the largest amount of anthocyanins [79]. The content of 
anthocyanins is up to 446.8 mg cyanidin-3-glucosides/100 g of fresh berries [242, 243].  Most 
anthocyanins in American elderberries are cyanidin-based. Cyanidin 3-(E)-p-coumaroyl-
sambubioside-5-glucoside and cyanidin-3-sambubioside-5-glucoside are the most abundant 
anthocyanins. Cyanidin-3-glucoside, cyanidin-3,5-diglucoside and cyanidin-3-sambubioside have 
been discovered in relatively high amounts in American elderberries [235]. More than 60% of 
American elderberry anthocyanins are acylated anthocyanins. In addition to cyanidin-3-(E)-p-
coumaroyl-sambubioside-5-glucoside, cyanidin-3-(Z)-(p-coumarin-sambubioside-5-glucoside, 
cyanidin-3-(p-coumarin)-glucoside and cyanidin-3-(p-coumarin)-sambubioside have also been 
identified [239]. The presence of these acylated anthocyanins may be used to distinguish 
American elderberries from European elderberries since acylated anthocyanins are not found in 
European elderberries [235, 244]. Anthocyanins in American elderberries are more stable than 
those in European elderberries when exposed to heat and light due to the presence of these 
acylated anthocyanins. This stability advantage allows American elderberries to be used as a 
source of industrial food colorants [244, 245].  Cinnamic acids, such as neo-chlorogenic acid, 
chlorogenic acid and crypto-chlorogenic acid have been identified in elderberries where 
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chlorogenic acid is dominant in most cultivars [235, 240]. Rutin (quercetin-3-rutinoside) is the 
predominant flavonol glycoside in elderberries; other flavonols, such as isoquercetin, 
kaempferol-3-rutinoside, isorhamnetin-3-rutinoside and isorhamnetin-3-glucoside have been 
identified, as well [235]. 
1.5.3 Health Promoting Characteristics of Elderberries 
The health-beneficial properties of European elderberries are well documented. 
However, most studies involving American elderberries are in regard to cultivation. Research 
that investigates the impact of American elderberries on health are limited. In this section, 
European elderberry studies are included to introduce the potential bioactivity of American 
elderberries on human health since they are closely related. 
1.5.3.1 Antioxidant Capacity of Elderberries 
 American elderberries have been shown to exhibit strong antioxidant capacity in-vitro. 
Ozgen et al. evaluated fourteen accessions of American elderberries by the ferric reducing 
antioxidant power (FRAP) and the 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging capacity 
[242]. All samples exhibited ferric reducing antioxidant power (13.4 – 31.7 µmol Trolox 
equivalents/ g on a fresh weight basis) and DPPH scavenging capacity (5.4 – 13.5 µmol Trolox 
equivalents/ g fresh weight basis). In the same study, authors observed a strong correlation 
between antioxidant capacity and the levels of total phenolic compounds [242]. In a study 
conducted by Simonyi et al., anthocyanin-rich extracts of American elderberries inhibited the 
production of ROS in LPS or IFN-γ-simulated mouse microglial cells (bv-2), which means 
American elderberries may help to decrease the cellular oxidative stress [246].  Currently, 
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little to no research studies have documented the ability of American elderberries to decrease 
oxidative stress in-vivo. The benefits of European elderberries on oxidative stress have been 
observed in several animal studies. Dubey et al. demonstrated that the fish oil-induced 
oxidative stress in BioF1B hamsters was attenuated by consuming European elderberry extract 
[247]. Ciocoiu et al. reported that the consumption of European elderberry extract (0.05 g/kg 
body weight every two days for 16 weeks) decreased lipid peroxides and inhibited LDL 
oxidation in STD-induced diabetic rats [248].  In the same study, levels of reduced GSH and SOD 
were elevated in both healthy and STD-induced diabetic rats [248]. These results indicate that 
the consumption of European elderberries reduced oxidative stress in rats, which may due to 
improving their antioxidant defense system. American elderberries may exhibit different 
antioxidant activity in-vivo compared to European elderberries due to the presence of acylated 
anthocyanins. More studies using rodent models or human subjects need to be conducted 
better to understand and utilize the potential health-promoting properties of American 
elderberries. 
1.5.3.2 Anti-inflammatory Activity of Elderberries 
 The anti-inflammatory activity of polyphenol-rich fruits has been observed by both in-
vivo and in-vitro studies [100, 249, 250]. However, studies on the anti-inflammatory activity of 
American elderberries are rare. Simonyi et al. observed that the NO production in LPS or IFN-γ-
stimulated mouse microglial cells (bv-2) was reduced by American elderberry extracts, which 
means that the inflammatory response was decreased [246]. Seeram et al. demonstrated that 
anthocyanin-rich extracts from American elderberries inhibited the activity of cyclooxygenase-1 
and cyclooxygenase-2 (COX-1 and COX-2) in-vitro. The COX inhibitory activity of American 
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elderberry anthocyanins was stronger than cranberries, blueberries and bilberries [251]. COX 
can catalyze the production of prostaglandins which are important compounds in the 
generation and promotion of the inflammation response [252]. Inhibition of COX activity can 
decrease the degree of inflammation. Farrell et al. conducted an in-vivo study where mice were 
fed European elderberry extracts for sixteen-weeks (20-40 and 200-400 mg/kg body weight). 
Researchers observed lower levels of inflammatory markers (TNF-α and chemoattractant 
protein-1) and decreased insulin resistance in obese mice compared to the control group [253]. 
However, the in-vivo anti-inflammatory activity of American elderberries has not been well 
documented. More research investigating the anti-inflammatory bioactivity of American 
elderberries needs to be conducted. 
In addition to antioxidant and anti-inflammatory activities, American elderberries may 
have other health-promoting properties that have been shown in research studies with 
European elderberries, such as hypoglycemia [254, 255], anti-influenza virus [256, 257], 
cardiovascular protective [258, 259] and chemoprotective activities [260]. However, the 
composition of phenolic compounds in American elderberries are different than European 
elderberries. Thus, the health-promoting properties of American elderberries may be different, 
which provides justification for investigating the potential health benefits of consuming 
American elderberries.  
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1.6 Kefir 
1.6.1 History and Production of Kefir  
 Kefir is a fermented dairy beverage that has a creamy texture and sour taste along with 
natural carbonation [261]. Kefir originated from the Caucasus Mountains in west Asia. The word 
“kefir” is derived from the Turkish word “keyif” which means “good feeling” [262]. Kefir was 
first discovered when the people of the Caucasus region stored fresh milk in leather pouches 
and the milk naturally fermented into an effervescent beverage [263]. Around the Caucasus 
region, kefir is commonly made with sheep milk. Currently, kefir is popular in European 
countries where cow milk is the typical base [263].  
 The major difference between kefir and other fermented dairy products is the presence 
of kefir grains and yeast. Kefir grains are white, cauliflower-shaped small granules (3-35 mm in 
diameter). These kefir grains are used in the production of kefir and are recovered after the 
fermentation process [264]. The composition of kefir grains varies due to many factors, such as 
the incubation conditions and the types of milk used [265]. Generally, they are mixtures of 
microflora, polysaccharides and proteins [261]. The microflora in kefir grains consists of up to 
30 species of lactic acid bacteria, yeasts and sometimes acetic acid bacteria [261, 266]. The kefir 
culture used in the research for this dissertation was a commercial products (Yogourmet®, 
Canada) containing Lactococcus lactis subsp. lactis, Lactococcus lactis subsp. cremoris, 
Lactococcus lactis subsp. bv. diacetylactis, Lactobacillus acidophilus and lactic yeasts. The 
polysaccharides in kefir grains are known as kefiran, which comprises glucose and galactose 
units [266], while the major proteins in kefir grains are caseins [261].  
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[267] 
Figure 1.4 Brief flowchart of traditional kefir production  
Traditionally, kefir fermentation is initiated by adding kefir grains to cooled pasteurized 
or unpasteurized milk. The fermentation process takes approximately twenty four hours at 
room temperature [267]. After fermentation, kefir grains are recovered and separated by 
filtering the kefir with sieves. The collected kefir grains are dried and stored at cold 
temperature (4˚C) until the next inoculation [267]. However, lyophilized starters are typically 
used in industry instead of kefir grains. One major reason is the difficulty of separating the kefir 
Raw milk 
Pasteurization 
Cooling 
Adding kefir grains 
Incubation 
Removal of kefir 
grains 
Kefir packaging 
Cold storage of kefir 
(4 ˚C) 
Kefir grains 
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grains at the end of fermentation [266, 267]. In order to obtain consistent kefir products, 
cultures with a known composition of microorganisms isolated from kefir grains may be used 
[268]. A flowchart of traditional kefir production was illustrated by Guzel-Seydim et al. and is 
shown in Figure 1.4 [269]. 
1.6.2 Nutritional Value of Kefir 
The nutritional profile of kefir is affected by the milk composition, kefir grain 
composition, fermentation conditions and storage conditions [270-272]. Sarkar reported that 
kefir typically contains 89-90% water, 0.2% lipid, 3% protein, 6% sugar and 0.7% ash [270]. Kefir 
is a source of complete protein, as the essential amino acid levels in kefir are reported to be: 
376 mg/100 g lysine, 262 mg/100 g isoleucine, 231 mg/100 g phenylalanine, 220 mg/100 g 
valine, 183 mg/100 g threonine, 137 mg/100 g methionine and 70 mg/100 g tryptophan [273, 
274]. Kefiran, a heteropolysaccharide (glucogalactan), is the major sugar in kefir [261]. During 
fermentation, the predominant sugar in milk – lactose, is hydrolyzed by β-galactosidase from 
bacteria in kefir grains and metabolized to glucose and galactose. Glucose is utilized by lactic 
acid bacteria which generates lactic acid. Lactic acid and/or galactose may be used as the 
carbon source for the yeasts in kefir grains [275]. Kefir is a suitable dairy beverage for lactose-
intolerant individuals due to the activity of β-galactosidase [270, 273, 275, 276]. Kefir contains 
various vitamins, such as vitamins B1, B2, B5, B6, B12, folic acid, A, C and K [270, 276]. The vitamin 
composition of kefir is influenced by both the type/composition of the milk used and the 
microbial profile of the kefir grains [270]. Kefir is a good source of potassium (1.65%), 
phosphorus (1.45%), calcium (0.86%) and magnesium (0.30%). Other minerals such as zinc, 
copper, iron, molybdenum and cobalt were also reported in kefir [274]. Kefir has also been 
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reported to have several bioactive compounds, such as bioactive peptides, exopolysaccharides 
(kefiran) and probiotics. These bioactive compounds may work independently or synergistically 
to enhance health-promoting activities [277]. The health-promoting properties of kefir will be 
introduced in the next section.  
1.6.3 Health Promoting Characteristics of Kefir  
1.6.3.1 Anti-inflammatory Activity of Kefir 
The anti-inflammatory activity of kefir has been documented by several studies using 
animal models with metabolic syndrome. In a study performed by Rosa et al., metabolic 
syndrome was induced in male SHR (Spontaneously Hypertensive Rats) by monosodium 
glutamate injection. After ten weeks of administrating kefir to their diet (kefir group, 1 mL/day) 
or using water as placebo (control group), a reduction in pro-inflammatory cytokines (IL-1β) and 
an increase in anti-inflammatory cytokine (IL-10) were observed in the kefir group compared to 
the control group. Beneficial effects on other biomarkers of metabolic syndrome, such as 
reductions in plasma triglycerides and insulin resistance, were also observed [278]. Hadisaputro 
et al. observed that the levels of pro-inflammatory cytokines (IL-1, IL-6) in STD-induced 
hyperglycemic rats were decreased after thirty days of plain kefir consumption (3.6 mL/day). 
Additionally, an increase in the anti-inflammatory cytokines (IL-10) was observed in the kefir-
fed rats [279]. The anti-inflammatory activity of certain compounds in kefir was investigated. 
Kwon et al. reported that the administration of kefiran (50 mg/kg body weight) reduced the 
numbers of inflammatory cells in the lavage fluid and the lung tissues of female mice with 
ovalbumin-induced asthma. The levels of inflammatory cytokines (IL-4 and IL-5) in 
bronchoalveolar lavage fluid was reduced to normal after kefiran consumption [280]. Chen et 
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al. performed an experiment using kefir peptide and male mice challenged with high-fructose 
corn syrup [281]. The results revealed that the status of mice with fatty liver syndrome was 
improved by kefir peptides administration. Decreased levels of inflammatory cytokines (TNF-α, 
IL-6 and IL-1β), hepatic triglycerides, cholesterol and serum alanine aminotransferase were 
observed in mice fed with kefir peptide compared to mice fed water [281]. In summary, regular 
consumption of kefir may help to ameliorate the symptoms of metabolic syndrome and 
decrease the risk of chronic diseases due to anti-inflammatory activities. Kefiran and bioactive 
peptides appear to contribute to the anti-inflammatory activities. 
1.6.3.2 Kefir Benefits for Diabetes 
 The consumption of kefir may benefit diabetic individuals by aiding in blood glucose 
control. In a double-blind intervention conducted by Ostadrahimi et al., sixty T2DM patients 
were divided into two groups and consumed 600 mL kefir per day (probiotic group) or 600 mL 
placebo per day (conventional fermented milk without probiotics). After an eight-week 
intervention, the fasting blood glucose levels and the glycated hemoglobin A1C (HbA1C) levels 
of the probiotic groups (6.40 ± 1.91) were significantly reduced compared to baseline (7.61 ± 
1.22) [282]. These results indicated that regular consumption of kefir could aid in the blood 
glucose control of individuals with diabetes. Compared to the control group, the fasting glucose 
levels and HbA1C levels of the probiotic groups were lower. These results also showed that the 
probiotic microorganisms (Lactobacillus casei, Lactobacillus acidophilus and Bifidobacteria) 
played an important role in the hypoglycemic activity of kefir [282]. In a study using diabetic 
KKAy mice, Maeda et al. observed that a thirty-day feeding of kefiran lowered the blood 
glucose in these mice [283]. Reductions in insulin resistance resulting from kefir 
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supplementation was observed by Rosa et al. in rats with metabolic syndrome [278]. Teruya et 
al. investigated the effects of kefir on glucose uptake in an insulin-responsive muscle cell line 
(L6 skeletal muscle cells). The authors reported that the glucose uptake ability of L6 cells was 
increased by a water-soluble fraction of kefir in the presence or absence of insulin [284]. 
Punaro et al. demonstrated that eight-weeks kefir consumption (1.8 mL/day) reduced glycogen 
accumulation in the renal tubules of STD-induced type 1 diabetic rats. This result indicates that 
kefir can slow the progression of renal injury in diabetic individuals [285]. Thus, kefir intake may 
be beneficial to diabetic individuals via modulating blood glucose levels, decreasing insulin 
resistance, increasing glucose uptake in muscle and reducing the progression of diabetic 
complications. The potential benefits of kefir for diabetes may be attributed to both the 
probiotic microorganisms and the microbial metabolites, such as kefiran. 
 In addition to anti-inflammatory properties and potential benefits to diabetes, kefir has 
been documented to have anti-allergic activities [286], anti-carcinogenic effects [287], 
cardiovascular protective activity [288, 289] and the ability to modulate gut microflora [286, 
290]. The probiotic microorganisms in kefir contribute to their health-promoting properties. In 
addition, the cell-free fractions of kefir, such as kefiran and bioactive peptides, also exhibit 
health-promoting activities [264, 291].  
1.7 Conclusions 
  The onset and progression of T2DM is associated with oxidative stress. The 
consumption of dietary antioxidants may help to reduce the risk of T2DM and slow the 
progression of secondary complications via decreasing oxidative stress. Dietary polyphenols are 
strong antioxidants. Higher consumption of polyphenols has been associated with many health 
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benefits. Aronia and American elderberries are polyphenol-rich fruits, and their health-
promoting properties have been suggested by many studies. The health-promoting properties 
of phenolic compounds, aronia berries and elderberries are shown in Table 1.1. Aronia berries 
and elderberries are suitable to be grown in most areas of the United States, including Maine, 
but the consumption of these berries is low due to their unpalatable taste and limited types of 
commercial products. The development of new products that are acceptable to consumers may 
help to increase the consumption of these berries. One concern about developing food 
products using these berries is that processing and the addition of other food ingredients may 
lower the amount of bioavailable berry phenolics. Kefir, a fermented dairy beverage, may be a 
suitable food matrix for the incorporation of berries due to the following reasons: 1) kefir is 
acidic and the low pH environment can be beneficial to the stability of phenolic compounds; 2) 
kefir is rich in proteins, which may help to mask the astringency of polyphenols; 3) the 
fermentative microorganisms in kefir may increase the bioavailability of phenolic compounds. 
In order to ensure consumers will receive the optimal health benefits of theses berries, the 
health-promoting properties of the newly developed products must be evaluated. Therefore, 
research studies in this dissertation focused on the development of berry-added kefirs and the 
evaluation of their bioavailability and heath-beneficial characteristics. 
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Table 1.1 Health-promoting characteristics of phenolic compounds, aronia berry, elderberry 
and kefir 
 Health-promoting characteristics 
Phenolic compounds 
Reduce oxidative stress in-vivo 
Attenuate chronic inflammation 
Beneficial to T2DM, including increase insulin sensitivity, aid in blood 
glucose control, and decrease AGE production 
Aronia berry 
Reduce oxidative stress in-vivo 
Anti-inflammatory activity 
Beneficial to T2DM, including increase insulin secretion and help to 
control postprandial blood glucose 
Others: anti-influenza activity, anti-infection, etc. 
Elderberries 
(American) 
Anti-oxidant capacity in-vitro 
Anti-inflammatory activity 
Kefir 
Anti-inflammatory activity  
Beneficial to diabetes, including decrease insulin resistance, aid in 
blood glucose control and reduce glycogen accumulation 
Others: anti-allergic activity, anti-carcinogenic effect, cardiovascular 
protective activity and gut microflora modulatory effect. 
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CHAPTER 2 
 DEVELOPMENT AND EVALUATION OF KEFIR PRODUCTS MADE WITH ARONIA OR ELDERBERRY 
JUICE: SENSORY AND PHYTOCHEMICAL CHARACTERISTICS 
 
This chapter is accepted by the International Food Research Journal and will be 
published in volume 25, issue 4. 
 
2.1 Chapter Abstract 
Aronia and elderberry are edible berries that are rich in anthocyanins and phenolic 
compounds. They are rarely consumed raw due to safety concerns and their unpalatable taste. 
Aronia and elderberry are not widely grown and they are not commonly used as food 
ingredients for commercial products, thus they are considered underutilized. Incorporating 
these berries into new products, such as kefir, provides diverse food choices and may increase 
the dietary consumption of these bioactive compounds. In this study, kefir containing either 
aronia or elderberry juice was developed using different sweeteners and levels of sweetness. 
Sensory tests were conducted to evaluate the consumer acceptability of the kefir products 
made with fresh aronia juice or commercial elderberry juice from Wyldewood Cellars® (Wichita, 
KS, U.S.). In the aronia kefir sensory test, the product sweetened with sucrose received the best 
overall acceptability (6.3) while the product sweetened with monk fruit extract was least 
favored (4.9). In the elderberry kefir sensory test, 5.7% sucrose-sweetened product was best 
accepted (6.6) followed by 4.3% sucrose-sweetened (6.1). Non-nutritive sweeteners (stevia and 
monk fruit extracts) were less accepted than sucrose in both tests. Phytochemical analyses 
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showed that aronia kefir contained high amounts of total phenolic compounds and 
anthocyanins. Kefir made with commercial elderberry juice had a moderate amount of total 
phenolics and a low amount of anthocyanins. Antioxidant capacity was observed in all products 
indicating that the consumption of berry-added kefir may benefit the decrease of oxidative 
stress. Kefir made with aronia or elderberry are acceptable functional foods which may 
contribute to the prevention of inflammation and chronic diseases when incorporated into a 
healthy diet. 
2.2 Introduction 
 Epidemiological studies suggest that the consumption of anthocyanin-rich fruits may 
contribute to decreasing the risk of type 2 diabetes [3]. The protective impacts of phenolic 
compounds on oxidative-stress-related diseases are related to their high antioxidant capacity 
[292-294]. Rios et al. indicate that blueberry extracts rich in polyphenols could decrease the 
levels of oxidized DNA bases in human subjects and attenuate DNA damage induced by H2O2 
[295]. Anthocyanin intake (two levels, 40 and 200mg/kg) is able to reduce high-fat-diet-induced 
oxidative stress in mice by boosting the activity of antioxidant enzymes (SOD and GPx). 
Systemic inflammation could be decreased with this range of intake by lowering the expression 
levels of inflammatory cytokines, such as IL-6 and TNF-α [296]. In-vitro studies revealed that 
anthocyanin-rich extracts could inhibit the formation of advanced glycation end products and 
consequently decrease the risk of diabetic complications [297]. 
Aronia melanocarpa (aronia) and Sambucus nigra L. ssp. canadensis (elderberry) are 
berries that contain high amount of anthocyanins and polyphenols [179, 239]. They are not 
widely commercial cultivated thus they are underutilized. These berries exhibit high antioxidant 
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capacity due to the phenolic compounds. Aronia and elderberry are known to reduce oxidative 
stress in humans [196, 298]. Aronia and elderberry are popular in Europe where they are 
utilized as functional food ingredients and color additives [179, 299]; however, a market for 
these berries in the United States has not been well developed.  
Kefir is a fermented dairy beverage that originated in the Caucasus Mountains region 
over one hundred years ago [268, 300]. Kefir grains consist of complex microbial communities 
and contain up to 30 species [301] where lactic acid bacteria is usually predominant, followed 
by yeast and acetic acid bacteria [264]. Several studies suggest that kefir has anti-microbial, 
anti-inflammatory, and anti-carcinogenic activities [275, 302, 303]. Kefir is naturally lactose-
free, this property makes kefir a good source of calcium and protein for lactose intolerant 
individuals [270]. The fermentative microorganisms may have the ability to increase the 
bioaccessibility and bioavailability of phenolic compounds due to the release of bound phenolic 
constituents by some lactic acid bacteria [315, 304]. The low acid environment of kefir is helpful 
to decrease the natural degradation of phenolic compounds [305]. Therefore, the combination 
of anthocyanin-rich berries and kefir may result in a value-added functional product. The 
objective of this study was to develop functional food products by incorporating either aronia 
or elderberry juice into a kefir beverage and evaluate their sensory and phytochemical 
characteristics. Different natural sweeteners (sucrose, stevia or monk fruit extract) were used 
to enhance the sweetness of the products. The consumer acceptability of the products was 
evaluated via sensory tests. The aronia sensory test focused on the impact of sweetener variety 
on consumer acceptability. The elderberry kefir sensory test assessed the influence of 
sweetness levels. Bioactive constituents of the kefir products were analyzed in the laboratory. 
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2.3 Material and Methods 
2.3.1 Chemicals 
Methanol, citric acid anhydrous, potassium chloride, hydrochloric acid, and sodium 
bicarbonate were obtained from Fisher’s Scientific (Waltham, MA, U.S.). 2, 2-diphenyl-1-
picrylhydrazyl (DPPH), Folin - Ciocalteu’s phenol reagent and gallic acid were purchased from 
Sigma-Aldrich (St. Louis, MO, U.S.), and sodium acetate from Chem-Impex int’l inc. (Wood Dale, 
IL, U.S.). Ultrapure water was obtained from a Millipore water system (EMD Millipore, Billerica, 
MA, U.S.).  
2.3.2 Dietary Material 
Aronia (Aronia melanocarpa, variety ‘Viking’) were obtained from the University of 
Connecticut (Storrs, CT, U.S.) from the 2014 growing season. Elderberry juice was a gift of Dr. 
John Brewer from Wyldewood Cellars® (Wichita, KS, U.S.). Elderberries (Sambucus nigra, L. ssp. 
canadensis) used in making samples for fresh juice phytochemical analyses were collected from 
the experimental garden at the University of Maine (Orono, ME, U.S.) during the 2015 harvest 
season. Berries were harvested at full ripeness which was determined by a deep purple color 
and softness of the berry. They were de-stemmed and washed, then frozen at -20˚C. The 
thawed berries were pasteurized (100˚C, 5 minutes) in an aluminum sauce pan then juiced with 
a domestic juicer (Hamilton Beach, Southern Pines, NC, U.S.). Juice yield from 1 kg berries 
averaged 360 g. Fresh juice was used immediately to make the kefir products. Commercial kefir 
culture (Yogourmet®, Lachute, QC, Canada) was used as the starter for the kefir.  The viability of 
the lactic bacteria in the starter was determined by inoculation on MRS agar (Nedgen, Lansing, 
MI, U.S.) at 40˚C for 48 hours. The viability of the yeast in the starter was measured by plating 
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on antibiotic plate counting agar (Alpha Biosciences, Baltimore, MD, U.S.) at room temperature 
for 96 hours. Sucrose (Great Value®, Bentonville, AR, U.S.), stevia extract (Stevia in the Raw®, 
New York City, NY, U.S.), monk fruit extract (Monk Fruit in the Raw®, New York City, NY, U.S.) 
and 2% milk (Oakhurst®, Portland, ME, U.S.) were purchased from local supermarkets.  
2.3.3 Kefir Manufacture and Formulas 
All kefir products were prepared by the following method: 2% milk was heated to 82˚C 
in a commercial size aluminum sauce pan, cooled to 26˚C using an ice bath, and then 
transferred to a 4 L pyrex glass bowl. The commercial starter was added to the milk (5 g per 
quart), and the mixture was stirred for 5 minutes to ensure the starter was dissolved. Either 
aronia juice (~13%, w/w) or elderberry juice (~10%, w/w) was added to the mixture. The 
amount of non-nutritive sweetener used in each product was adjusted according to the 
instruction on the package to create equal sweetness to sucrose. After the addition of all 
ingredients, the mixture was covered with a cloth and left at room temperature to ferment for 
24 hours. The kefir was homogenized with a Hamilton Beach immersion blender (Southern 
Pines, NC, U.S.). Each kefir product was divided into two containers with sealed lids and stored 
at 4˚C. The kefir was allowed to chill at 4 ˚C for 2 hours prior the sensory tests. The sensory 
tests were completed within 36 hours. Formulas are shown in Table 2.1.  Kefir products were 
only formulated with juice and sweetening agents (sucrose, stevia extract, or monk fruit 
extracts); no additional modifiers were used. Low sucrose levels were selected for reducing 
calorie content and to ensure that the predominant flavor was from the berry juice. 
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  An aliquot of the kefir prepared for the sensory test was collected and stored at -20˚C 
until laboratory analyses. The initial study design was to utilize fresh berry juices for the kefir 
products but due to crop failures in 2013 and 2014, fresh elderberries were not available. 
Commercial elderberry juice (shelf-stable product) was used in this study. To better understand 
the difference between commercial and fresh elderberry juice, an additional set of elderberry 
kefir products made with fresh juice was prepared and analyzed in the laboratory at a later 
date.  
Table 2.1 Formulas of kefir products for sensory evaluation 
Product Sweetener Milk with 
starter (g) 
Commercial 
elderberry 
juice (g) 
Fresh 
elderberry 
juice (g) 
Fresh 
aronia 
juice (g) 
Sucrose 
(g) 
Stevia 
(g) 
Monk 
fruit 
(g) 
Aronia kefir 
sucrose 83 ---- ---- 13 4.0 ---- ---- 
stevia 83 ---- ---- 13 ---- 0.40 ---- 
monk fruit 83 ---- ---- 13 ---- ---- 0.80 
Elderberry 
kefir 
(commercial 
juice) 
low sucrose 
(4.3%) 
90 10 ---- ---- 4.5 ---- ---- 
high sucrose 
(5.7%) 
90 10 ---- ---- 6.0 ---- ---- 
low stevia 
(0.4%) 
90 10 ---- ---- ---- 0.45 ---- 
high stevia 
(0.6%) 
90 10 ---- ---- ---- 0.60 ---- 
Elderberry 
kefir 
(Fresh juice) 
low sucrose 
(4.3%) 
90 ---- 10 ---- 4.5 ---- ---- 
high sucrose 
(5.7%) 
90 ---- 10 ---- 6.0 ---- ---- 
low stevia 
(0.4%) 
90 ---- 10 ---- ---- 0.45 ---- 
high stevia 
(0.6%) 
90 ---- 10 ---- ---- 0.60 ---- 
Note: ---- indicates the ingredient was not used in the formula 
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2.3.4 Sensory Analyses  
All sensory tests were performed in the Sensory Testing Center at the University of 
Maine, Orono campus. Sensory tests were approved by the Institutional Review Board for the 
Protection of Human Subjects at the University of Maine (IRB). Two tests were conducted and 
100 healthy participants for each test were recruited from the community. Demographic 
information was collected, such as age and gender. Consumer familiarity with the berries and 
kefir was assessed. Consumer attitude toward purchasing healthy food was asked. Color, flavor, 
sweetness, texture and overall acceptability of all samples were evaluated using a 9-point 
hedonic scale (1=dislike extremely, 5=neither like nor dislike, 9=like extremely). Products 
received random 3-digit codes and samples were presented to the consumers in a randomized 
sequence. Samples were served cold (4 ˚C) in transparent 2 oz plastic cups and water was 
offered as a palate cleanser. Information was collected anonymously with computers using 
SIMS Sensory Software® (Berkeley Heights, NJ, U.S.). Each participant was compensated with $2 
for completion of the sensory test.  
2.3.5 pH, Titratable Acidity, Total Soluble Solids and Color Measurements 
pH, titratable acidity (TA), and total soluble solids (˚Brix) were evaluated following the 
methods reported by Mena et al. with minor modification [306]. Briefly, pH was measured 
using a Sartorius pH meter (Bohemia, NY, U.S.). TA was determined by titrating 5 g of kefir with 
0.1 M NaOH solution. The results were expressed as % lactic acid [307] in kefir and % citric acid 
in juice. Total soluble solids were tested using a PAL-3 refractometer by Atago (Tokyo, Japan) 
and values were expressed as ˚Brix. The color was measured using a LabScan XE 
spectrophotometer manufactured by HunterLab (Reston, VA, US) and was recorded as L* 
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(lightness), a* (redness/greenness), and b* (yellowness/blueness). Hue angle and Chroma 
values were calculated by the following formulas [308, 309].  
Hue = Arc tan(𝑏∗ 𝑎∗⁄ ) for the first quadrant (+a, +b) 
Hue = 360 + Arc tan(𝑏∗ 𝑎∗⁄ ) for the fourth quadrat (+a, -b) 
 Chroma =  √(𝑎∗2 + 𝑏∗2) 
pH and ˚Brix were measured in triplicate, TA was measured in duplicate due to limited 
sample availability. Color was measured in five independent tests to confirm the uniformity of 
the sample and obtain representative results.  
2.3.6 Extraction 
Phenolic compounds were extracted following the method reported by Scibisz et al. 
with modification [310]. After adding acidified 80% methanol (1% citric acid, w/v, 1:10, 
sample:solvent) to the kefir matrix, the mixture was vortexed then sonicated in a Branson 5510 
sonicator (Danbury, CT, U.S.) for 1 hour. Samples were centrifuged at 16639×g (Eppendorf 
5804R, Hamburg, Germany) for 30 minutes at 4˚C. The supernatant was collected. This process 
was repeated three times. The combined supernatant was evaporated under a vacuum 
(Eppendorf Vacufuge plus, Hamburg, Germany) at room temperature. Dried samples were re-
suspended using acidified 100% methanol (1%, citric acid), and kept at ˗20˚C for one hour to 
precipitate the protein. The slurry was then centrifuged at 16639×g for 30 minutes at 0˚C and 
the supernatant was collected. Supernatant was dried under a vacuum and re-suspended with 
80% acidified methanol (1%, w/v). The extract samples were kept at ˗20˚C until analyses. 
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2.3.7 Total Phenolic Content 
TP content was determined using the Folin-Ciocalteu method as described by Velioglu et 
al., with minor modifications [311]. Briefly, after mixing extract (20 µl) and Folin-Ciocalteu 
reagent (90 µl), the plate was left at room temperature for 5 minutes and then sodium 
bicarbonate (6 g/100 ml, 90 µl) was added. The plate was covered and incubated at room 
temperature in the dark for 90 minutes. The absorbance was read at 750 nm with a Biotek plate 
reader (ELx 800, Winooski, VT, U.S.). All samples were measured in triplicate, and the results 
are expressed as gallic acid equivalents (GAE). 
2.3.8 Total Monomeric Anthocyanin Content 
TMA content was determined using the pH differential method developed by Lee et al. 
with modifications to fit a 96-well plate format [82]. Briefly, the extract (20 µl) was diluted with 
180 µl of pH 1.0 buffer (0.025 M, potassium chloride) and 180 µl pH 4.5 buffer (0.4 M, sodium 
acetate) separately. The mixture was incubated for 20 minutes at room temperature in the 
dark. The absorbance (abs) was read at 520 nm and 690 nm using the plate reader. The TMA 
content was calculated by the following formula and expressed as cyanidin-3-glucoside (C3G) 
equivalents. 
Anthocyanin (cyanidin − 3 − glucoside equivalents , mg L⁄ ) =  
A ×MW×DF×103
ε×L
  
Where: A = (abs520 nm – abs700 nm) pH 1.0 – (abs520 nm – abs700 nm) pH 4.5; 
MW (molecular weight) = 449.2g/mol for cyanidin-3-glucoside; 
DF = dilution factor; 
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L = pathlength in cm; 
ε= 26900L/mol·cm, for cyanidin-3-glucoside; 
103 = factor for conversion from g to mg. 
2.3.9 Antioxidant Capacity  
Antioxidant capacity was determined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
free radical scavenging method by Duymus et al. with minor modifications [312]. 150 µl of 
DPPH solution (0.3 mM) were added to 150 µl serially diluted extracts, the mixture was 
incubated in the dark at room temperature for 30 minutes and read at 515 nm. The inhibition 
rate was calculated by the following formula:  
%inhibition =  
Abs𝐶𝑜𝑛𝑡𝑟𝑜𝑙−Abs𝑆𝑎𝑚𝑝𝑙𝑒
Abs𝐶𝑜𝑛𝑡𝑟𝑜𝑙
× 100  
Inhibition (%) was plotted against extract concentration, and the IC50 (the concentration 
to scavenge fifty percent of DPPH free radical) was calculated. Gallic acid was used as a positive 
control.  
2.3.10 Statistical Analysis 
Data are shown as mean ± standard deviation. Sensory data were analyzed with one-
way analysis of variance using JMP 12 software by SAS Institute Inc. (Cary, NC, U.S.). Tukey’s 
Honest Significant Difference (HSD) test was used for mean comparisons. Pearson test was used 
to determine correlations. A significance level was set at α = 0.05.  
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2.4 Results and Discussion 
2.4.1 Aronia Kefir Evaluations 
2.4.1.1 Aronia Kefir Sensory Test 
Three aronia kefir products containing different sweeteners were evaluated in this test. 
The only difference among aronia kefir products was the type of the sweetener. Participants’ 
perception about different sweeteners could be assessed. Demographic results demonstrated 
that participants in this test were balanced in gender (54 female and 46 male), and the general 
age range was 18-34 years old. A question about the importance of purchasing food with 
potential health benefits was addressed and 94% of participants responded positively. Thus, 
functional food products, like aronia kefir, comply with consumer purchasing trends. Sensory 
attributes and overall acceptability results are shown in Figure 2.1. The results show that the 
participants accepted the color of all the products equally; however, significant differences in 
acceptability were detected for other attributes. Based on the ratings for sweetness, the 
participants liked the sucrose-sweetened sample best followed by stevia and monk fruit extract 
was the least favored. Similar results were obtained by another study where chocolate milk 
sweetened with sucrose received better acceptability compared to stevia or monk fruit extracts 
[313]. A study by Cardello et al. demonstrate that many non-nutritive sweeteners, such as 
stevia and aspartame have a residual bitter taste which is not well accepted by the consumers 
[314]. In our test, consumers noted that kefir products sweetened with non-nutritive 
sweeteners (stevia and monk fruit extract) had a “bad”, “longer”, or “unpleasant aftertaste” 
which lowered consumer liking of the products. Flavor was best received in the sucrose-
sweetened aronia product. Kefir has a unique flavor due to the lactic acid and carbon dioxide 
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[273]. In this study, aronia juice and sweeteners were added to the kefir, and contributed to the 
overall flavor profile. Aftertaste of non-nutritive sweeteners may be a reason for the low 
hedonic scores of the products in the flavor attribute. The best texture was received in the 
sucrose-sweetened product where a thicker consistency was noticed. Cardoso and Bolini 
indicated that sucrose contributed a more viscous texture to a beverage product compared to 
non-nutritive sweeteners [315]. The unique foamy texture of kefir generated by carbonation 
during fermentation [267] may be novel to the American palate and may have an impact on the 
acceptability. Consumer preference of the texture may be influenced by the viscosity and the 
carbonation of the product. The best overall acceptability (6.3) was received in aronia kefir 
made with sucrose. Aronia kefir made with monk fruit extract, by contrast, received the lowest 
hedonic score (4.9). In addition to the influence by sweeteners, consumers’ unfamiliarity with 
the kefir and/or aronia berry may be another reason which had an impact on the overall 
acceptability of the products. Over half of the participants (57%) were naive to kefir (never 
consumed kefir previously) and 78% were not familiar with aronia. Orjuela-Palacio et al. proved 
that repeated exposure to a high-polyphenol beverage increased the consumer acceptance 
[316]. This indicates that the acceptability of the kefir products in this study could be higher if 
our participants were more familiar with either kefir or aronia. Generally, overall acceptability 
of each aronia kefir product was better received by participants who were previously familiar 
with kefir compared to the kefir-naive participants (data not shown).  
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Figure 2.1. Consumer acceptability of aronia kefir made with different sweeteners 
Note: Data are shown as means ± standard deviation. n=100.  
Different letters indicate significant differences among means within each attribute, 
p<0.05. 
2.4.1.2 Aronia Kefir Quality Parameters 
The results of pH, TA, ˚Brix and color of aronia kefir are shown in Table 2.2. The pH 
values of aronia kefir were in the acidic range as expected and this acidic environment is 
necessary to maintain the integrity of the phenolic compounds [305]. TA is representative of 
the sour taste in the product. Lactic acid produced by the kefir culture and organic acids in 
aronia juice contributed to TA values. No correlation was observed between TA and pH (r = -
0.13, p = 0.73). The highest ˚Brix value was observed in the sucrose-sweetened product as 
expected. Several factors contribute to the ˚Brix of the product. They include the added 
sucrose, fructose in aronia berries and the breakdown products of the milk disaccharides by the 
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living culture. Concentrations of viable lactic acid bacteria and yeasts in the commercial kefir 
starter were 9.83 × 108 CFU/g and 5.3 × 104 CFU/g, respectively. 
Table 2.2 Quality evaluation of juices, aronia kefir, elderberry kefir made with commercial juice, 
and elderberry kefir made with fresh juice  
Product 
pH 
(n=3
) 
TSS 
(˚Brix 
n=3) 
%TA 
(w/w 
n=2) 
Color (n=5) 
L* a* b* 
Hue 
angle 
Chroma 
Aronia kefir 
Sucrose 
4.4±
0.01 
13.2 ± 
0.10 
0.64 
53.1 ± 
0.26 
16.9 ± 
0.29 
-4.9 ±  
0.14 
359.7 
± 0.01 
17.6 ± 
0.24 
Stevia 
4.4±
0.01 
8.9 ±  
0.06 
0.67 
53.2 ±  
0.04 
16.7 ±  
0.11 
-5.1 ±  
0.04 
359.7 
± 0.00 
17.5 ±  
0.09 
Monk fruit 
4.4± 
0.01 
9.5 ± 
0.12 
0.66 
54.0 ± 
0.12 
16.9 ±  
0.17 
-4.6 ±  
0.09 
359.7 
± 0.01 
17.5 ±  
0.14 
Elderberry 
kefir 
(commercial 
juice) 
4.3% sucrose 
4.5± 
0.01 
13.1 ±  
0.06 
0.73 
60.5 ± 
0.11 
10.9 ±  
0.02 
1.5 ±  
0.04 
360.1 
± 0.00 
11.0 ±  
0.03 
5.7% sucrose 
4.6± 
0.01 
14.6 ± 
0.06 
0.70 
60.4 ± 
0.11 
10.9 ± 
0.03 
1.6 ± 
0.05 
360.1 
± 0.00 
11.1 ±  
0.04 
0.4% stevia 
4.5± 
0.01 
9.2 ± 
0.00 
0.77 
60.8 ± 
0.48 
10.8 ± 
0.07 
1.7 ±  
0.08 
360.2 
± 0.01 
10.9 ±  
0.08 
0.6% stevia 
4.5± 
0.01 
9.2 ± 
0.06 
0.75 
61.6 ± 
0.27 
10.6 ± 
0.16 
1.6 ±  
0.05 
360.2 
± 0.00 
10.7 ±  
0.17 
Elderberry 
kefir  
(fresh juice) 
4.3% sucrose 
4.5± 
0.01 
13.5 ± 
0.01 
0.74 
60.7 ± 
0.07 
12.0 ± 
0.09 
0.1 ±  
0.06 
360.0 
± 0.01 
12.0 ± 
0.09 
5.7% sucrose 
4.5± 
0.01 
14.9 ± 
0.06 
0.74 
60.6 ± 
0.02 
12.1 ± 
0.03 
-0.3 ± 
0.04 
360.0 
± 0.00 
12.1 ± 
0.03 
0.4% stevia 
4.6± 
0.01 
9.1 ± 
0.06 
0.76 
59.9 ± 
0.04 
12.2 ± 
0.03 
0.6 ± 
0.03 
360.1 
± 0.00 
12.2 ± 
0.03 
0.6% stevia 
4.6± 
0.01 
9.5 ± 
0.01 
0.74 
59.6 ± 
0.09 
12.7 ± 
0.05 
0.3 ± 
0.07 
360.0  
± 0.01 
12.7 ± 
0.05 
Juice 
Aronia 
3.4± 
0.00 
17.1 ± 
0.06 
1.15 
0.4 ± 
0.01 
0.1 ± 
0.02 
-0.3 ± 
0.03 
358.7 
± 0.07 
0.3 ± 
0.02 
Commercial 
elderberry 
4.0± 
0.01 
20.7 ± 
0.06 
1.90 
0.3 ± 
0.00 
-0.1 ± 
0.01 
-0.8 ± 
0.01 
361.4  
± 0.01 
0.8 ± 
0.01 
Fresh 
elderberry 
4.3± 
0.01 
12.5 ± 
0.00 
0.55 
2.40 ± 
0.12 
2.7 ± 
0.22 
3.5 ± 
0.22 
360.9  
± 0.05 
4.4 ± 
0.24 
Note: Data are shown as means ± standard deviation except for %TA.  
Since hue values were close to 0°/360° on hue angle scale, hue angle values were 
transformed by adding 360° for comparison [308]. 
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Chroma values indicate the saturation or the intensity of the color. High Chroma values 
of the aronia kefir products indicated the color was saturated. Based on the similar Chroma 
values among the aronia kefir products, there was no difference in the color intensity. Hue 
angle values close to 0° (360°) indicated reddish color. The hue angle values of aronia kefir 
indicate that the products displayed a reddish color. High L* values of the aronia kefir show the 
products had a bright color. Positive a* values and negative b* values of the products indicate 
the products presented a bluish-red color. Anthocyanins present a red to a blue color when the 
environment changes from acidic to alkaline. The bluish-red color was expected in the products 
due to the acidic environment of kefir. 
2.4.1.3 Aronia Kefir Phytochemical Analyses 
The results of the phytochemical analyses of aronia kefir samples are shown in Table 
2.3. Aronia kefir products had high TMA contents (16.57-17.22 mg C3G/100 g kefir). A typical 
serving size of kefir is 8 oz. One serving of the aronia kefir product would provide more than 39 
mg TMA. Average TMA intake in the United States is 12.5 mg/day/person [201]. Our products 
provided three times more than the average intake for TMA. An epidemiologic study shows 
that in a population with an intake of 22.3-24.3 mg/day of TMA there was a lower incidence of 
type 2 diabetes compared to a population with only 2.0-2.3 mg/day [3]. In addition, Jennings et 
al. indicated that a TMA intake of 39.9 mg/day was associated with lower inflammation levels 
and improved insulin resistance compared to a TMA consumption of only 3.54 mg/day [317]. 
According to Seymour et al., consumption of cherries containing 25.83 mg TMA increased the 
plasma antioxidant capacity for 12 hours in healthy humans [149]. This evidence confirms that 
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the consumption of aronia kefir could increase anthocyanin intake in a normal diet and 
contribute to decreasing in inflammation and preventing type 2 diabetes.  
Table 2.3 Phytochemical evaluation results of juices, aronia kefir, elderberry kefir made with 
commercial juice and elderberry kefir made with fresh juice 
Product Anthocyanin 
Content 
(mg C3G/100 g 
sample) 
Total Phenolic 
Compounds 
(mg GAE/100 g 
sample) 
DPPH IC50 
(mg 
sample/mL) 
Aronia kefir 
Sucrose 17.22 ± 0.17 43.04 ± 1.05 28.84 ± 0.26 
Stevia 16.57 ± 0.44 40.32 ± 1.02 27.59 ± 0.26 
Monk fruit 16.94 ±0.38 40.37 ± 0.51 27.84 ± 0.26 
Elderberry kefir 
(commercial 
juice) 
4.3% sucrose 1.02 ± 0.22 19.61 ± 0.25 59.19 ± 0.37 
5.7% sucrose 0.95 ± 0.01 18.76 ± 0.19 65.52 ± 0.13 
0.4% stevia 1.13 ± 0.02 19.86 ± 0.32 60.36 ± 0.56 
0.6% stevia 1.06 ± 0.02 20.13 ± 0.58 61.65 ± 0.76 
Elderberry kefir  
(fresh juice) 
4.3% sucrose 18.67 ± 0.08 42.31 ± 0.96 20.86 ± 0.43 
5.7% sucrose 20.10 ± 0.14 43.66 ± 1.90 20.36 ± 0.86 
0.4% stevia 17.05 ± 0.06 39.00 ± 0.46 24.11 ± 0.67 
0.6% stevia 18.90 ± 0.07 43.50 ± 0.82 20.68 ± 0.55 
Juice 
Aronia 275.64 ± 3.18 604.49 ± 14.90 1.54 ± 0.04 
Commercial 
elderberry 
25.59 ± 1.58 337.28 ± 4.75 4.39 ± 0.03 
Fresh 
elderberry 
416.92 ± 3.18 369.47.59 ± 1.38 2.14 ± 0.01 
Note: Data are shown as means ± standard deviation, n=3. 
TP content in aronia products were 40.32 – 43.04 mg GAE/100 g kefir. An 8 oz serving 
provides more than 95 mg GAE of phenolics to the consumers. This equals about one-fifth of 
the average daily consumption of TP (450 mg GAE/person) in the American diet [318]. Dall’Asta 
et al. proved that dietary polyphenols could stimulate insulin secretion and protect β-cells from 
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the damage induced by oxidative stress [106]. Aronia kefir products could add to the overall 
consumption of total phenolics in the diet and contribute to the prevention of diabetes. DPPH 
IC50 values of aronia kefir products were between 27.59 to 28.84 mg kefir/mL. These results 
showed that the products had the ability to sequester free radicals. The antioxidant capacity of 
aronia kefir products is associated with the amount of TMA and TP. Kefir is a live culture and 
the environment is dynamic. TMA and TP are being actively metabolized which helps explain 
the low recovery rates. Recovery rates of TMA and TP were about 45% and 55% respectively. 
TMA ingested from fruit and vegetables are usually conjugated and have low bioavailability 
[319]. Using a food matrix like kefir that contains live cultures may enhance the bioaccessibility 
of the aronia bioactive compounds by increasing TMA due to the de-conjugation of the 
anthocyanins.  
2.4.2 Elderberry Kefir Evaluations (Commercial Juice) 
2.4.2.1 Elderberry Kefir Sensory Test 
Four elderberry kefir products sweetened with either sucrose or stevia were evaluated 
in this test. In the previous sensory test of aronia kefir, monk fruit extract was not well accepted 
and it was eliminated from the test of elderberry kefir. The elderberry kefir products were 
sweetened to two levels to test the impact of sweetness. Commercial products, such as 
blueberry flavored Lifeway® kefir, usually have about 20% sugars including 8 g added sugars. 
The ˚Brix values of the products in this study without added sweetener were approximately 9% 
(data not shown). Thus 4.3% or 5.7% sucrose was used to sweeten elderberry kefir to keep the 
total ˚Brix at least 5% lower than commercial products. 0.4% and 0.6% stevia extracts were 
used to create equal sweetness to the sucrose products respectively. Demographic results 
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showed that participants in this test were balanced for gender (55 female and 45 male) and the 
major age range was 18-34 years old. All participants in this test responded positively that 
purchasing health-beneficial food was important.  
The consumer acceptability test (Figure 2.2) demonstrated that the products were 
accepted equally for color. The best acceptability in sweetness was observed in elderberry kefir 
sweetened with higher sucrose content (5.7%). Significantly lower ratings were observed in the 
two products sweetened with stevia extract. This is potentially driven by the unpleasant 
aftertaste of stevia extract based on the consumer comments. Sweeter products (5.7% sucrose 
and 0.6% stevia) were accepted better compared to less sweet products (4.3% sucrose and 
0.4% stevia), but there was no significant difference between two stevia-sweetened products in 
this study. A similar trend was observed by Johansen et al. [320]. Their study indicated that 
yogurt sweetened with 13% sucrose significantly increased consumer preference compared to a 
product sweetened with 9% sucrose. Flavor was rated best in elderberry kefir sweetened with 
higher sucrose content (5.7%) which was not significantly different from elderberry kefir 
sweetened with 4.3% sucrose. The acid in kefir matrix, added sweetener and elderberry juice 
contributed to the complex flavor of the elderberry products. Fermented dairy products have a 
distinctive sour taste which may be a negative influencing factor on the consumers’ 
acceptability [321]. The addition of sucrose to the products resulted in an increased sweet to 
sour ratio (˚Brix:TA) and may present a better-balanced flavor. The two products sweetened 
with stevia extract were less-accepted for flavor. The reason may be the unpleasant aftertaste 
of stevia extract. The best texture was received in the elderberry product with 5.7% sucrose. 
Sucrose contributes to a more viscous texture which was observed in this product. 
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Effervescence in dairy products induced by fermentation may be unfamiliar to consumers and 
might be an influencing factor. Best overall acceptability (6.6) was rated in elderberry kefir 
sweetened with high sucrose content (5.7%), and the product made with low stevia content 
(0.4%) received the lowest rating (5.8). Similar to what was observed in the previous aronia 
kefir consumer testing, participants’ unfamiliarity with either kefir or elderberry may 
undermine the overall acceptability of the products. In this test, 40% of the consumers had 
never consumed kefir and 58% of the participants were unfamiliar or had never heard of 
elderberry. Elderberry kefir products were better accepted by previous kefir consumers 
compared to the kefir-naive group (data not shown).  
 
Figure 2.2 Consumer acceptability of elderberry kefir made with different sweeteners 
Note: Data are shown as means ± standard deviation. n=100. Different letters indicate 
significant differences among means within each attribute, p<0.05. 
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2.4.2.2 Elderberry Kefir Quality Parameters (Commercial Juice) 
pH, TA, ˚Brix and color results of elderberry kefir made with commercial juice are shown 
in Table 2.2. The pH values demonstrated that the elderberry kefir products were acidic, which 
is necessary for the stability of bioactive compounds [305]. TA of products sweetened with 5.7% 
sucrose was the lowest while stevia-sweetened (0.4%) elderberry kefir was the highest. TA 
represents the sour taste. The sour taste in elderberry kefir was associated with the lactic acid 
generated by fermentation and the organic acids from the elderberry juice. There was no 
significant correlation between TA and pH (r = 0.49, p = 0.25). The highest ˚Brix value was 
observed in 5.7% sucrose-sweetened products as expected. Product sweetened with 4.3% 
sucrose was second highest. Stevia products both had low ˚Brix values. Color was analyzed for 
elderberry kefir products. All elderberry kefir products had similar color intensity based on the 
Chroma values. Hue angle values of all elderberry products were close to 0 (360) indicating that 
the products presented as a reddish color. High L* values indicated that the products had a light 
color. a* and b* values of all products were positive. This indicated that elderberry kefir 
products present light red color. Since anthocyanins present a red color in an acidic 
environment, this color was reasonable. 
2.4.2.3 Elderberry Kefir Phytochemical Analyses (Commercial Juice) 
Phytochemical results of elderberry kefir made with commercial juice are shown in 
Table 2.3. Kefir products made with commercial elderberry juice contained a low amount of 
TMA (0.95 – 1.13 mg C3G/100 g kefir) and a moderate amount of TP (18.76 – 20.13 mg 
GAE/100 g kefir). The TMA and TP contents of commercial elderberry juice were 25.59 mg 
C3G/100 g and 337.28 mg GAE/100 g respectively. These amounts were much lower than the 
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reported values in the literature [322]. The recovery rates of TMA and TP were about 40% and 
60% respectively (data not shown). Literature suggests several factors may impact TMA content 
in elderberry or elderberry products. For instance, plant variety and growing conditions can 
alter anthocyanin content [322, 323]. Processing, such as thermal treatments or filtration, could 
result in anthocyanin loss [324-326]. The processing parameters and elderberry varieties of 
commercial juice (a shelf stable product) are unknown, an additional set of kefir made with 
fresh juice was made to better understand the difference between the commercial and fresh 
elderberry juice. The same product formulas were used. Phytochemical evaluation of the 
additional elderberry kefir products is discussed in the next section. 
2.4.3 Elderberry Kefir Evaluation (Fresh Juice) 
The results for the biochemical measurements of the fresh elderberry juice are shown in 
Table 2.2. ˚Brix and TA values of the fresh elderberry juice were lower than the commercial 
juice. Color parameter values of commercial and fresh elderberry juice are different. Based on 
the Chroma values, fresh elderberry juice had a more saturated color than commercial juice. 
Phytochemical properties of the fresh and the commercial elderberry juices were measured to 
better understand the difference (Table 2.3). The results demonstrated that the TMA content in 
fresh elderberry juice was 16 times higher than the commercial juice. Higher TP content was 
observed in fresh elderberry juice. Gonzalez-Molina et al. revealed that anthocyanin content in 
elderberry juice decreased more than 50% during 56 days storage at room temperature [327]. 
Elderberry juice should be utilized fresh to ensure the highest levels of anthocyanins in 
products like elderberry kefir. 
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A sensory test was not conducted on the products made with fresh juice due to 
insufficient fresh elderberries. pH, TA, ˚Brix and color results of elderberry kefir made with fresh 
juice are shown in Table 2.2. The elderberry kefir products made with fresh juice exhibited 
similar pH, TA and ˚Brix values. No correlation was found between pH and TA (r = 0.22, p = 
0.61). Based on the Chroma values, fresh-elderberry-juice-added kefir product with 0.6% stevia 
had a more saturated color.  
Phytochemical analyses results of elderberry kefir made with fresh juice are shown in 
Table 2.3. TMA content of kefir made with fresh elderberry juice was 14 times higher than that 
in the product made with commercial juice. TP content in fresh-juice elderberry kefir was two 
times higher compared to the products made with commercial juice. Smaller IC50 values in the 
products made with fresh elderberry juice were observed. This indicates that kefir made with 
fresh elderberry juice exhibits stronger antioxidant capacity than the commercial-elderberry-
juice kefir. The higher TMA and TP contents in fresh-elderberry-juice kefir due to the larger 
amount of TMA and TP in the fresh juice. One serving (8 oz) of the elderberry kefir products 
made with fresh juice contains more than 40 mg TMA and 93 mg TP. Elderberry kefir products 
made with fresh juice could contribute to the enhancement of consumers’ dietary intake for 
both TMA and TP. Increased consumption of TMA and TP may contribute to a decrease in the 
chronic inflammation and in the risk of type 2 diabetes [3, 106]. Therefore, the freshness of 
juice and a shorter shelf life are important to maximize the delivery of bioactive compounds. 
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The recovery rate of TMA in products made with fresh elderberry juice was around 45%. 
For TP, the recovery rate exceeded 100%. Similarly, increased total phenolics were observed in 
myrtle berry homogenate after fermentation with Lactobacillus plantarum C2 and the main 
increase was in phenolic acids [176]. This study suggested that the increase was due to the 
esterase activity in the lactic bacteria. Esterase cleaves the ester bond which liberates the 
phenolic acids from their glycosylated form. During fermentation, the constituents of 
elderberry juice are metabolized by the living kefir culture. This enhancement may lead to a 
functional food with an increased amount of bioavailable phenolic compounds. 
2.5 Conclusion 
Kefir products made with aronia or elderberry were evaluated for their sensory 
attributes, quality parameters and phytochemical properties. Both sensory tests indicated that 
consumers preferred sucrose over non-nutritive sweeteners. Results of phytochemical analyses 
revealed that the freshness of juice was critical for maximum bioactive compounds in the 
products. The fermentation process may contribute to the liberation of phenolic compounds in 
part by esterase activity and may be important to enhance the bioavailability of bioactive 
compounds. Further research is needed to better understand the impact of fermentation on 
bioavailability and liberating the phenolic compounds to potentially increase their absorption. 
Developing value-added functional food products could be a good way to utilize aronia or 
elderberries. Kefir products with berries may increase dietary intake of anthocyanins and total 
phenolics, which may contribute to the prevention of type 2 diabetes and other inflammatory 
chronic diseases.   
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CHAPTER 3 
FERMENTATION ALTERS THE BIOACCESSIBLE PHENOLIC COMPOUNDS AND INCREASES THE 
 ALPHA-GLUCOSIDASE INHIBITORY EFFECTS OF ARONIA JUICE IN A DAIRY MATRIX 
FOLLOWING IN-VITRO DIGESTION 
 
This chapter is published in the Food & Function 2018, volume 9, page 2998-3007. 
 
3.1 Chapter Abstract 
The prevalence of diabetes reached 415 million worldwide in 2015. Polyphenol-rich food 
intake can benefit the glycemic control for individuals with diabetes. Fermentation may 
increase the bioavailability of polyphenols, w°°hich is generally low.  Aronia (Aronia 
melanocarpa) is a polyphenol-rich berry that is native to North America. Proanthocyanins and 
anthocyanins are the major phenolic compounds in aronia. In this study, aronia kefir was made 
by fermenting cow’s milk with added aronia juice. The changes in bioaccessible polyphenols of 
aronia kefir during digestion were assessed using an in-vitro model. The impact of fermentation 
on the potential bioactivity of aronia polyphenols was evaluated. Results showed that the 
bioaccessible polyphenols in aronia kefir were elevated during digestion and the antioxidant 
capacity increased (IC50 of DPPH scavenging decreased from 24.07 mg kefir/mL to 8.97 mg 
kefir/mL). Digested aronia kefir had stronger inhibitory activity on α-glucosidase (IC50: 152.53 
mg kefir/mL) compared to the non-fermented control (IC50: 484.93 mg kefir/mL). Both aronia 
kefir and the non-fermented control had weak inhibition on pancreatic α-amylase. Specific 
inhibitors of α-glucosidase, such as aronia polyphenols, have the potential to delay 
carbohydrate digestion and reduce the absorption of glucose without side effects. Utilizing 
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aronia kefir in the diet is a good strategy to help control blood glucose levels. Fermentation may 
be an effective method to increase the bioavailability of dietary polyphenols in other food. 
More studies about the effects of fermentation on polyphenol-rich food are needed to optimize 
the potential health-promoting properties. 
3.2 Introduction 
Diabetes has been a global issue for the past few decades. In 2015, 30.3 million people 
(9.4%) in the United States and 415 million people in the world had diabetes [328]. Diabetes is 
associated with a decline in life expectancy and a reduction in life quality [32]. Tight blood 
glucose control is crucial for diabetic patients to delay the progression of complications, such as 
diabetic retinopathy, neuropathy and nephropathy [329]. The modulation of postprandial 
glucose absorption is one important method for management of hyperglycemia. Synthetic 
pharmaceutical agents are used to inhibit carbohydrate-hydrolyzing enzymes for delaying and 
reducing the absorption of glucose. Despite the effectiveness of the drugs, most of them have 
side effects that impact the gastrointestinal tract and hepatic system [329, 330]. Studies 
suggest that dietary polyphenols derived from plant-based food exhibit similar activity in 
inhibiting carbohydrate-hydrolyzing enzymes in-vitro and have the potential to aid in blood 
glucose control without side effects [329].  
Dietary polyphenols are commonly ingested as a part of daily diet. They are found in 
high levels in plant-based foods, especially in berries. Generally, polyphenols have low 
bioavailability due to their instability in the small intestine and their large molecular size [331]. 
The food matrix may limit or improve the absorption of polyphenols and influence the 
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bioavailability [92]. Several methods have been suggested to increase the bioavailability of 
polyphenols, such as using encapsulation to increase the stability in the gastrointestinal tract 
[332, 333]. Additionally, some microorganisms are capable of breaking down the complex 
phenolic compounds and the metabolites may be more bioactive [177].  
Aronia (Aronia melanocarpa) fruit is a berry native to eastern North America [334]. 
Aronia contains more total polyphenols (10-20 mg gallic acid equivalent/g fresh weight) than 
many other plant-based food, such as blueberry (1 to 4 mg gallic acid equivalent/g fresh weight) 
[202, 335, 336]. The astringent mouth-feel of aronia is caused by the high procyanidin content. 
Aronia is rarely consumed raw due to the astringency and the lack of sweetness.  Aronia was 
traditionally used by Native Americans as medicine to treat the common cold [179].  The 
phenolic compounds are the major bioactives that are responsible for the therapeutic effects of 
aronia. In Russia, aronia has been used as a natural remedy to treat hypertension and 
atherosclerosis [179]. A recent study conducted by Loo et al. showed that consumption of 
aronia juice decreased low-grade inflammation in hypertensive patients [219]. Broncel et al. 
observed that consuming aronia extract reduced the oxidative stress in patients with metabolic 
syndrome [337]. 
Kefir is a fermented dairy product consisting of up to 30 species of microorganisms 
including lactic bacteria, yeast and sometimes acetic acid bacteria [338]. Functional properties 
of kefir are well documented, including anti-bacterial, anti-carcinogenic and anti-inflammatory 
effects [261]. Kefir is naturally lactose-free, making it a good calcium and protein source for 
lactose-intolerance individuals. In this study, kefir was selected as the matrix to incorporate 
78 
 
aronia polyphenols for the following reasons: 1) kefir is rich in protein, which can minimize the 
astringent mouth-feel of aronia [339] and may protect the polyphenols from degradation in the 
small intestine [340]; 2) the diverse microorganism community in kefir starter has the potential 
to metabolize phenolic compounds and increase the bioavailability [341]. Incorporating aronia 
into kefir may be a good way to optimize the potential health-promoting properties of aronia; 
3) the acidic pH of kefir helps to protect the anthocyanins from degradation. 
Digestion is a key process influencing the bioavailability of a dietary component [134] 
because factors such as pH and enzymes in the digestive tract can modify the components and 
alter their liberation behavior [333]. Understanding the changes of the aronia polyphenols 
during digestion is important to assess their potential bioactivity. The functional properties of 
aronia before ingestion is well studied, but knowledge about the changes in a fermented matrix 
and the potential anti-diabetic properties after digestion remain unknown. To our knowledge, 
this is the first study to examine the bioaccessibility of aronia polyphenols in a fermented dairy 
matrix. The objectives of this study were: 1) to investigate the effects of kefir-fermentation on 
the potential bioactivity of aronia polyphenols in a dairy matrix; 2) to evaluate the changes in 
the bioaccessibility and antioxidant capacity of aronia kefir in the digestive tract using an in 
vitro model.    
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3.3 Materials and Methods 
3.3.1 Chemicals 
 Acetonitrile (HPLC grade), ammonium chloride, sodium phosphate dibasic, hydrochloric 
acid, methanol, potassium chloride, potassium thiocyanate, sodium hydroxide, sodium 
bicarbonate, soluble starch and urea were purchased from Fisher Scientific (Waltham, MA, 
U.S.). 2,2-diphenyl-1-picrylhydrazyl (DPPH), dinitrosalicylic acid, formic acid, ox-bile, p-
nitrophenyl β-D-glucopyranoside (pnp-G), potassium sodium tartrate tetrahydrate, porcine α-
amylase, rat intestinal powder and HPLC standards (quercetin, chlorogenic acid, neo-
chlorogenic acid and cyanidin-3-galactoside) were obtained from Sigma-Aldrich (St. Louis, MO, 
U.S.). Bovine serum albumin, glucose, glucosamine hydrochloride, glucuronic acid, lipase, 
magnesium chloride, mucin, pepsin, sodium phosphate monobasic and uric acid were 
purchased from MP Biomedicals (Santa Ana, CA, U.S.). Calcium chloride was purchased from 
Ward’s Science (Rochester, NY, U.S.), potassium dihydrogen phosphate was purchased from 
Alfa Aesar (Haverhill, MA, U.S.). All water used was obtained from a Millipore water system 
(EMD Millipore, Billerica, MA, U.S.). 
3.3.2 Food Material 
 Aronia (Aronia melanocarpa, variety ‘Viking’) were harvest based on the apparent 
ripeness of uniform deep purple color from the University of Connecticut (Storrs, CT, U.S.) from 
the 2014 growing season. Berries were de-stemmed, washed and stored at -20 ˚C. Frozen 
berries were thermal-treated (100 ˚C, 5 minutes) and juiced with a domestic juicer (Hamilton 
Beach, Southern Pines, NC, U.S.). Juice was used immediately. Commercial kefir starter 
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(Yogourmet®, Lachute, QC, Canada) and 2% milk (Oakhurst®, Portland, ME, U.S.) were 
purchased from a local supermarket.  
3.3.3 Sample Preparation 
 Aronia kefir was prepared by the following method: 2% milk was heated to 82 ˚C in an 
aluminum saucepan, and cooled to 26 ˚C in an ice bath. The cooled milk and the commercial 
starter (5 g per quart of milk) were combined in a glass bowl. The mixture was stirred for 5 
minutes to ensure that the starter was fully dissolved. Freshly made aronia juice was added to 
the milk-starter matrix (15%, w/w) and mixed well. The mixture was covered with a breathable 
cloth and kept at room temperature (23 ˚C) to ferment overnight. After 24 hours of 
fermentation, the aronia kefir was homogenized with an immersion blender (Hamilton Beach®, 
Southern Pines, NC, U.S.). The homogenized aronia kefir was transferred into a sealed glass jar 
and stored at 4 ˚C for 24 hours before carrying out the in-vitro digestion. Three batches of 
aronia kefir were made and in-vitro digestion was performed individually. 
 Milk and aronia juice without the addition of kefir starter was used as a non-fermented 
control. Non-fermented control was made by mixing 2% milk with 15% (w/w) freshly made 
aronia juice in a glass jar and sealed with a lid. The mixture was kept at 4 ˚C for 24 hours (the 
fermentation time of making kefir) and then acidified to pH 4.5 (the pH of kefir). The acidified 
non-fermented control was stored in the refrigerator (4 ˚C) for another 24 hours before the in-
vitro digestion process was carried out. Batches were made in triplicate. 
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3.3.4 in-vitro Digestion Procedure 
The digestion process was simulated using a modified method from Oomen et al. to 
assess the changes of polyphenols in the digestive tract after ingestion [342]. For each 
digestion, three compartments in the digestive tract were simulated: mouth, stomach and small 
intestine. Artificial digestive juices (saliva, gastric juice, intestinal juice and bile) were prepared 
fresh before the in-vitro digestion was performed. The composition of digestive juices are listed 
in Table 3.1. pH values of the digestive juices were adjusted with concentrated HCl or 2M NaOH 
to the appropriate range. The digestion process was carried out as follows: the process was 
initiated by adding saliva to 27 mL aronia kefir (2:3, v/v). The mixture was stirred gently for 5 
minutes at 37˚C in an Isotemp™ water bath (Fisher’s Scientific, Waltham, MA, U.S.). One-third 
of the oral-digested sample was removed and collected as the oral-digested fraction. Gastric 
digestion was initiated by adding in gastric juice to the remaining oral-digested sample (4:5, v/v) 
and incubating the mixture at 37 ˚C in a shaking water bath (Edvotek®, Washington D.C., U.S.) 
for 2 hours. This process consisted of two steps because the pH environment in the stomach is 
not stable at the beginning of gastric digestion due to food influx: for the first hour, one portion 
of gastric juice was added to the remaining oral digesta and the pH of the mixture was not 
adjusted; for the second hour, three portions of gastric juice were added to the mixture, the pH 
was adjusted to 2.0 with concentrated hydrochloric acid. At the end of gastric digestion, half of 
the gastric digesta was removed and collected as the gastric-digested fraction. Digestion in the 
small intestine was initiated by adding NaHCO3 (1 M) to the remaining gastric-digested sample, 
resulting in a pH of 5.7. Intestinal juice and bile were added to the mixture (4:2:9, v/v). pH of 
the mixture was adjusted to 7.5 with 2 M sodium hydroxide and the mixture was incubated at 
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37 ˚C in the shaking water bath for two hours. All of the intestinal digesta were collected as the 
small intestine-digested fraction. Though the collected volume of the individual fractions was 
different, each fraction contained an equal amount of aronia kefir (9 mL). All incubations were 
conducted in the dark and the mixtures were sealed with parafilm to reduce oxygen exposure. 
The aronia kefir controls for each stage of digestion were processed by the same procedure in 
the absence of enzymes and bile. Non-fermented control was treated with the same in-vitro 
digestion procedure.  
All collected samples were centrifuged at 16639×g (Eppendorf 5804R, Hamburg, 
Germany) for 10 minutes at 0 ˚C. The collected supernatant was acidified to pH 2.0 with 
concentrated hydrochloric acid to inactivate the digestive enzymes and to stabilize the phenolic 
compounds [331]. Methanol was added to the supernatant (2:1, v/v) and it was chilled at -20 ˚C 
to precipitate proteins. After 30 minutes, proteins in the mixture were removed by 
centrifugation at 0 ˚C for 30 minutes (16639×g, Eppendorf 5804R). Samples were filtered 
through a 0.20 µm syringe filter (Corning Inc., Corning, NY, U.S.) where an aliquot of the filtered 
supernatant was stored at -80 ˚C for phenolic compound quantification and antioxidant 
capacity evaluation. The remaining filtered supernatant was evaporated under a vacuum 
(Eppendorf Vacufuge plus, Hamburg, Germany) to remove methanol. The aqueous supernatant 
was purified with a C18 cartridge (Sigma-Aldrich, St. Louis, MO, U.S.) and washed with water to 
remove reducing sugars. The phenolic compounds in the supernatant were eluted with 
methanol. The purified sample was dried under a vacuum and resuspended in ultrapure water. 
The re-suspended samples were stored at -80 ˚C for enzyme inhibition activity analyses. 
Digestion was carried out in triplicate. 
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Table 3.1 The composition of digestive juices 
Artificial saliva Gastric juice Intestinal juice Bile 
Inorganic compounds 
10 mL KCl 89.6 g/L 15.7 ml NaCl 175.3g/L 40 ml NaCl 175.3 g/L 
30 mL NaCl  
           175.3 g/L 
10 mL KSCN 20 g/L 
18 mL CaCl2·2H2O 
            22.2 g/L 
40 mL NaHCO3  
           84.7 g/L 
68.3 mL NaHCO3  
              84.7 g/L 
10 mL NaH2PO4  
            88.8 g/L 
9.2 mL KCl 89.6 g/L 
10 mL KH2PO4  
           8.0 g/L 
4.2 mL KCl 89.6 g/L 
10 mL Na2PO4  
            57.0 g/L 
3 mL NaH2PO4  
          88.8 g/L 
6.3 mL KCl 89.6 g/L 200 µl HCL 37% g/g 
1.7 mL NaCl  
           175.3 g/L 
10 mL NH4Cl 30.6 g/L 10 mL MgCl2 5 g/L  
1.8 mL NaOH  
            40.0 g/L 
8.3 mL HCl 37% g/g 180 µl HCl 37% g/g  
Organic compounds 
8 mL urea 25.0 g/L 10 mL glucose 65.0 g/L 4 mL urea 25.0 g/L 10 mL urea 25.0 g/L 
 
10 mL glucuronic acid  
            2.0 g/L 
  
 3.4 mL urea 25.0 g/L   
 
10 mL glucosamine  
           hydrochloride  
           33.0 g/L 
  
Others 
145 mg α-amylase 1.0 g BSA 
9 mL CaCl2·2H2O  
          22.2 g/L 
10 mL CaCl2·2H2O  
            22.2 g/L 
15 mg uric acid 1.0 g pepsin 1.0 g BSA 1.8 g BSA 
50 mg mucin 3.0 g musin 3.0 g pancreatin 6.0 g bile 
  0.5 g lipase  
pH    
       6.5 ± 0.2 1.07 ± 0.07 7.8 ± 0.2 8.0 ± 0.2 
Note: The organic and inorganic solutions were adjusted into 500mL with distilled water 
separately. Other constituents were added to the mixture of organic and inorganic 
solutions and the pH was adjusted to the appropriate intervals with 2 M NaOH or 
concentrated HCl 
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3.3.5 UPLC Analysis of Phenolic Compounds 
 The profile of polyphenols would be altered during digestion, monitoring these changes 
is important to understand the possible metabolism of polyphenols in the digestive tract and 
the impacts of digestion on the potential bioactivity of polyphenols. In this study, the 
quantification of the anthocyanins and phenolic acids (chlorogenic acid and neo-chlorogenic 
acid) in the collected digesta was performed on an Ultra Performance Liquid Chromatography 
(UPLC) (Agilent Technologies1290 Infinity, Santa Clara, CA, U.S.) with a Photodiode Array (PDA) 
detector. The method used was modified from Teleszko et al. [343]. Separation was carried out 
using a C18 column (3 µm, 150 × 4.6 mm, Thermo Scientific, Waltham, MA, U.S.) at 25 ˚C. 
Samples were injected at a flow rate of 1.3 mL/min. Phenolic compounds were eluted with a 
gradient mobile phase consisting 4.5% formic acid in water (phase A) and 4.5% formic acid in 
acetonitrile (phase B). The gradient was as follows: 0 min: 1% phase B; 4.5 min: 10% phase B; 7 
min: 20% phase B; 10 min: 24% phase B; 14 min: 36% phase B; 15min: 60% phase B; 16 min: 1% 
phase B. The post run time was 5 min. Samples were spiked with quercetin (25 µg/mL) as an 
internal standard. An external calibration curve was drawn using cyanidin-3-galactoside (3.9, 
7.8, 15.6, 31.2, 62.5, 125 and 250 µg/mL, r2 = 0.9987), chlorogenic acid (3.9, 7.8, 15.6, 31.2, 
62.5, 125 and 250 µg/mL, r2 = 0.9999) and neo-chlorogenic acid (3.9, 7.8, 15.6, 31.2, 62.5, 125 
and 250 µg/mL, r2 = 0.9998) standards. Anthocyanins were detected at 520 nm and expressed 
as cyanidin-3-galactoside equivalents. The individual anthocyanins were identified by the 
elution order reported by Jakobek et al. [202]. Chlorogenic acid and neo-chlorogenic acid were 
detected at 320 nm. Peak areas were used for quantification and the results were expressed as 
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mg polyphenols per part (one part contains 9 mL aronia kefir). Measurements were conducted 
in triplicate. 
3.3.6 DPPH Free Radical Scavenging Assay 
 Antioxidant capacity of polyphenols is a crucial parameter to evaluate their potential 
health benefits. In the presented study, the antioxidant capacity of each digested fraction was 
evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity. The method 
was slightly modified from Duymus et al. [312]. Briefly, equal amounts of 0.3 mM DPPH solution 
(150 µL) and the diluted samples (150 µL) were loaded to a 96-well plate. The mixture was 
incubated in the dark at room temperature for 30 minutes and the absorbance was read at 515 
nm with a Biotek plate reader (ELx800, Winooski, VT, U.S.). A mixture of DPPH solution and 
water was used as the negative control for this assay. Scavenging percentage was calculated 
with the following formula:  
%Scavenging =  
Abs𝐶𝑜𝑛𝑡𝑟𝑜𝑙 − Abs𝑆𝑎𝑚𝑝𝑙𝑒
Abs𝐶𝑜𝑛𝑡𝑟𝑜𝑙
× 100 
Scavenging activity of each fraction was measured at five different concentrations to 
calculate IC50 values, which is the concentration of the sample to scavenge 50% of the DPPH 
free radicals. Measurements were conducted in triplicate. 
3.3.7 Rat Intestinal α-glucosidase Inhibitory Activities  
 Alpha-glucosidase is a vital carbohydrate-hydrolyzing enzyme catalyzes the breakdown 
of disaccharides and oligosaccharides to release glucose in the small intestine [344]. In this 
study, α-glucosidase inhibitory activity was evaluated using a method reported by Oki et al. 
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with modification [345]. Alpha-glucosidase was extracted from rat intestine powder by using 
0.1 M sodium phosphate buffer at pH 6.9 (1:30, w/v) in an ice bath with sonication. Sonication 
was performed 12 times (30 seconds for each round) and the mixture was vortexed after each 
sonication. The mixture was centrifuged at 0 ˚C for 10 minutes at 16639×g. The supernatant 
was filtered through a 0.45 µm syringe filter (Phenomenex, Torrance, CA, U.S.) and kept on ice 
until use in the assay. Samples (50 µL) and α-glucosidase extract (100 µL) were mixed and 
incubated at 37 ˚C for 10 minutes in the dark. Water was used to prepare controls. The reaction 
was initiated by the addition of 50 µL 4-nitrophenyl α-glucopyranoside (pnp-G, 5 mM). The 
mixture was incubated at 37 ˚C for 30 minutes in the dark and read at 405 nm. Phosphate 
buffer (0.1 M) was used to prepare sample blank to correct for the background color. The 
inhibitory activity of the sample on intestinal α-glucosidase was calculated as follows: 
%inhibition =  
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − (𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒 − 𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒 𝑏𝑙𝑎𝑛𝑘)
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 × 100 
 Five dilutions of each sample were measured to calculate IC50 values. Measurements 
were carried out in triplicate. 
3.3.8 Porcine Pancreatic α-amylase Inhibitory Activities 
Pancreatic α-amylase is a key enzyme that starts the digestion of complex 
carbohydrates by hydrolyzing the glycosidic linkages in the small intestine. Inhibitory effects of 
samples on porcine pancreatic α-amylase were conducted with the method reported by 
Nampoothiri et al. with modification [346]. Briefly, sodium phosphate buffer (0.02 M, pH 6.9) 
with 0.006 M sodium chloride was used to dissolve α-amylase and the starch. 100 µL sample 
and 100 µL α-amylase solution (100 unit/mL) were mixed and incubated at 25 ˚C for 10 min. 
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The reaction was initiated by adding 100 µL starch solution (1 g/mL). The mixture was 
incubated at 25 ˚C for an additional 10 min. The reaction was stopped by adding 200 µL 
dinitrosalicylic acid reagent and incubating the mixture in a water bath for 5 minutes at 100 ˚C. 
The dinitrosalicylic acid reagent was made of 1 g/mL dinitrosalicylic acid in water containing 2% 
NaOH (2 M, v/v) and 30% (w/v) potassium sodium tartrate tetrahydrate. When the mixture 
temperature reached the room temperature (23 ˚C), 50 µL of the mixture was loaded to a 96-
well microplate, diluted with 200 µL water and read at 540 nm. Sample blank was prepared 
using sodium phosphate buffer to correct for the background color. The control was prepared 
with sodium phosphate buffer instead of samples. The α-amylase inhibitory activity of the 
samples was calculated as follows:  
%inhibition =  
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − (𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒 − 𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒 𝑏𝑙𝑎𝑛𝑘)
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 × 100 
The inhibitory activities of individual samples were tested at five different dilutions. IC20 
values, the concentration of the sample required to inhibit 20% porcine pancreatic α-amylase, 
were calculated. The measurements were conducted in triplicate.  
3.3.9 Statistical Analysis 
 Data are shown as means ± standard deviations. Statistical analyses were conducted 
using SAS Studio (Cary, NC, USA). Analysis of Variance and Tukey’s HSD post hoc were carried 
out to evaluate the differences. A significance level was set at α = 0.05. 
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3.4 Results 
3.4.1 Quantification of Bioaccessible Phenolic Compounds  
The contents of the bioaccessible phenolic compounds in aronia kefir and non-
fermented control during in-vitro gastrointestinal digestion are presented in Table 3.2. Four 
major monomeric anthocyanins (cyanidin-3-galactoside, cyanidin-3-glucoside, cyanidin-3-
arabinoside and cyanidin-3-xyloside) and two dominant phenolic acids (chlorogenic acid and 
neo-chlorogenic acid) were identified and quantified via UPLC analyses. Caffeic acid, a 
metabolite of chlorogenic acid, was not detected. Most phenolic compounds in aronia kefir 
increased after gastric digestion, with the exception of cyanidin-3-glucoside which showed no 
change compared to the oral-digested sample. During intestinal digestion, the chlorogenic acid 
content was increased (from 1.04 ± 0.02 mg/part to 1.29 ± 0.09 mg/part) and the other 
identified anthocyanins and phenolic acids remained the same.  
The total anthocyanin content is shown in Figure 3.1. After the entire gastrointestinal 
digestion, total bioaccessible anthocyanins were increased by 96.9% compared to the 
undigested aronia kefir. Total anthocyanins in intestinal-digested kefir was 5.09 ± 0.40 mg/part 
(1 part = 9 mL aronia kefir). One serving of commercial kefir is 240 mL thus one serving aronia 
kefir would provide 135.73 mg bioaccessible anthocyanins.  
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Table 3.2 Quantification of individual phenolic compounds (mg/part)  
Fractions 
Cyanidin-
3-
galactoside 
Cyanidin3-
glucoside 
Cyanidin-
3-
arabinoside 
Cyanidin-3-
xyloside 
Chlorogenic 
acid 
Neo-
chlorogenic 
acid 
Aronia 
Kefir 
Undigested 1.87 ± 0.11 
d 
0.09 ± 0.01 
cd 
0.57 ± 0.03 
e 
0.05 ± 0.01 
e 
0.61 ± 0.03 
g 
0.49 ± 0.02 
e 
Oral 
C
* 
1.87 ± 0.15 
d  
0.07 ± 0.02 
d 
0.55 ± 0.07 
e 
0.05 ± 0.01 
e 
0.76 ± 0.02 
efg 
0.59 ± 0.02 
cde 
D
* 
1.96 ± 0.13 
d 
0.07 ± 0.02 
d 
0.58 ± 0.06 
e 
0.06 ± 0.01 
e 
0.78 ± 0.02 
efg 
0.60 ± 0.02 
cde 
Gastric 
C
* 
2.60 ± 0.34 
cd 
0.10 ± 0.03 
bcd 
0.85 ± 0.14 
de 
0.08 ± 0.01 
de 
0.92 ±0.04 
cde 
0.69 ± 0.02 
abc 
D
* 
3.14 ± 0.42 
c 
0.12 ± 0.04 
abcd 
1.13 ± 0.19 
cd 
0.11 ± 0.02 
cd 
1.04 ± 0.02 
bc 
0.75 ± 0.02 
ab 
Intestinal 
C
* 
3.10 ± 0.33 
c 
0.11 ± 0.02 
abcd 
1.08 ± 0.12 
cd 
0.10 ± 0.01 
cd 
1.17 ± 0.11 
ab 
0.74 ± 0.03 
ab 
D
* 
3.50 ± 0.29 
bc 
0.13 ± 0.01 
abcd 
1.33 ± 0.10 
bc 
0.13 ± 0.01 
bc 
1.29 ± 0.09 
a 
0.70 ± 0.09 
abc 
Non-
fermented 
control  
Undigested 
2.60 ± 0.13 
cd 
0.13 ± 0.01 
abcd 
0.87 ± 0.06 
de 
0.08 ± 0.01 
de 
0.70 ± 0.04 
fg 
0.54 ± 0.03 
de 
Oral 
 
C
* 
3.10 ± 0.45 
c 
0.12 ± 0.03 
abcd 
1.06 ± 0.21 
cd 
0.11 ± 0.02 
cd 
0.84 ± 0.06 
def 
0.65 ± 0.04 
bcd 
D
* 
3.29 ± 0.16 
bc 
0.13 ± 0.02 
abcd 
1.15 ± 0.07 
cd 
0.11 ± 0.01 
cd 
0.85 ± 0.05 
def 
0.64 ± 0.04 
bcd 
Gastric 
C
* 
4.13 ± 0.32 
ab 
0.16 ± 0.04 
abc 
1.56 ± 0.17 
ab 
0.16 ± 0.02 
ab 
0.97 ± 0.02 
cd 
0.72 ± 0.02 
ab 
D
* 
4.59 ± 0.41 
a 
0.18 ± 0.04 
a 
1.79 ± 0.21 
a 
0.18 ± 0.02 
a 
1.08 ± 0.05 
bc 
0.77 ± 0.03 
a 
Intestinal 
C
* 
4.67 ± 0.29 
a 
0.17 ± 0.02 
ab 
1.85 ± 0.11 
a 
0.19 ± 0.01 
a 
1.19 ± 0.07 
ab 
0.78 ± 0.01 
a 
D
* 
4.69 ± 0.36 
a 
0.17 ± 0.03 
ab 
1.88 ± 0.19 
a 
0.19 ± 0.02 
a 
1.31 ± 0.06 
a 
0.72 ± 0.07 
ab 
Note: data are shown as means ± standard deviations (n=3), values in the same column with the 
same letter are not significantly different at p < 0.05; *: C stands for control and D stands 
for digesta; one part was equivalent to 9 mL sample; anthocyanins were expressed as mg 
cyanidin-3-galactoside/part; chlorogenic acid was expressed as mg chlorogenic/part; neo-
chlorogenic acid was expressed as mg neo-chlorogenic/part. 
No differences were observed among phenolic compounds in the individual stages of 
digestion between aronia kefir digesta and aronia kefir controls (Table 3.2 and Figure 3.1). After 
intestinal digestion, the non-fermented control contained larger amount of cyanidin-3-
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galactoside, cyanidin-3-arabinoside and cyanidin-3-xyloside (4.69 ± 0.36 mg/part, 1.88 ± 0.19 
mg/part and 0.19 ± 0.02 mg/part) compared to aronia kefir (3.50 ±  0.29 mg/part, 1.33 ±  0.10 
mg/part and 0.13 ± 0.01 mg/part respectively). Differences in the other identified phenolic 
compounds between non-fermented control and aronia kefir were not observed. The total 
bioaccessible anthocyanins in intestinal-digested non-fermented control was 88.5% higher than 
in the undigested non-fermented control. After digestion, the increase of anthocyanins was 
lower in non-fermented control compared to the increase in aronia kefir.  
 
Figure 3.1 Quantification of total anthocyanins during in-vitro digestion 
Note: Data are shown as means ± standard deviations (n=3), one part was equivalent to 9 mL 
sample, bars with the same letter are not significantly different at p < 0.05. 
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3.4.2 Antioxidant Capacity  
 Antioxidant activity of aronia kefir and the non-fermented control was measured using 
the capacity to scavenge DPPH free radicals. IC50 values were calculated and the results are 
shown in Figure 3.2.  Aronia kefir exhibited antioxidant capacity during the entire 
gastrointestinal digestion. Antioxidant capacity of aronia kefir digesta was improved during 
gastric digestion (DPPH IC50 values from 24.07 ±  0.78 mg/part to 12.01 ± 0.57 mg/part) and 
held consistent after intestinal digestion (DPPH IC50: 8.97 ± 0.93 mg/part). Aronia kefir digesta 
exhibited similar antioxidant capacity compared to the corresponding aronia kefir controls at 
each digestive stage. Aronia kefir digesta and non-fermented control digesta exhibited similar 
antioxidant capacity after gastric- and intestinal-digestion. A strong correlation between IC50 
values of DPPH and total anthocyanins was observed (r = - 0.89) as well as between IC50 values 
and the sum of chlorogenic and neo-chlorogenic acid contents (r = - 0.90). 
 
Figure 3.2 Antioxidant capacity of kefir during in-vitro digestion 
Note: Data shown as means ± standard deviations (n=3), bars with the same letter are not 
significantly different at p < 0.05. 
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3.4.3 Inhibitory Activity of Carbohydrate-hydrolyzing Enzymes  
 The inhibitory effects of intestinal digested aronia kefir and non-fermented control on α-
glucosidase and pancreatic α-amylase were tested. The results are shown in Figure 3.3 and 
Figure 3.4. Digested aronia kefir exhibited strong inhibitory activity toward α-glucosidase and 
weak inhibitory activity on α-amylase. Compared to the digested non-fermented control, 
digested aronia kefir had a stronger inhibitory effect on α-glucosidase. The IC50 values for α-
glucosidase inhibition of aronia kefir and non-fermented controls were 152.53 ± 15.24 mg 
kefir/mL and 365.16 ± 48.84 mg non-fermented control/mL respectively. Digested aronia kefir 
as well as the digested non-fermented control exhibited similar inhibitory activity against 
pancreatic α-amylase. IC20 values of α-amylase for the aronia kefir and the non-fermented 
control were 146.52 ± 5.37 mg kefir/mL and 196.21 ± 5.50 mg non-fermented control/mL. Plain 
kefir was processed using the in-vitro digestion system with the same method as the samples. 
Inhibitory activity of plain kefir on enzymes was not observed.  
 
Figure 3.3 α-glucosidase inhibitory activity 
Note: Data shown as means ± standard deviations (n=3), bars with the same letter are not 
significantly different at p < 0.05. 
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Figure 3.4 Pancreatic α-amylase inhibitory activity  
Note: Data shown as means ± standard deviations (n=3), bars with the same letter are not 
significantly different at p < 0.05.  
3.5 Discussion 
This study examined the bioaccessibility and the antioxidant capacity of phenolic 
compounds in aronia kefir during a simulated gastrointestinal digestion. The impacts of 
fermentation on aronia polyphenols and on their carbohydrate-hydrolyzing enzyme inhibitory 
activities were evaluated.  
The in-vitro digestion model used in this study simulated three compartments of the 
digestive tract: mouth, stomach and small intestine. Digestive juices (saliva, gastric juice, 
duodenal juice and bile) used in this model contained not only corresponding enzymes but also 
other compounds that exist in human digestive juices, such as calcium chloride which may 
chelate phenolic compounds in the digestive tract and alter their bioaccessibility [347].  
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In this study, salivary α-amylase, which is the main digestive enzyme in the mouth, had 
negligible effects on the release of bioaccessible phenolic compounds in aronia kefir as 
expected, because the aronia kefir is a protein-rich beverage and the duration for the simulated 
oral digestion is short. 
During gastric digestion, the acidic environment helps to stabilize the free anthocyanins 
and phenolic acids in aronia kefir. The low pH environment in the stomach contributes to the 
liberation of the phenolic compounds from the phenolic-protein complex and lead to the 
increase in bioaccessible anthocyanins and phenolic acids [143, 305, 333].  In addition, 
proanthocyanins, the oligomeric and/or polymeric flavan-3-ols, are the most abundant 
bioactive constituents in aronia. The depolymerization of proanthocyanins due to the acidic 
environment may contribute to the enhancement of the monomeric anthocyanin levels and 
potentially increase the bioavailability of aronia polyphenols [22, 135]. Bermudezsoto et al. 
reported that digestive enzymes did not affect the aronia polyphenol content in the absence of 
food matrix [331]. In this study, a similar trend was observed. Though the amount of 
bioaccessible polyphenols in the gastric-digested aronia kefir (4.50 ± 0.66 mg/part for total 
anthocyanins, 1.04 ± 0.02 mg/part for chlorogenic acid and 0.75 ± 0.02 mg/part for neo-
chlorogenic acid) was slightly higher than that in the gastric control (3.63 ± 0.52 mg/part for 
total anthocyanins, 0.92 ± 0.04 mg/part for chlorogenic acid and 0.69 ± 0.02 mg/part for neo-
chlorogenic acid), the difference was not significant.  
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The small intestine is the major absorption site for most phenolic compounds so the 
quantity of bioaccessible polyphenols is important [141]. Many studies demonstrated that 
phenolic compounds are labile in the small intestine due to the mild alkaline environment. 
Bermudezsoto et al. conducted a study demonstrating that more than 35% of anthocyanins and 
20% phenolic acids were lost after in-vitro intestinal digestion of aronia juice [331]. Similar 
results were reported by Correa-Betanzo et al. where anthocyanins in blueberry decreased to 
10% – 15% during in-vitro intestinal digestion [348]. Bouayed et al. reported a complete loss of 
anthocyanins but an increase in phenolic acids after in-vitro intestinal digestion of apples [349]. 
However, depending on the type of polyphenols and the food matrix, the changes of 
bioaccessible polyphenols in the small intestine may be different. In the present study, the 
bioaccessible chlorogenic acid in aronia kefir increased and the anthocyanins content remained 
the same during intestinal digestion.  The increases in chlorogenic acid may be attributed to the 
degradation of anthocyanins in addition to the liberation from the kefir matrix. Similar results 
were observed in other studies that utilized a protein-rich food matrix to protect the 
polyphenols from degradation in the small intestine. A study conducted by Lamothe et al. 
showed that the stability of tea polyphenol in the small intestine was improved by dairy 
matrices (milk, yogurt and cheese) [340].  The protective effects of food matrices (dairy and 
egg) on the stability of grape anthocyanins during the intestinal digestion were observed by 
Pineda-Vadillo et al. [350]. Stanisavljevic et al. reported that after in-vitro digestion of aronia 
juice in a food matrix, bioaccessible anthocyanins and total phenolic compounds increased 
[351]. It is important to note that the referenced study only tested the anthocyanin and the 
total phenolic contents before and after the entire gastrointestinal digestion process (not at the 
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individual digestive stage). The changes of the soluble anthocyanins in the small intestine 
remains unknown. Digestive enzymes and bile did not contribute to the liberation of phenolic 
compounds in aronia kefir since the differences in anthocyanins, chlorogenic acid and neo-
chlorogenic acid between the digested aronia kefir and aronia kefir controls were not 
significant.  
The antioxidant capacity of polyphenols is associated with their health-promoting 
properties. The consumption of polyphenols may help to decrease oxidative stress, attenuate 
the production of pro-inflammatory biomarkers and lower the risk of chronic diseases, such as 
type 2 diabetes [352]. Foods that have strong antioxidant capacity before consumption may 
lose their antioxidant activity during the digestion process. This is caused by the structural 
alterations that occur due to the harsh conditions in the digestive tract and/or the interaction 
with other food ingredients. A loss of antioxidant capacity of polyphenol-rich food after in-vitro 
gastrointestinal digestion was documented in many studies and this loss was associated with 
the degradation of phenolic compounds [348, 353]. In this study, the antioxidant capacity of the 
intestinal-digested aronia kefir was higher than the oral-digested aronia kefir. The progressive 
release of phenolic compounds during digestion may contribute to the increase [350]. It is 
important for food to exhibit antioxidant capacity in the gut lumen, where dietary polyphenols 
could inhibit the proliferation of abnormal cells and slow the progression of cancer [331]. In 
addition, dietary polyphenols in the lumen may have protective effects on other food 
components during digestion, such as protecting unsaturated fatty acids from oxidation [350, 
354]. The protective activity of polyphenols on unsaturated fatty acids may contribute to a 
healthier cardiovascular status.   
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Alpha-glucosidase and pancreatic α-amylase are carbohydrate-hydrolyzing enzymes that 
play a vital role in catalyzing the breakdown of complex carbohydrates. Inhibition of these 
enzymes can delay the absorption of carbohydrates and aid in the management of 
hyperglycemia. In the present study, only intestinal-digested samples were tested for enzyme 
inhibitory activity because pancreatic α-amylase and α-glucosidase exist in the small intestine. 
It is important to note that yeast α-glucosidase was frequently used in other research, but this 
study used α-glucosidase extracted from rat small intestinal powder because mammalian α-
glucosidase is more relevant to human α-glucosidase [355]. This study demonstrated that 
polyphenols in aronia were the major compounds affecting the enzyme inhibitory activity 
because plain kefir treated in the same method did not show any inhibitory activity (data not 
shown). The inhibitory effects of dietary polyphenols on pancreatic α-amylase and α-
glucosidase are well documented [356]. In this study, intestinal-digested aronia kefir exhibited 
strong inhibitory activity on α-glucosidase and minor inhibitory effect on pancreatic α-amylase. 
Strong inhibition of pancreatic α-amylase may lead to undigested complex carbohydrates in the 
large intestine and cause abdominal pain, flatulence, and/or diarrhea [357]. Therapeutic agents, 
such as acarbose, can cause gastrointestinal side effects because of their non-specific inhibitory 
effects on both pancreatic α-amylase and α-glucosidase. Due to this effect, the specific 
inhibitory activity of aronia kefir on α-glucosidase over pancreatic α-amylase might be desirable 
for hyperglycemia management [358, 359]. Incorporating aronia kefir into a normal diet may be 
a good strategy to control postprandial plasma glucose level without causing side effects. 
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Fermentation altered the composition of bioaccessible aronia polyphenols in kefir and 
changed their potential bioactivity. The impacts of the fermentative microorganisms on 
polyphenols from various studies suggest that the phenolic metabolites produced by 
microorganisms might be more bioavailable. This is due to the smaller size of the metabolites 
and thus they are better absorbed compared to the parent compounds [173, 177]. A study 
conducted by Curiel et al. observed that fermentation by lactic acid bacteria increased the 
antioxidant capacity of Myrtle berry homogenate [176]. In addition, Hunaefi et al. stated that 
24 hours lactic acid fermentation decreased the total phenolic compounds in red cabbage 
sprouts but increased the antioxidant activity [360]. Zhao et al. also reported that fermentation 
by lactic acid bacteria decreased the flavan-3-ols content and increased phenolic acid 
derivatives in tea extract [341]. There was also evidence that the antioxidant activity was 
elevated [341]. These results demonstrate that fermentation may be a feasible method to 
enhance the antioxidant capacity of dietary polyphenols in different food matrices. However, in 
this study, there was no difference in the antioxidant capacity between aronia kefir and the 
non-fermented control after gastric- and intestinal-digestion. 
In this study, digested aronia kefir had stronger inhibitory activity on α-glucosidase than 
the digested non-fermented control (IC50 values are 152.53 mg kefir/mL and 365.16 mg non-
fermented control/mL, respectively) though digested non-fermented control had higher 
cyanidin-3-galactoside, cyanidin-3-arabinoside and cyanidin-3-xyloside. The stronger enzyme 
inhibitory effects of digested aronia kefir may due to the metabolites of polyphenols generated 
by the fermentation. Frediansyah et al. observed similar results where fermentation by lactic 
acid bacteria increased the inhibitory activity of black grape juice for α-amylase and α-
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glucosidase [174]. Fermentation may be a good strategy to increase the bioavailability of 
polyphenols in other foods. In addition, a fermented dairy matrix may be a suitable carrier for 
dietary polyphenols due to their protective effects on the stability of phenolics in the small 
intestine. More research is needed to better utilize the potential activity of fermentation on 
improving the bioavailability of dietary polyphenols.  
3.6 Conclusion 
In this study, the stability and bioaccessibility of the polyphenols in aronia kefir were 
evaluated using an in-vitro gastrointestinal digestion model, where the impacts of fermentation 
on aronia polyphenols were evaluated. After digestion, the bioaccessible polyphenols in aronia 
kefir and its antioxidant capacity increased. The digested aronia kefir exhibited strong inhibitory 
activity toward α-glucosidase but weak inhibition of pancreatic α-amylase. Intestinal-digested 
aronia kefir contained less cyanidin-3-galactoside, cyanidin-3-arabinoside and cyanidin-3-
xyloside compared to the intestinal-digested non-fermented control but exhibited similar 
antioxidant capacity. Fermentation enhanced the inhibitory activity of aronia polyphenols on α-
glucosidase. In conclusion, consuming aronia kefir may aid in controlling blood glucose level 
without side effects. Fermentation may be a good strategy to enhance the bioavailability of 
dietary polyphenols. In order to better understand the positive impacts of fermentation on the 
bioavailability of dietary polyphenols, the identification of the metabolites in aronia kefir is 
necessary. 
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CHAPTER 4 
 OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
4.1 Study Conclusions 
 Aronia and elderberry are underutilized fruits with great health-promoting properties. 
They are rarely consumed raw due to the astringent sensation caused by a large amount of 
phenolic compounds. In this research, berries were incorporated into a fermented dairy matrix, 
kefir, and sweetened with different natural sweeteners (sucrose, stevia extract and monk fruit 
extract) to mask the astringency. Studies were conducted to evaluate the consumer 
acceptability and health-promoting properties of these products. The key findings are 
summarized in table 4.1. 
The first objective of this study was to develop new palatable kefir products using aronia 
or elderberries. The levels of sucrose used in the aronia and elderberry kefir were lower than 
most flavored commercial kefir products in the market, such as blueberry, mango and 
raspberry flavored Lifeway® kefirs. The reason for minimizing the amounts of added sucrose is 
to ensure that these products are attractive to health-conscious consumers.  The final level of 
sucrose in aronia and elderberry kefirs was at least 5% lower than flavored commercial kefirs. In 
order to test how berry kefirs were received by the potential consumers, two separate sensory 
tests on either aronia or elderberry kefir products were conducted to evaluate the consumer 
acceptability. In the first sensory test, aronia kefir products were sweetened with sucrose, 
stevia extract or monk fruit extract to the same level of sweetness. Both the sucrose- and 
stevia-sweetened aronia kefirs were slightly liked by the consumers where the overall 
acceptability of the sucrose-sweetened products were higher (6.3). Monk fruit-sweetened 
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aronia kefir was not well accepted by the consumers. In the second sensory test, elderberry 
kefirs were sweetened with either sucrose or stevia extract to two levels of sweetness. The 
highest overall acceptability was observed in elderberry kefir sweetened with a higher amount 
of sucrose (5.7%). All elderberry kefirs were accepted by the consumers where all ratings were 
higher than 5. In summary, berry kefirs, which were less sweetened than most commercial 
products, were accepted by consumers. Sucrose appeared to be the best accepted sweetener 
than monk fruit or stevia extract based on the consumers’ rating. Aronia and elderberry kefirs 
have the potential to be successful commercial products. Additionally, the berry kefirs made 
with stevia and monk fruit extracts are suitable for pre-diabetic and diabetic individuals. 
 The second objective of this study was to evaluate the health-related characteristics of 
the aronia and elderberry kefirs, including the total phenolic levels, monomeric anthocyanins 
content and antioxidant capacity. The results showed that all the berry kefirs contained high 
levels of phenolic compounds and exhibited moderate antioxidant capacity. Compared to 
elderberry kefirs made with commercial juice, a pasteurized shelf-stable product, elderberry 
kefir made with fresh juice had approximately twenty times more anthocyanins, and two times 
more total phenolics.  One serving of aronia kefir or elderberry kefir made with fresh juice can 
provide three times more than the average intake for anthocyanins and contribute to 
approximately one-fifth of the average intake of phenolic compounds in the United States. The 
consumption of phenolic compounds may help to decrease the risk of T2DM and slow the 
progression of its complications. Currently, the available food products of aronia and 
elderberries are limited in the United States. More commercial available products using aronia 
or elderberry may help to increase the consumption of phenolic compounds among consumers. 
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In addition, the development of aronia and elderberry products may enhance consumers 
demand for these berries, which may encourage farmers to grow them and gain profits.  
 The third objective of this research was to evaluate the bioaccessibility of phenolic 
compounds in aronia kefir and their potential to assist blood glucose control. The levels of free 
phenolic compounds and their antioxidant capacity during digestion were assessed using an in-
vitro model of simulated digestion. The inhibitory activity of digested aronia kefir on the 
carbohydrate-hydrolyzing enzymes was measured. After digestion, the bioaccessible phenolic 
compounds and antioxidant capacity of the aronia kefir increased. The digested aronia kefir 
exhibited a strong inhibitory activity toward α-glucosidase and weak inhibitory activity for 
pancreatic α-amylase. The inhibition of α-glucosidase and pancreatic α-amylase can slow the 
digestion of carbohydrates and thus reduce their absorption. However, strong inhibition of 
pancreatic α-amylase can lead to un-digested complex carbohydrates in the large intestine, 
affect the bacterial fermentation and then cause side effects, such as abdominal pain and 
flatulence. Thus, the consumption of aronia kefir may aid in blood glucose control without side 
effects due to its specific inhibition of α-glucosidase over pancreatic α-amylase. In addition, the 
impacts of fermentation on the potential bioactivity of aronia kefir were evaluated in this part. 
Compared to the non-fermented control, aronia kefir exhibited stronger inhibitory activity of α-
glucosidase after digestion. Both the digested aronia kefir and the non-fermented control had 
weak inhibition on pancreatic α-amylase. This is the first study to investigate the impact of kefir 
fermentation on berry polyphenols and their health-promoting properties. Kefir fermentation 
may be a good strategy to improve the bioavailability of dietary polyphenols.  
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 In summary, this research provides evidence that both aronia and elderberries have the 
potential to be used as food ingredients in commercial food products. Also, the results of 
sensory tests show a possibility for the industry to lower the sucrose content of their products 
without sabotaging the consumers’ acceptability. A reduction in sucrose content may lead to 
healthier products which may be favored by health-conscious consumers. The berry-containing 
kefirs developed in these studies may be beneficial to pre-diabetic and diabetic individuals for 
their potential to help control blood glucose. Additionally, the berry-containing kefirs are a 
good source of protein and calcium for individuals with lactose intolerance due to the lactose-
free properties of kefir.  
Table 4.1 Key findings of these studies 
Chapter No. Samples Evaluations Key findings 
2 
Elderberry 
and aronia 
kefirs 
sweetened 
with 
sucrose, 
stevia or 
monk fruit 
extract 
Consumer 
acceptability test 
1. Kefirs that were less sweetened than 
commercial products were accepted by 
consumers;  
2. Sucrose-sweetened kefirs were best 
accepted compared to the products 
sweetened with stevia or monk fruit extract. 
Phytochemical 
analyses  
1. Berry kefirs contained high levels of 
phenolic compounds and exhibited moderate 
antioxidant capacity; 
2. Freshness of juice used in making kefirs 
affected their phenolic content 
3 
Aronia 
kefir 
Bioaccessibility 
Levels of bioaccessible phenolic compounds, 
including anthocyanins and phenolic acids, 
increased during digestion 
Benefits to 
diabetes 
Consumption of aronia kefir may aid in blood 
glucose control 
Impact of 
fermentation 
Fermentation increased the inhibitory activity 
of polyphenols toward α-glucosidase 
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4.2 Study Limitations 
 In the sensory test (chapter 2), we investigated the impacts of sweetener type and 
sweetness levels on consumers’ acceptability toward aronia or elderberry kefirs. The first 
limitation of this study is that we did not include a control sample in sensory tests. If we 
included an aronia or elderberry kefir without additional sweetener in each individual test, we 
could know if the addition of sweetener can increase the consumer acceptability. Alternatively, 
we could add a plain kefir sample with the same sweetness levels to each sensory tests, which 
would allow us to draw a conclusion if the addition of berry juice is favored by consumers. 
However, more than four samples are not recommended to be evaluated in one sensory 
session because increased sample numbers will lead to participant fatigue, which may 
negatively affected the accuracy of the evaluation. Thus, in order to obtain accurate results, we 
did not add a control sample. The second limitation was that the phenolic metabolites in 
digested aronia kefir could not be identified (chapter 3). We observed new peaks in the 
digested aronia kefir compared to the digested non-fermented control. However, due to lack of 
mass spectrometry, the identification could not be conducted. 
4.3 Future Directions 
4.3.1 Impacts of Kefir Culture on Proanthocyanins 
In a previous study (presented in Appendix A), we made an assumption that the 
increases of monomeric anthocyanins in elderberry kefir during storage may be related to the 
microbial depolymerization of proanthocyanins. Proanthocyanins exist in many berry fruits and 
cereals. One major restriction of the bioavailability of proanthocyanins is the large molecular 
size. Kefir culture may contain microorganisms that can depolymerize proanthocyanins and 
105 
 
produce smaller, more bioavailable molecules, such as monomeric anthocyanins. To date, there 
is no study that investigates the impact of kefir culture on the bioavailability of 
proanthocyanins. It is worth investigating the impact of kefir fermentation on the bioavailability 
of proanthocyanins from various foods. Studies aiming at separation and identification of the 
microorganisms in kefir culture may be needed. The microorganisms which could depolymerize 
proanthocyanins may be good candidates for the bioprocessing of proanthocyanin-rich foods to 
increase their bioavailability. 
4.3.2 Identification of the Metabolites in Aronia Kefir after Digestion 
In chapter four of this dissertation, the in-vitro digested aronia kefir exhibited stronger 
α-glucosidase inhibitory activity than the non-fermented control. This result may be due to the 
phenolic metabolites generated by microorganisms in the kefir. However, due to limitations of 
our experiments, the metabolites in aronia kefir were not identified. The identification of these 
metabolites needs to be conducted in order to better understand how kefir microorganisms 
interact with phenolic compounds. In addition, the metabolites may be isolated and used as 
nutraceutical agents to aid in blood glucose control of diabetic individuals. Currently, there is no 
available literature investigating the phenolic metabolites from kefir fermentation. 
4.3.3 Evaluation of Berry-incorporated Kefir with in-vivo Studies  
 For this research study, the strong inhibitory activity of aronia kefir on α-glucosidase 
was observed in-vitro. However, the question if aronia kefir can alter the activity of α-
glucosidase in-vivo and decrease the postprandial blood glucose level has not been answered.  
Though in-vitro studies showed positive results, the results of in-vivo studies may be different.  
106 
 
In order to confirm the potential benefits of berry kefirs in an integrated metabolic system, in-
vivo studies need to be conducted. Currently, no research in regards to the in-vivo bioactivity of 
polyphenol-enriched kefirs has been done. In addition, no publication is available on the 
bioavailability of kefir-fermented phenolic metabolites using animal models. Studies utilizing 
animal models are needed to investigate if kefir fermentation improves the bioavailability of 
dietary polyphenols in-vivo.  
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APPENDIX A: EFFECTS OF SWEETENERS ON THE LEVELS OF PHENOLIC COMPOUNDS AND 
ANTIOXIDANT CAPACITY OF ARONIA AND ELDERBERRY KEFIRS DURING STORAGE 
1. Chapter Abstract 
 Aronia berries and elderberries are rich in phenolic compounds including anthocyanins. 
Some phenolic compounds, specifically anthocyanins, are very labile. The instability of phenolic 
compounds can restrict their applications in the food industry. The addition of sweeteners may 
help the stability of phenolic compounds. In this study, aronia and elderberry juice were 
individually incorporated into kefir, a fermented dairy beverage. Products were sweetened with 
natural sweeteners, sucrose, stevia extract or monk fruit extract, at varying concentrations. The 
total phenolic (TP) content, total monomeric anthocyanin (TMA) content and DPPH (2,2-
diphenyl-1-picrylhydrazyl) free radical scavenging capacity of each product was tested every 
seven days during twenty-eight days of storage at 4˚C. The results demonstrated that, 
compared to aronia kefir without added sucrose, the addition of sucrose at 4.8% and 6.3% 
negatively affected the levels of TP and TMA. Compared to sucrose, monk fruit extract 
appeared to be a better sweetener for aronia kefir and elderberry kefir with a low level of 
sweetness to produce kefirs with a higher amount of TP and TMA. Stevia-sweetened berry 
kefirs contained more TMA but exhibited lower antioxidant capacity than sucrose-sweetened 
products. After twenty-eight days of cold storage (4˚C), TP content decreased in most berry 
kefirs. The levels of TMA decreased in aronia kefirs but increased in elderberry kefirs during 
storage. DPPH scavenging capacity of all kefir products declined after twenty-eight days of 
storage. The changes in the levels of TP, TMA and antioxidant capacity over time may be 
associated with both natural degradation and microbial metabolism of polyphenols. 
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2. Introduction  
 Aronia (Aronia melanocarpa) and elderberry (Sambucus nigra L. spp. canadensis) fruits 
are underutilized berries that are rich in polyphenols, especially anthocyanins. Development of 
new products using these berries could increase the diversity of food products on the market 
and potentially help to increase the consumer’s daily intake of anthocyanins. The utilization of 
anthocyanins in food products is restricted because anthocyanins are labile, which means the 
levels of anthocyanins in food products will decrease during processing and storage.  Reque et 
al. reported that after 10 days of storage at 4˚C, the anthocyanins in blueberry juice degraded 
by 83% [83].  Queiros et al. demonstrated that the level of anthocyanins in sweet cherry juice 
was reduced by 42% after 28 days of refrigeration [361]. Anthocyanins are stable at pH levels 
ranging from 1 to 4. The degradation of anthocyanins is accelerated in an alkaline environment 
[83]. An acidic food matrix such as a fermented dairy beverage, may help to decrease the 
degradation of anthocyanins compared to a neutral food matrix. The presence of sweeteners 
may alter the stability of anthocyanins during storage. Kopjar et al. reported that blackberry 
juice with sucrose added  contained a higher amount of anthocyanins than juice without added-
sucrose after ten days of storage stored at 4˚C [362]. In order to ensure the quality of an 
anthocyanin-rich product during its shelf life, methods to increase the stability of anthocyanins 
are important.  
 Kefir is a fermented dairy product that originated in the Caucasus Mountain region. Kefir 
is an effervescent beverage with a sour taste and creamy texture [261]. Kefir was chosen to be 
the food matrix for incorporating aronia and elderberries for the following reasons: 1) kefir is 
acidic, which may help to stabilize the phenolic compounds during storage; 2) studies have 
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showed that fermentation with lactic acid bacteria or yeast increased the antioxidant capacity 
of polyphenol-rich foods [176, 177, 360]. Kefir is a symbiotic community of various lactic acid 
bacteria and yeast. Some lactic acid bacteria and yeast in kefir may have the ability to increase 
the antioxidant capacity of phenolic compounds in berries. 3) kefir is a suitable dairy beverage 
for lactose-intolerant individuals due to the consumption of lactose by the microorganisms. In 
this study, aronia or elderberry juice was incorporated into kefir, and different sweeteners were 
added. The objective of this study was to investigate the influence of sweeteners on the 
phenolic compounds and the antioxidant capacity of berry kefirs during storage. In the first part 
of this study, the impacts of sucrose on phenolic compounds in berry-added kefirs were tested 
at five concentrations. The effects of sucrose and two non-nutritive sweeteners (stevia and 
monk fruit extracts) were evaluated in the second part.  
3. Material and Methods 
3.1 Chemicals and Dietary Ingredients 
Citric acid anhydrous, hydrochloric acid, methanol, potassium chloride, and sodium 
bicarbonate were purchased from Fisher’s Scientific (Waltham, MA, U.S.). 2, 2-diphenyl-1-
picrylhydrazyl (DPPH), Folin - Ciocalteu’s phenol reagent and gallic acid monohydrate were 
obtained from Sigma-Aldrich (St. Louis, MO, U.S.). Sodium acetate was purchased from Chem-
Impex international, Inc. (Wood Dale, IL, U.S.). Ultra pure water used in this study was obtained 
from a Millipore water system (EMD Millipore, Billerica, MA, U.S.). 
 Aronia berries (Aronia melanocarpa, variety ‘Viking’) used in the first part of this 
experiment were obtained from the University of Connecticut (Storrs, CT, U.S.) in 2013. Aronia 
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berries used in the second part of this study to test the effects of different sweeteners were 
harvested from the University of Connecticut (Storrs, CT, U.S.) in 2014. Elderberries (Sambucus 
nigra L. spp. canadensis) were harvested from the Littlefield experimental garden at the 
University of Maine from the 2014 growing season (Dr. Myracle’s Hatch Projet, Hatch # 
ME021924). The berries were harvested at their full ripeness based on their deep purple color.  
The berries were de-stemmed, washed and stored at -20˚C until use. A commercial kefir culture 
(Yogourmet®, Lachute, QC, Canada) containing lactic bacteria (Lactococcus lactis subsp. lactis, 
Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. bv. diacetylactis, Lactobacillus 
acidophilus) and lactic yeasts was used to make kefir products. Dietary sweeteners and low-fat 
milk (2%, Oakhurst®, Portland, ME, U.S.) were purchased from a local supermarket. The dietary 
sweeteners used in this study include sucrose (Great Value®, Bentonville, AR, U.S.), stevia 
extract (Stevia in the Raw®, New York City, NY, U.S.) and monk fruit extract (Monk Fruit in the 
Raw®, New York City, NY, U.S.).  
3.2 Kefir Preparation and Formulas 
 The kefir formulas products are shown in Table A.1, Table A.2 and Table A.3. All kefir 
products were prepared using the following method: low-fat milk was heated to 82˚C on the 
gas stove and then cooled to 26˚C using an ice bath within 30 min. The temperature was 
measured using a digital thermometer. During the cooling process, frozen aronia berries or 
elderberries were heated (100˚C, 5 min) and then juiced using a domestic juicer (Hamilton 
Beach®, Southern Pines, NC, U.S.). The cooled milk was transferred to a glass bowl and the 
commercial starter was added (5 g/quart). The mixture was stirred for 5 minutes to fully 
dissolve the starter. Aronia or elderberry juice was added to the mixture, and then the 
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sweeteners were added. The amounts of non-nutritive sweeteners (stevia and monk fruit 
extracts) used in the individual samples were adjusted according to the instructions on the 
package to standardize the sweetness to equal sucrose. The sweetness levels of the aronia 
kefirs presented in Table A.2 was the same. Elderberry kefirs (Table A.3) were grouped 
according to the sweetness levels. The products with 3 g sucrose, 0.3 g stevia or 0.6 g monk 
fruit extract were grouped as products with a low level of sweetness (Group L). The other 
elderberry kefirs were grouped as products with a high level of sweetness (Group H). Once 
prepared, kefir mixture samples were covered with a cloth and incubated at room temperature 
(23˚C) for fermentation. After 24 hours, pH values of the kefir products were 4.5. Then the kefir 
products were homogenized with a blender (Hamilton Beach®, Southern Pines, NC, U.S.) and 
transferred to sealable glass containers, and each sample batch was divided into five aliquots, 
sealed and stored at 4˚C. The phenolic analyses were performed after 2 hours of storage (day 
0), and subsequent analyses were conducted on days 7, 14, 21 and 28 of storage. Samples are 
duplicated.  
Table A.1 Aronia kefir formulas sweetened with sucrose 
Product Code Milk (g) Aronia Juice (g) Sucrose (g) 
Aronia-S0.0 100 20 0 
Aronia-S1.6 100 20 2 
Aronia-S3.2 100 20 4 
Aronia-S4.8 100 20 6 
Aronia-S6.3 100 20 8 
Note: Aronia-S0.0: aronia kefir without added sucrose; Aronia-S1.6: aronia kefir with 1.6% 
added sucrose; Aronia-S3.2: aronia kefir with 3.2% added sucrose; Aronia-S4.8: aronia 
kefir with 4.8% added sucrose; Aronia-S6.3: aronia kefir with 6.3% added sucrose. 
145 
 
 
Table A.2 Aronia kefir formulas sweetened with different sweeteners 
Aronia kefir Milk (g) Aronia Juice (g) 
Sweetener (g) 
Sucrose Stevia 
Monk 
fruit 
AroniaSucrose 100 20 4 ----- ----- 
AroniaStevia 100 20 ----- 0.4 ----- 
AroniaMonk 100 20 ----- ----- 0.8 
Note: ----- indicates the ingredient was not used in the product. 
AroniaSucrose: aronia kefir sweetened with sucrose; AroniaStevia: aronia kefir 
sweetened with stevia extract; AroniaMonk: aronia kefir sweetened with monk fruit 
extract. 
Table A.3 Elderberry kefir formulas sweetened with different sweeteners 
Group* Elderberry kefir 
Milk 
(g) 
Elderberry juice 
(g) 
Sweetener (g) 
Sucrose Stevia 
Monk 
fruit 
L 
EberrySucrose-L 80 20 3 ----- ----- 
EberryStevia-L 80 20 ----- 0.3 ----- 
EberryMonk-L 80 20 ----- ----- 0.6 
H 
EberrySucrose-H 80 20 4.5 ----- ----- 
EberryStevia-H 80 20 ----- 0.5 ----- 
EberryMonk-H 80 20 ----- ----- 0.9 
Note: ----- indicates the ingredient was not used in the product 
*: Products in each group had a similar level of sweetness. Products in group L were less 
sweet than products in group H. 
EberrySucrose-L: elderberry kefir sweetened with 3% sucrose; EberryStevia-L: elderberry 
kefir with 0.3% stevia extract; EberryMonk-L: elderberry kefir with 0.6% monk fruit 
extract; EberrySucrose-H: elderberry kefir sweetened with 4.5% sucrose; EberryStevia-H: 
elderberry kefir with 0.5% stevia extract; EberryMonk-H: elderberry kefir with 0.9% monk 
fruit extract. 
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3.3 Extraction 
Phenolic compounds were extracted from the berry kefirs following a modified method 
from Scibisz et al. [310]. Briefly, kefir products were extracted with 80% acidified methanol (1% 
citric acid, w/v). The kefir to solvent ratio was 1:10.  The samples were sonicated for one hour 
in a Branson 5510 sonicator (Danbury, CT, USA) and centrifuged at 16639×g (Eppendorf 5804R, 
Hamburg, Germany) for 30 min at 4˚C. The supernatant was collected and the residue was 
extracted two additional times. The supernatant was pooled and dried under a vacuum 
(Eppendorf Vacufuge plus, Hamburg, Germany). The dried extracts were re-suspended using 
100% acidified methanol (citric acid, 1%, w/v) and kept at -20˚C to precipitate proteins. The 
slurry was centrifuged at 0˚C for 30 minutes at 16639×g. The supernatant was vacuum-dried at 
room temperature and re-suspended with 80% acidified methanol (citric acid, 1%, w/v). The 
samples were stored at -20˚ C until analysis. 
3.4 Total Phenolic Content  
 The total phenolic (TP) content in kefir extracts was measured using a modified Folin-
Ciocalteu method reported by Velioglu et al. [311]. The extract (20 µL) and Folin-Ciocalteu 
reagent (90 µL, 1:9 diluted with water) were loaded into a 96-well plate. After 5 min incubation 
at room temperature in the dark, sodium bicarbonate (6 g/100 mL, 90 µL) was added to 
samples. The mixture was incubated for 90 minutes at room temperature in the dark. Gallic 
acid was used to create the standard curve. Absorbance was read at 750 nm using a Biotek 
plate reader (Elx 800, Winooski, VT, USA). The data are presented in gallic acid equivalents 
(GAE), as the average of triplicate measurements of duplicated samples. 
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3.5 Total Monomeric Anthocyanin Content  
 The total monomeric anthocyanin (TMA) levels in the kefir products was measured using 
the pH differential method established by a modified method from Lee et al. [82]. Generally, 
the extract (20 µL) was mixed with either pH 1.0 buffer (0.025 M potassium chloride, 180 µL) or 
pH 4.5 buffer (0.4 M sodium acetate, 180 µL) in 96-well plates. The mixture was incubated at 
room temperature for 20 minutes in the dark. The absorbance (Abs) was read at 515 nm and 
690 nm using a Biotek plate reader (Elx 800, Winooski, VT, USA). The total monomeric 
anthocyanin content was calculated using the following formula and expressed in cyanidin-3-
glucoside (C3G) equivalents. Samples were measured in triplicate. 
𝐴𝑛𝑡ℎ𝑜𝑐𝑦𝑎𝑛𝑖𝑛 (𝑚𝑔 𝐶3𝐺 𝐿⁄ ) =  
𝐴 × 𝑀𝑊 × 𝐷𝐹 × 103
Ɛ × 𝐿
 
Where: A = (Abs515-Abs690) pH 1.0 – (Abs515-Abs690) pH 4.5; 
 MW (molecular weight) = 449.2/mol for cyanidin-3-glucoside; 
DF = dilution factor; 
L = pathlength in cm; 
Ɛ = 26900 L/mol·cm, for cyanidin-3-glucoside; 
103 = factor for conversion from g to mg. 
3.6 Antioxidant capacity 
 The antioxidant capacity of kefir products was evaluated using the 2,2-diphenyl-1-
picrylhydrazyl (DPPH) free radical scavenging capacity method. The method was modified from 
Duymus et al. [312]. Equal amounts (150 µL) of the sample and DPPH methanol solution (0.3 
mM) were loaded into a 96-well plate. The plate was incubated at room temperature in the 
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dark for 30 min. A mixture of 80% acidified methanol (solvent of the extract) and DPPH solution 
was used as the control. The absorbance was read at 515nm. The inhibition rate of the sample 
was calculated using the following formula:  
%𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝐴𝑏𝑠𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑏𝑠𝑐𝑜𝑛𝑡𝑜𝑙
× 100 
 Five dilutions of each sample were measured for DPPH scavenging capacity. The IC50 
values, which is the concentration of the sample required to scavenge 50% of DPPH radicals, 
were calculated and expressed as mg/mL. Measurements were conducted in triplicate. 
3.7 Statistical Analysis 
 Data are shown as mean ± standard deviations. Significant differences among sample 
means were evaluated using one way Analysis of Variance and Tukey’s HSD post hoc tests (p ≤ 
0.05). Pearson correlation coefficient test was conducted to determine the correlation between 
the levels of phenolic compounds and DPPH scavenging capacity. Data were analyzed using SAS 
University Edition (Cary, NC, U.S.). 
4. Results 
4.1 The Impacts of Sucrose on the Levels of Phenolic Compounds, Monomeric Anthocyanins 
and Antioxidant Activity of Aronia Kefir 
The impacts of sucrose concentration on the phenolic compounds including 
anthocyanins were evaluated by comparing the five samples (Aronia-S0.0, Aronia-S1.6, Aronia-
S3.2, Aronia-S4.8 and Aronia-S6.3) that had been stored for the same duration. TP of aronia 
kefir sweetened with different concentrations of sucrose are shown in Figure A.1. Compared to 
Aronia-S0.0 (no added sucrose), the TP levels were higher in the sample with 1.6% added 
149 
 
sucrose on day 0 (95.23 ± 2.02 mg GAE/100 g) and 3.2% sucrose on day 14 (110.57 ± 0.52 mg 
GAE/100 g). On every individual testing day, TP content of Aronia-S4.8 and Aronia-S6.3 were 
lower than Aronia-S0.0.  
 
Figure A.1 Total phenolic compound levels of aronia kefir sweetened with different 
concentrations of sucrose 
Note: Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements). Among 
the samples that were tested on the same day, different letters indicate significant 
differences at p≤0.05. 
TMA in different concentrations of sucrose-sweetened aronia kefir are shown in Figure 
A.2.  All samples contained the highest TMA on day 0. After fermentation (on day 0), only 
aronia kefir sweetened with 6.3% sucrose (Aronia-S6.3) contained less monomeric 
anthocyanins (41.14 ± 0.85 mg C3G/100 g) than Aronia-S0.0 (44.50 ± 1.95 mg C3G/100 g). No 
significant differences of TMA among all samples were detected on day 7. After day 14, 21 or 28 
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of storage, Aronia-S4.8 and Aronia-S6.3 contained less monomeric anthocyanins compared to 
Aronia-S0.0 that had been stored for the same period.  
 
Figure A.2 Total monomeric anthocyanin levels in aronia kefir sweetened with different 
concentrations of sucrose 
Note: Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements). Among 
the samples that were tested on the same day, different letters indicate significant 
differences at p≤0.05. 
The antioxidant capacity of the aronia kefir samples were evaluated and the results are 
shown in Figure A.3. Aronia-S0.0 exhibited either higher or similar antioxidant capacity 
compared to the other samples on every testing day during storage, with the exception of Day 
21. On day 21, Aronia-S1.6 exhibited the strongest scavenging capacity (IC50 was 13.25 ± 0.27 
mg kefir/mL). Overall, the antioxidant capacity of aronia kefir samples sweetened with different 
concentrations of sucrose were slightly decreased during 28 days of storage. 
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Figure A.3 DPPH IC50 values of aronia kefir sweetened with different concentrations of sucrose 
Note: Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements). Among 
the samples that were tested on the same day, different letters indicate significant 
differences at p≤0.05. 
4.2 The Impacts of Different Sweeteners on the Levels of Total Phenolic Compounds, 
Monomeric Anthocyanins and Antioxidant Capacity in Aronia Kefir 
  TP content of aronia kefirs are shown in Figure A.4.  The impact of sweetener type 
(sucrose, stevia and monk fruit) on TP levels were evaluated by comparing the three aronia 
kefirs stored for the same time period (day). Compared to AroniaSucrose, AroniaMonk 
contained more TP on each testing day except for day 0. On day 0, the TP content of 
AroniaSucrose and AroniaMonk was the same. Compared to AroniaSucrose, AroniaStevia had 
an equal amount of TP on day 0, higher levels on day 7, 14 and 21, and then a lower level on 
day 28.  
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The effects of storage time on the TP content of samples assessed. TP levels of 
AroniaSucrose decreased on day 14, and then increased on day 28. TP levels of AroniaMonk 
decreased on day 14 and gradually increased on days 21 and 28. A decreases of the TP in the 
AroniaStevia sample was observed after 14 days of storage, and the TP content of AroniaStevia 
increased on day 21. After twenty-eight days of storage, the TP levels of AroniaSucrose and 
AroniaMonk were almost the same as their corresponding values on day 0. The AroniaStevia 
sample had a lower amount of TP on day 28 compared to day 0.  
 
Figure A.4 Total phenolic compound levels of aronia kefir sweetened with sucrose, stevia 
extract and monk fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
3. Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time.  
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The TMA content of aronia kefir is shown in Figure A.5. The impacts of sweetener types 
were evaluated by comparing the three products tested on the same day. On each testing day, 
AroniaMonk contained higher levels of TMA than AroniaSucrose. AroniaStevia also had slightly 
higher levels TMA than AroniaSucrose on day 0 (31.53 ± 0.18 and 29.94 ± 0.76 mg C3G/100 g, 
respectively) and day 28 (13.67 ± 0.36 and 11.50 ± 0.11 mg C3G/100 g, respectively). The TMA 
levels of AroniaStevia and AroniaSucrose were similar on all other testing days.  
The TMA content of all aronia kefirs dramatically decreased after seven days of storage. 
TMA levels of AroniaMonk declined until day 21 and slightly increased during the last week of 
storage. The amount of TMA in AroniaStevia decreased until Day 14, remained the same on day 
21 and slightly increased on day 28. The level of TMA in AroniaSucrose maintained the same 
from day 14 to the end of the storage study.  
The antioxidant capacity levels of the aronia kefirs are shown in Figure A.6. Comparisons 
among products stored for the same time period were conducted to evaluate the impacts of 
the sweeteners. On days 0, 7 and 14, the antioxidant activity of AroniaMonk (IC50s were 16.31 ± 
0.47, 15.59 ± 0.16, 16.54 ± 0.34 mg kefir/mL) was higher than AroniaSucrose (IC50s were 17.86 ± 
0.47, 16.97 ± 0.10, 16.95 ± 0.57 mg kefir/mL). However, the antioxidant capacity of AroniaMonk 
(IC50s were 19.87 ± 0.33 and 20.07 ± 0.32 mg kefir/mL) was lower than AroniaSucrose (IC50s 
were 18.09 ± 0.36 and 19.42 ± 0.21 mg kefir/mL) on Day 21 and 28. AroniaStevia exhibited 
similar antioxidant capacity as AroniaSucrose on most testing days except for day 21 where the 
antioxidant capacity of AroniaStevia (IC50 was 19.02 ± 0.28 mg kefir/mL) was lower than 
AroniaSucrose (IC50 was 18.09 ± 0.36 mg kefir/mL). The antioxidant capacity of all aronia kefir 
154 
 
samples were maintained over 14 days of storage but slightly decreased on either day 21 or day 
28. Decreases in antioxidant capacity of AroniaMonk and AroniaStevia were observed on day 
21. The antioxidant activity of AroniaSucrose decreased on day 28. 
 
Figure A.5 Total monomeric anthocyanin levels of aronia kefir sweetened with sucrose, stevia 
extract and monk fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
3. Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time.  
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Figure A.6 DPPH IC50 means of aronia kefir sweetened with sucrose, stevia extract and monk 
fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
3. Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time.  
4.3 The Impacts of Different Sweeteners on the Levels of Total Phenolic Compounds, 
Anthocyanins and Antioxidant Capacity of Elderberry Kefir 
  The TP contents of elderberry kefir samples are shown in Figure A.7. Comparisons were 
conducted among the products with a comparable level of sweetness.  The impacts of 
sweetener type were evaluated by comparing the different products over storage time. In 
group L (products with a low level of sweetness), EberryMonk-L higher TP levels than 
EberrySucrose-L on days 0, 14 and 28. Compared to EberrySucrose-L, EberryStevia-L had a 
0.00
5.00
10.00
15.00
20.00
25.00
day 0 day 7 day 14 day 21 day 28
D
P
P
H
 IC
5
0
(m
g 
K
ef
ir
/m
L)
AroniaSucrose (3.0%) AroniaStevia (0.3%) AroniaMonk (0.6%)
ab,C 
a,BC 
ab,B b,BC 
a,B a,C 
b,C
 
b,A
 
a,A
 c,B
 
a,A
 
b,A
 
b,A  
a,BC
 
b,B
 
156 
 
higher TP content on day 14 but a less amount on day 21. No significant differences of TP levels 
were noted between EberryStevia-L and EberrySucrose-L on other testing days. In group H 
(products with a high level of sweetness), the EberryMonk-H and EberryStevia-H samples 
contained higher TP content than EberrySucrose-H on day 0.  There was no significant 
difference in TP content among EberrySucrose-H, EberryStevia-H and EberryMonk-H on day 7, 
14 and 21.  
The TP levels of elderberry kefirs appeared to decrease over storage time for samples 
with both high and low sweetness levels. In group L, TP content of EberrySucrose-L decreased 
after one week of storage and maintained the same level until day 21 and then decreased 
again. The TP levels of EberryStevia-L and EberryMonk-L fluctuated during the first 21 days of 
storage. The lowest amount of TP for all elderberry kefir samples was observed on day 28.  In 
group H, TP levels of EberryStevia-H decreased over storage time. The TP content of 
EberrySucrose-H and EberryMonk-H slightly fluctuated during storage time. After 28 days, all 
elderberry kefirs in group H contained less TP levels than day 0. 
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Figure A.7 Total phenolic compound levels of elderberry kefir sweetened with sucrose, stevia 
extract and monk fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Graph I: Results of elderberry kefir with a low level of sweetness; 
Graph II: Results of elderberry kefir with a high level of sweetness. 
3. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time. 
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The TMA content of elderberry kefir samples is shown in Figure A.8. In group L, 
EberryMonk-L sample contained higher TMA content than EberrySucrose-L samples on days 7, 
14, 21 and 28. EberryStevia-L levels were also higher than EberrySucrose-L on day 7, 14 and 28. 
In Group H, EberryMonk-H sample contained higher TMA content than EberrySucrose-H on 
days 0, 21 and 28. No significant differences among all samples were observed on day 7. 
EberryStevia-H and EberrySucrose-H contained similar amounts of TAM content on days 0, 7, 14 
and 21. On Day 28, EberryStevia-H had higher TAM content than EberrySucrose-H. 
The TMA content of elderberry kefir samples for both sweetness level groups increased 
over time. Over storage time, the highest TMA amount for each elderberry kefir treatment was 
observed on day 28. After twenty-eight days of storage, the amount of TMA in EberrySucrose-L, 
EberryStevia-L, EberryMonk-L, EberrySucrose-H, EberryStevia-H, EberryMonk-H increased by 
32.6%, 36.2%, 46.4%, 32.3%, 43.8% and 35.6% compared to their corresponding values on day 
0, respectively. 
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Figure A.8 Total monomeric anthocyanin content of elderberry kefir sweetened with sucrose, 
stevia extract and monk fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Graph I: Results of elderberry kefir with a low level of sweetness; 
Graph II: Results of elderberry kefir with a high level of sweetness. 
3. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time. 
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Figure A.9 DPPH IC50 means of elderberry kefir sweetened with sucrose, stevia extract and 
monk fruit extracts 
Note: 1. Data are shown as mean ± standard deviation, n=2 (batches) x 3 (measurements).  
2. Graph I: Results of elderberry kefir with a low level of sweetness; 
Graph II: Results of elderberry kefir with a high level of sweetness. 
3. Lowercase letters indicate significant differences (p ≤ 0.05) among the three samples 
that were tested on the same day; 
Capital letters indicate significant differences (p ≤ 0.05) of the same sample over 
storage time. 
0
5
10
15
20
25
30
35
40
Day 0 Day 7 Day 14 Day 21 Day 28
Low level of sweetness
D
P
P
H
 IC
5
0
(m
g 
ke
fi
r/
m
L)
EberrySucrose-L EberryStevia-L EberryMonk-L
a,C a,E 
a,C a,C ab,D b,C 
a,B a,C b,C 
a,B 
b,A c,B 
a,A b,A 
c,A 
I 
0
5
10
15
20
25
30
35
Day 0 Day 7 Day 14 Day 21 Day 28
High level of sweetness
D
P
P
H
 IC
5
0
 (m
g 
ke
fi
r/
m
L)
EberrySucrose-H EberryStevia-H EberryMonk-H
a,C a,C 
b,D 
a,C 
b,D b,C 
a,B a,B 
b,B 
a,A a,A 
b,B 
b,A 
a,A 
c,A 
II 
161 
 
 
 The antioxidant activity levels of elderberry kefir samples are shown in Figure A.9. In 
group L, no significant differences in antioxidant capacity were detected among kefir samples 
on day 0. EberryMonk-L exhibited a higher antioxidant capacity than EberrySucrose-L on days 
14 and 21 but a lower antioxidant capacity on days 7 and 28. The antioxidant capacity of 
EberryStevia-L was similar with EberrySucrose-L samples on day 0, 7 and 14 but lower than 
EberrySucrose-L on day 21 and 28. In group H, the antioxidant capacity of EberryMonk-H 
sample was higher than EberrySucrose-H on days 0 and 21 but lower on all other testing days. 
Compared to EberrySucrose-H, EberryStevia-H exhibited a lower antioxidant capacity on days 
14 and 28 but no significant difference on days 0, 7 and 21. 
 After twenty-eight days of storage, the antioxidant capacity of elderberry kefir samples 
decreased over storage time. The decreases in antioxidant capacity of EberrySucrose-L, 
EberryStevia-L, EberryMonk-L occured on day 14, day 7 and day 21, respectively. The 
antioxidant capacity of EberrySucrose-H, EberryStevia-H and EberryMonk-H reduced on day 14, 
day 14 and day 7, respectively.  
5. Discussion 
5.1 Impacts of Sucrose 
In our study, aronia kefir samples with 4.8% and 6.3% added-sucrose contained less TP 
and TMA levels than aronia kefir without added-sucrose on each testing day. The addition of 
sucrose did not appear to protect the TP or TMA levels during storage. To our knowledge, this is 
the first study to investigate the impacts of sucrose concentration on polyphenols in a 
fermented dairy matrix. The aronia phenolic compounds in our study were exposed to various 
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fermentative microorganisms, such as lactic bacteria and yeasts in kefir. Some fermentative 
microorganisms may have the ability to alter the amount of phenolic compounds by releasing 
the bound phenolic compounds and/or metabolizing them [173, 363]. The ability of yeast 
(Kluyveromyces marxianus) isolated from kefir to increase the antioxidant capacity of grape 
polyphenols synergistically has been observed in other research studies [364]. In addition, 
researchers noted that the presence of added-sucrose (1%) altered the growth pattern of both 
lactic acid bacteria and yeast in soymilk kefir compared to samples without sucrose [365]. Thus, 
the concentration of sucrose may influence TP and TMA levels by altering the capacity of 
microorganisms to metabolize phenolic compounds. The protective impacts of sucrose on 
phenolic compounds in fruit juice have been documented by several studies [366-368]. These 
protective impacts may be related to a decrease in water activity [367, 369]. In our study, the 
addition of 6.3% sucrose may not be sufficient to substantially affect water activity levels of the 
kefir sample to a critical point that would be beneficial to the stabilize polyphenols over storage 
time.  
The antioxidant capacity of aronia kefir is contributed by the phenolic compounds. 
However, in this study, the correlation analyses did not show a significant relationship between 
TP and the DPPH radical scavenging activity. These results indicate that in addition to changes 
of TP levels, there were other alterations that may have affected the antioxidant capacity of 
aronia kefir samples, such as changes in polyphenol composition. The changes in phenolic 
composition may lead to altered antioxidant capacity levels because the antioxidant capacity of 
individual phenolic compound differs [370]. Fermentation may have affected the composition 
of polyphenols in our study. Aronia kefir was stored at 4˚C, at which temperature the 
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fermentation process might be slowed but not stopped because the ˚brix values of sucrose-
added aronia kefir decreased over storage (data not shown). The addition of sucrose at 
different concentrations may lead to varied activities of microorganisms during storage and 
influence the profile of the fermentative metabolites. Wang et al. reported that fermentation 
with yeasts (Saccharomyces cerevisiae bayanus EC 118) decreased the amount of total 
polyphenols but increased the level of gallic acid and the antioxidant capacity of maqui berry 
juice [177]. Jimenez-Lopez et al. demonstrated that fermentation decreased the concentration 
of epicatechin, increased the amount of total phenolic compounds and resulted in slightly 
enhanced antioxidant capacity in caper berries [371]. In summary, the impacts of sucrose on 
the antioxidant capacity of aronia kefir during storage may be achieved by altering the 
metabolism activity of microorganisms in addition to the changes of phenolic levels. More 
research is needed to verify this assumption.  
5.2 Effects of Non-nutritive Sweeteners 
In our study, monk fruit-sweetened aronia kefir contained more TP and TMA compared 
to sucrose-sweetened kefir samples at the lower sweetness levels. However, among the 
elderberry kefirs in group H, the levels of TP and TMA between monk fruit- and sucrose-
sweetened samples fluctuated at different testing points. Based on our results, no clear 
apparent trend occurred between antioxidant capacities of monk fruit and sucrose-sweetened 
berry kefirs. These results indicate that monk fruit extract may be a preferred sweetener to use 
than sucrose for aronia kefirs and elderberry kefirs with a low level of sweetness to produce 
products with higher levels of TP and TMA. Our results are similar to a study conducted by 
Nowicka and Wojdylo [372]. They demonstrated that after six months storage at 4˚C, sour 
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cherry puree with the addition of 1% monk fruit (referred as “Luo Han Kuo”), had higher TP and 
TMA levels compared to the sample with 7% added sucrose [372]. To our knowledge, this 
research is the only study involving monk fruit extract on the stability of phenolic compounds to 
date. However, the food matrix and the amount of sweeteners used in our study was different 
from the referenced study. In addition to the direct interactions between sweeteners and 
polyphenols, the impacts of sweeteners on the microorganisms may also contribute to our 
results. There has been no published study about the impacts of monk fruit on fermentation.  
Compared to sucrose, the addition of stevia appeared to be beneficial to maintain TMA 
levels but decreased the antioxidant capacity of berry kefirs over time. However, the results did 
not show a clear trend of the TP content among stevia- and sucrose-sweetened aronia kefir and 
elderberry kefir in group L. Some of our findings are in agreement with a former study 
conducted by Skapska et al., where  the replacement of sucrose with stevia extract reduced the 
antioxidant capacity of an aronia-herbal beverage [373]. However, Wozniak et al. demonstrated 
that in the absence of microorganisms, sucrose exhibited protective effects on anthocyanins 
but steviol glycosides (the sweet compounds in stevia extract) did not, which was different than 
our findings [374]. One factor that may influence the impact of sweeteners on TMA levels in our 
study is the presence of fermentative microorganisms. Both sucrose and stevia are carbon 
sources for lactic acid bacteria [375]. The addition of sucrose or stevia may alter the 
fermentation activity of microorganisms in kefir and then influence their pattern to interact 
with polyphenols. One other factor that may result in this difference is the type of 
anthocyanins. In the referenced study, purified cyanidin-3-glucoside and pelargonidin-3-
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glucoside were used. In our study, both aronia and elderberries contain various types of 
anthocyanins.  
Twenty-eight days of storage at 4˚C decreased the TP levels in most berry kefirs and 
reduced the antioxidant capacity of all berry kefirs. The decreases may be caused by the natural 
and microbial degradation of phenolic compounds. In a study conducted by Muniandy et al., 
decreases of TP levels in tea extract-enriched yogurt was observed during 21 days of storage. 
However, the DPPH scavenging capacity of tea extract-added yogurt was not altered [376]. The 
different results may be due to the different fermentation culture and polyphenol sources used 
in our study versus the referenced study. 
 During storage, the TMA content of the aronia kefirs decreased but the TMA levels in 
the elderberry kefirs increased over time. The decreases in aronia kefir are associated with the 
degradation of monomeric anthocyanins over time. Reque et al. also observed that 10 days of 
storage at 4˚C decreased the anthocyanin content in blueberry juice by 83% [74]. The increases 
of TMA content in elderberry kefir may be related to the microbial activity in the kefir. Some 
microorganisms can produce enzymes that can catalyze the hydrolysis of proanthocyanins, such 
as tannase [377, 378]. The hydrolysis of proanthocyanins can yield monomeric anthocyanins. 
The proanthocyanin compositions of aronia and elderberries are different [198], and this may 
be a reason for the different trends of TMA changes in aronia versus elderberry kefirs. The 
majority of the proanthocyanins in aronia are polymers with more than ten degrees of 
polymerization. In elderberries, the polymerization degrees of the predominant 
proanthocyanins are lower than seven. More studies are needed to test this assumption.   
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6. Conclusion 
 The impacts of sweeteners (sucrose, stevia and monk fruit) on the levels of TP, TMA and 
antioxidant capacity of berry-added kefir were tested during 28 days of storage at 4˚C. Results 
showed that compared to Aronia kefir without sucrose, the addition of sucrose at 4.8% and 
6.3% decreased the contents of TP and TMA. Compared to sucrose, monk fruit extract may be a 
preferred sweetener for aronia kefirs and elderberry kefirs with a low level of sweetness for 
protecting the levels of TP and TMA. Berry kefirs sweetened with stevia contained more TMA 
than the samples sweetened with sucrose, but the free radical scavenging capacity showed an 
opposite trend.  
Twenty-eight days of storage at 4˚C decreased the antioxidant capacity of all berry 
kefirs. Decreases of TP were observed during storage, but with fluctuations. The TMA content in 
aronia kefir decreased over time, but the content in elderberry kefir increased. The different 
trends may be related to the distinct polyphenol compositions of aronia and elderberries. In 
addition, it may be associated with the activity of microorganisms in kefir. More studies are 
needed to understand the influences of microorganisms on polyphenols during storage. 
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APPENDIX B: APPLICATION FOR APPROVAL OF RESEARCH WITH HUMAN SUBJECTS 
1. Summary of the proposal 
Chronic diseases have become a global issue causing many health issues with increased 
morbidity and mortality. A healthy diet is critical to the prevention of many chronic diseases 
such as type 2 diabetes and cancer. The functional properties of food and the bioactive 
compounds they contain are current research interests to increase health benefit. 
Fermented products such as kefir and berries that contain phytonutrients are two attractive 
topics in this area. 
Fermented milk products have a good reputation in maintaining gut health due to their 
microorganisms that influence the fermentation process and make them a rich source of 
probiotics. Probiotics are also linked to healthy metabolic effects such as reducing blood 
cholesterol, boosting the immune system, preventing cancer, and attenuating lactose 
intolerance symptoms [1]. Kefir, a fermented dairy product, has been proven to have similar 
impacts on human health similar to other fermented dairy products such as yogurt. In 
addition, due to the composition of several different microorganisms in kefir, it is naturally 
free of lactose, which is very important. As reported, lactose intolerance is a popular 
disorder that influences approximately 75% of the world’s adults [2]. Considering there is no 
lactose in kefir, it would be a good source of protein and calcium for the lactose intolerance 
population. 
Berries are rich in phenolic compounds, especially anthocyanins which make them an 
attractive resource for health related research. Anthocyanins are secondary plant 
metabolites that are proven to have high antioxidant capacity [3]. The health benefits of 
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anthocyanins, especially their antioxidant effects which are related to their role in lowering 
the risk of several chronic diseases, have been reported by many articles [4]. 
Aronia and elderberries are under-utilized berries, reported to have high anthocyanin 
content [5, 6]. Due to the astringent mouth feel caused by the high phenolic content, they 
are considered unpleasant to consumers. The use of these berries in a dairy matrix may 
minimize this flavor, and the acidic environment of fermented dairy could stabilize the 
phenolic compounds in berries. The aim of this study is to develop new desirable products 
that incorporate elderberry and aronia into kefir. The consumption of this berry product 
might help to decrease the prevalence of chronic diseases by boosting the public’s intake of 
antioxidant compounds, especially anthocyanins. 
New products will be made with low fat milk (2%) and a commercial-available kefir 
starter mix (Yogourmet™), either aronia or elderberry will be added to the product. Each 
product will be sweetened by natural sweeteners (monk fruit or stevia extract) or table 
sugar. One concentration of each sweetener will be applied to aronia products, while two 
different concentrations will be used in elderberry products. Overall, three products will be 
developed using aronia berry and six p tests will be carried out in the Consumer Testing 
Center in University of Maine in four days, two days for aronia products and another two 
days for elderberry products. During each test, three or six samples (about one ounce each) 
marked with three randomized digit numbers will be served to every participant. Flyers, 
Consent form, and Questionnaires are presented in Appendices A to F. 
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2. Personnel 
Principal Investigator: Xue Du, MS. 
Xue Du is a PhD student in the School of Food and Agriculture in University of Maine, 
majoring in Food Science and Nutrition. She will be in charge of participant 
recruitment, sample preparation, conduction of sensory evaluation, and data 
analysis. CITI training is current. 
Mentor (Faculty Sponsor): Angela Myracle, MPH, PhD. 
Dr. Myracle is an Assistant Professor in the School of Food and Agriculture in 
University of Maine. She obtained her PhD in Human Nutrition, Purdue University. 
She has 25 years of experience in biochemical analysis, epidemiological studies, and 
sensory evaluation. She is the major supervisor of this project and will oversee the 
entire project. CITI training is current. 
Research Associates:   
Mary Ellen Camire, PhD. 
Dr. Camire is a Professor of the School of Food and Agriculture, University of Maine. 
She has more than 20 years’ sensory evaluation experience, and presently teaches 
the graduate course: Sensory Evaluation. CITI training is current. 
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Katherine Davis-Dentici. 
Ms Davis-Dentici is an employee in University of Maine since 1993, and she has rich 
experience with sensory evaluation and product development. She will help through 
the entire project. CITI training is current. 
Students: Some students in the School of Food and Agriculture might help with this project, 
and all of them will complete CITI training before assisting the project. 
3. Participant recruitment 
100 participants who aged 18 or older will be recruited for each sensory evaluation test 
(elderberry or aronia products tasting) via flyers, Facebook, and FirstClass notices (attached 
as Appendix C and D); both male and female will be recruited. Consumers who are allergic to 
any ingredient of the products, such as milk and elderberry / aronia, will be excluded. The 
number of subjects for the study is chosen according to Gacula and Rutenbeck [7], to allow 
enough power to obtain statistically significant results. 
4. Informed consent 
Subjects will be asked to read the printed informed consent form (as presented in 
Appendices E and F), which will be written at an 8th reading level, before participation. 
Participation in the study will be assumed to indicate consent. 
5. Confidentiality 
Subjects will login on the SIMS program in the Consumer Testing Center of University of 
Maine; data will be collected anonymously and only available to the study investigators. 
Password protected data file will be saved in the computers that are kept in a locked room. 
171 
 
Data will be deleted once the analysis is completed and the resulting article has been 
accepted; data will not be kept for more than one year after the completion of the study, 
which is December 20th, 2016. 
6. Risks to participants 
Potential food allergens will be announced to the subjects in the recruitment notices 
and informed consent forms.  
Subjects will risk losing personal time. Even though each test should take no more than 
30 minutes, unfamiliarity of the SIMS computer program may lead to longer testing time. 
Assistance will be provided during the test to minimize the time. 
In general, the risks involved are minimal, and should be no greater than daily eating. 
7. Benefits 
 Participants will have the opportunity to taste new products and may like them. 
 Developing new products in this project may help the elderberry and aronia farmers to 
utilize the berries. In addition, new products will contribute to the varieties of diary food 
products, and may also boost the consumption of polyphenols, which is a health-beneficial 
phytochemical that has been related to lower the risk of chronic disease. 
 Risk of this project will be no more than associated with normal eating, so the benefits 
are expected to outweigh the risk. 
8. Compensation 
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 Participants who complete the whole evaluation process will receive $2 as 
compensation. 
References 
1. Guzel-Seydim ZB, Kok-Tas T, Greene AK, Seydim AC. Review: Functional Properties of Kefir. 
Crit. Rev. Food Sci. Nutr. 2011;51:261-8. 
 
2. Hertzler S, Clancy S. Kefir improves lactose digestion and tolerance in adults with lactose 
maldigestion. J. Am. Diet. Assoc. 2003;103:582-7.  
 
3. Martin Bueno J, Saez-Plaza P, Ramos-Escudero F, Maria Jimenez A, Fett R, Asuero AG. 
Analysis and Antioxidant Capacity of Anthocyanin Pigments. Part II: Chemical Structure, 
Color, and Intake of Anthocyanins. Crit. Rev. Anal. Chem. 2012;42:126-51. 
 
4. Galvano F, La Fauci L, Lazzarino G, Fogliano V, Ritieni A, Ciappellano S, Battistini N, Tavazzi B, 
Galvano G. Cyanidins: metabolism and biological properties. J. Nutr. Biochem. 2004;15:2-11.  
 
5. Wangensteen H, Braunlich M, Nikolic V, Malterud KE, Slimestad R, Barsett H. Anthocyanins, 
proanthocyanidins and total phenolics in four cultivars of aronia: Antioxidant and enzyme 
inhibitory effects. Journal of Functional Foods. 2014;7:746-52. 
 
6. Mikulic-Petkovsek M, Schmitzer V, Slatnar A, Todorovic B, Veberic R, Stampar F, Ivancic A. 
Investigation of Anthocyanin Profile of Four Elderberry Species and Interspecific Hybrids. J. 
Agric. Food Chem. 2014;62:5573-80. 
 
7. Gacula JR. M, and Rutenbeck S. 2006. Sample size in consumer test and descriptive analysis. 
Journal of Sensory Studies 21: 129-145. 
 
 
 
 
 
 
 
173 
 
APPENDIX C: ELDERBERRY KEFIR TASTING RECRUITMENT NOTICE 
Would you like to taste kefir, a fermented milk beverage?  New kefir products are 
developed and volunteers are needed to provide their opinions; if you are aged 18 or older, and 
have about 20 minutes spare time, please come and help the researchers! 
Testing session will be held in the Consumer Testing Center, Hitchner Hall 158. The date 
will be announced. Scheduling a time by calling (207)889-7117 or e-mailing xue.du@maine.edu 
will be preferred; however, volunteers are welcome to show up at any time. 
Volunteers will receive $2 for participating in the study; however, if you are allergic to 
milk, elderberry, sugar, monk fruit or stevia, please do not participate.  
 
Contacts: Xue Du (Magic): (207)889-7117 or e-mail xue.du@maine.edu;  
 Dr. Angela Myracle at (207)581-1617 or angela.myracle@maine.edu. 
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APPENDIX D: ARONIA KEFIR TASTING RECRUITMENT NOTICE 
Would you like to eat kefir, a fermented milk beverage? New kefir products are 
developed and volunteers are needed to provide their opinions; if you are aged 18 or older, and 
have about 20 minutes spare time, please come and help the researchers! 
Testing session will be held in the Consumer Testing Center, Hitchner Hall 158. The date 
will be announced. Scheduling a time by calling (207)889-7117 or e-mailing xue.du@maine.edu 
will be preferred; however, volunteers are welcome to show up at any time. 
Volunteers will receive $2 for participating in the study; however, if you are allergic to 
milk, aronia berry (chockberry), sugar, monk fruit or stevia, please do not participate. 
 
Contacts: Xue Du (Magic): (207)889-7117 or e-mail xue.du@maine.edu;  
Dr. Angela Myracle at (207)581-1617 or angela.myracle@maine.edu. 
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APPENDIX E: ELDERBERRY KEFIR INFORMED CONSENT FORM 
Dear Consumer, 
You are invited to participate in a research study being carried out by Xue Du, a PhD 
student under the supervision of Dr. Angela Myracle, Assistant Professor of Human Nutrition 
from the School of Food and Agriculture at the University of Maine. The purpose of this study is 
to determine whether new kefir products with underutilized berries (elderberries) and different 
sweeteners are well accepted by consumers. 
If you know that you are allergic or sensitive to milk, elderberry, sugar or stevia, please 
do not participate; and you must be at least 18 years of age to participate. 
 
What Will You Be Asked to Do? 
If you decide to participate in this study, you will be asked to answer a list of questions 
about yourself. The questions will include your age, gender, and your familiarity of elderberry 
and kefir. You will be given 6 different samples to taste and evaluate. The test might take 20 
minutes. 
Risks 
The risks of participating in this study should be minimal and no greater than normal 
daily eating. 
Benefits  
You will taste new products and may like them. Also, this research may help the 
elderberry farmers and industries to develop new products and increase food varieties. In 
addition, this research may increase the fruit intake of consumers. 
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Compensation 
After completing all the questions listed, you will receive $2. No compensation will be 
offered if the questions are not completed. 
Confidentiality 
The data will be collected anonymously, and your name will not be shown in any 
document. Data will be kept on pass-word protected computers in a locked room. All data will 
be destroyed no later than 12 months after this study is completed (December 20th, 2016). 
Voluntary 
Participation is voluntary. You may choose to not participate at the beginning or stop at 
any time during the study. Compensation will be provided only if you complete the tasting and 
the questions. 
Contact Information 
If you have any questions about this study, please contact Xue Du at (207)889-7117 or 
xue.du@maine.edu; or Dr. Angela Myracle at (207)581-1617 or angela.myracle@maine.edu. If 
you have any questions about your rights as a research participant, please contact Gayle Jones, 
Assistant to the University of Maine’s Protection of Human Subjects Review Board, at 581-1498 
(or e-mail gayle.jones@umit.maine.edu).   
 
Your participation in the study indicates that you have read and understand the above 
information and agree to participate in the study. 
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APPENDIX F: ARONIA KEFIR INFORMED CONSENT FORM 
Dear Consumer, 
You are invited to participate in a research study being carried out by Xue Du, a PhD 
student under the supervision of Dr. Angela Myracle, Assistant Professor of Human Nutrition 
from the School of Food and Agriculture at the University of Maine. The purpose of this study is 
to determine whether new kefir products with underutilized berries (aronia berries) and 
different sweeteners are well accepted by consumers. 
If you know that you are allergic or sensitive to milk, aronia berry, sugar, monk fruit or 
stevia, please do not participate; and you must be at least 18 years of age to participate. 
 
What Will You Be Asked to Do? 
If you decide to participate in this study, you will be asked to answer a list of questions 
about yourself. The questions will include your age, gender, and your familiarity of aronia 
(chockberry) and kefir. You will be given 3 different samples to taste and evaluate. The test 
might take 20 minutes. 
Risks 
The risks of participating in this study should be minimal and no greater than normal 
daily eating. 
Benefits 
You will taste new products and may like them. Also, this research may help the aronia 
farmers and industries to develop new products and increase food varieties. In addition, this 
research may increase the fruit intake of consumers. 
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Compensation 
After completing all the questions listed, you will receive $2. No compensation will be 
offered if the questions are not completed. 
Confidentiality 
The data will be collected anonymously, and your name will not be shown in any 
document. Data will be kept on a pass-word protected computer in a locked room. All data will 
be destroyed no later than 12 months after this study is completed (December 20th, 2016). 
Voluntary 
Participation is voluntary. You may choose to not participate at the beginning or stop at 
any time during the study. Compensation will be provided only if you complete the tasting and 
the questions. 
Contact Information 
If you have any questions about this study, please contact Xue Du at (207)889-7117 or 
xue.du@maine.edu; or Dr. Angela Myracle at (207)581-1617 or angela.myracle@maine.edu. If 
you have any questions about your rights as a research participant, please contact Gayle Jones, 
Assistant to the University of Maine’s Protection of Human Subjects Review Board, at 581-1498 
(or e-mail gayle.jones@umit.maine.edu).   
 
Your participation in the study indicates that you have read and understand the above 
information and agree to participate in the study. 
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APPENDIX G: SENSORY EVALUATION QUESTIONNAIRE OF ELDERBERRY KEFIR  
Attribute 1: Instruction 
Thank you for agreeing to participate in our research. Please click the bottom button on 
the screen to start the evaluation, and evaluate the samples following the order shown on the 
screen and verify that each 3-digit code matches the sample that you taste. Please choose the 
answers that best describe your attitude towards the product. Please take a sip of water 
between tasting samples. 
Attribute 2: check all that apply 
Please indicate your gender: 
 Male 
 Female 
 Would prefer not to say 
Attribute 3: check one 
Please indicate your age range: 
 18-24 
 25-34 
 35-44 
 45-54 
 55-65 
 Over 65 
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Attribute 4: yes or no 
Have you ever consumed kefir? 
 Yes 
 No 
 I don’t know what kefir is 
Attribute 5: check one 
How familiar are you with elderberries? 
 Never heard of 
 Somewhat unfamiliar 
 Somewhat familiar 
 Very familiar 
Attribute 6: check one 
How important is it to you to consider the health benefits of food before purchasing? 
 Not important 
 Slightly important 
 Neutral 
 Moderately important 
 Extremely important 
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Attribute 7: hedonic scale 
How much do you like the color of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 8: hedonic scale 
How much do you like the flavor of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 9: hedonic scale 
How much do you like the sweetness of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 10: hedonic scale 
How much do you like the texture of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
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Attribute 11: hedonic scale 
How do you rate the overall acceptability of this product? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 12: comment 
If you want to refer to any product you have tasted, please use the three-digit code of 
the product. 
 
Thank you for your time. 
Please lift the window up to let the staff know that you are finished.  
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APPENDIX H: SENSORY EVALUATION QUESTIONNAIRE OF ARONIA KEFIR 
Attribute 1: Instruction 
Thank you for agreeing to participate in our research. Please click the bottom button on 
the screen to start the evaluation, and evaluate the samples following the order shown on the 
screen and verify that each 3-digit code matches the sample you taste. Please choose the 
answers that best describe your attitude towards the product. Please take a sip of water 
between tasting samples. 
Attribute 2: check all that apply 
Please indicate your gender: 
 Male 
 Female 
 Would prefer not to say 
Attribute 3: check one 
Please indicate your age range: 
 18-24 
 25-34 
 35-44 
 45-54 
 55-65 
 Over 65 
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Attribute 4: yes or no 
Have you ever consumed kefir? 
 Yes 
 No 
 I don’t know what kefir is 
Attribute 5: check one 
How familiar are you with aronia berries (Chokeberries)? 
 Never heard of 
 Somewhat unfamiliar 
 Somewhat familiar 
 Very familiar 
Attribute 6: check one 
How important is it to you to consider the health benefits of food before purchasing? 
 Not important 
 Slightly important 
 Neutral 
 Moderately important 
 Extremely important 
 
 
 
185 
 
Attribute 7: hedonic scale 
How much do you like the color of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 8: hedonic scale 
How much do you like the flavor of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 9: hedonic scale 
How much do you like the sweetness of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 10: hedonic scale 
How much do you like the astringency (dry, shrinking mouth-feel of dry wine, tea, or coffee) of 
this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
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Attribute 11: hedonic scale 
How much do you like the texture of this sample? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 12: hedonic scale 
How do you rate the overall acceptability of this product? 
1 2 3 4 5 6 7 8 9 
Dislike 
extremely 
Dislike 
very much 
Dislike 
moderately 
Dislike 
slightly 
Neither like 
nor dislike  
Like 
slightly  
Like 
moderately  
Like very 
much 
Like 
extremely 
 
Attribute 13: comment 
If you want to refer to any product you have tasted, please use the three-digit code of the 
product. 
 
Thank you for your time. 
 Please lift the window up to let the staff know that you are finished. 
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